
<html lang="en"     class="pb-page"  data-request-id="34da74a1-c430-4b79-92c7-c85a42aa9a66"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b00799;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-15;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease" /></meta><meta name="dc.Creator" content="Augustin  Amour" /></meta><meta name="dc.Creator" content="Nick  Barton" /></meta><meta name="dc.Creator" content="Anthony W. J.  Cooper" /></meta><meta name="dc.Creator" content="Graham  Inglis" /></meta><meta name="dc.Creator" content="Craig  Jamieson" /></meta><meta name="dc.Creator" content="Christopher N.  Luscombe" /></meta><meta name="dc.Creator" content="Josie  Morrell" /></meta><meta name="dc.Creator" content="Simon  Peace" /></meta><meta name="dc.Creator" content="David  Perez" /></meta><meta name="dc.Creator" content="Paul  Rowland" /></meta><meta name="dc.Creator" content="Chris  Tame" /></meta><meta name="dc.Creator" content="Sorif  Uddin" /></meta><meta name="dc.Creator" content="Giovanni  Vitulli" /></meta><meta name="dc.Creator" content="Natalie  Wellaway" /></meta><meta name="dc.Description" content="A four-step process of high-quality modeling of existing data, deconstruction, identification of replacement cores, and an innovative synthetic regrowth strategy led to the rapid discovery of a nov..." /></meta><meta name="Description" content="A four-step process of high-quality modeling of existing data, deconstruction, identification of replacement cores, and an innovative synthetic regrowth strategy led to the rapid discovery of a nov..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 27, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00799" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00799" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00799" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00799" /></link>
        
    
    

<title>Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00799" /></meta><meta property="og:title" content="Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0018.jpeg" /></meta><meta property="og:description" content="A four-step process of high-quality modeling of existing data, deconstruction, identification of replacement cores, and an innovative synthetic regrowth strategy led to the rapid discovery of a novel oral series of PI3Kδ inhibitors with promising selectivity and excellent in vivo characteristics." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00799"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00799">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00799&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00799&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00799&amp;href=/doi/10.1021/acs.jmedchem.6b00799" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 7239-7251</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00777" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00827" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.6b01157"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.6b01461"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Augustin++Amour">Augustin Amour</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nick++Barton">Nick Barton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+W.+J.++Cooper">Anthony W. J. Cooper</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Graham++Inglis">Graham Inglis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Craig++Jamieson">Craig Jamieson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+N.++Luscombe">Christopher N. Luscombe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Josie++Morrell">Josie Morrell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon++Peace">Simon Peace</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Perez">David Perez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Rowland">Paul Rowland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chris++Tame">Chris Tame</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sorif++Uddin">Sorif Uddin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanni++Vitulli">Giovanni Vitulli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natalie++Wellaway">Natalie Wellaway</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, U.K.</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#92e1fbfffdfcbca0bce2f7f3f1f7d2f5e1f9bcf1fdff"><span class="__cf_email__" data-cfemail="0a79636765642438247a6f6b696f4a6d796124696567">[email protected]</span></a>. Telephone: (+44)1438551573.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00799&amp;href=/doi/10.1021%2Facs.jmedchem.6b00799" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 7239–7251</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 18, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 June 2016</li><li><span class="item_label"><b>Published</b> online</span>27 July 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 August 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00799" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00799</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7239%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAugustin%2BAmour%252C%2BNick%2BBarton%252C%2BAnthony%2BW.%2BJ.%2BCooper%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D15%26contentID%3Dacs.jmedchem.6b00799%26title%3DEvolution%2Bof%2Ba%2BNovel%252C%2BOrally%2BBioavailable%2BSeries%2Bof%2BPI3K%25CE%25B4%2BInhibitors%2Bfrom%2Ban%2BInhaled%2BLead%2Bfor%2Bthe%2BTreatment%2Bof%2BRespiratory%2BDisease%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7251%26publicationDate%3DAugust%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00799"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1951</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00799" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Augustin&quot;,&quot;last_name&quot;:&quot;Amour&quot;},{&quot;first_name&quot;:&quot;Nick&quot;,&quot;last_name&quot;:&quot;Barton&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;W. J. Cooper&quot;},{&quot;first_name&quot;:&quot;Graham&quot;,&quot;last_name&quot;:&quot;Inglis&quot;},{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;Jamieson&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;N. Luscombe&quot;},{&quot;first_name&quot;:&quot;Josie&quot;,&quot;last_name&quot;:&quot;Morrell&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;Peace&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Perez&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Rowland&quot;},{&quot;first_name&quot;:&quot;Chris&quot;,&quot;last_name&quot;:&quot;Tame&quot;},{&quot;first_name&quot;:&quot;Sorif&quot;,&quot;last_name&quot;:&quot;Uddin&quot;},{&quot;first_name&quot;:&quot;Giovanni&quot;,&quot;last_name&quot;:&quot;Vitulli&quot;},{&quot;first_name&quot;:&quot;Natalie&quot;,&quot;last_name&quot;:&quot;Wellaway&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7239-7251&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00799&quot;},&quot;abstract&quot;:&quot;A four-step process of high-quality modeling of existing data, deconstruction, identification of replacement cores, and an innovative synthetic regrowth strategy led to the rapid discovery of a novel oral series of PI3Kδ inhibitors with promising selectivity and excellent in vivo characteristics.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00799&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00799" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00799&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00799" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00799&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00799" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00799&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00799&amp;href=/doi/10.1021/acs.jmedchem.6b00799" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00799" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00799" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00799%26sid%3Dliteratum%253Aachs%26pmid%3D27429068%26genre%3Darticle%26aulast%3DAmour%26date%3D2016%26atitle%3DEvolution%2Bof%2Ba%2BNovel%252C%2BOrally%2BBioavailable%2BSeries%2Bof%2BPI3K%25CE%25B4%2BInhibitors%2Bfrom%2Ban%2BInhaled%2BLead%2Bfor%2Bthe%2BTreatment%2Bof%2BRespiratory%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D15%26spage%3D7239%26epage%3D7251%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291155" title="Bioavailability">Bioavailability</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/jmcmar.2016.59.issue-15/20160811-01/jmcmar.2016.59.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A four-step process of high-quality modeling of existing data, deconstruction, identification of replacement cores, and an innovative synthetic regrowth strategy led to the rapid discovery of a novel oral series of PI3Kδ inhibitors with promising selectivity and excellent in vivo characteristics.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The phosphoinositide-3-kinases (PI3Ks) are a family of lipid kinases that are implicated in the development of a range of diseases, including respiratory inflammation.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> They comprise three classes based on structure, mode of regulation, and phospholipid substrate. The class I targets have been extensively investigated due to their role in various cancers and inflammatory disease,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> with their biochemical role mediating the phosphorylation of phosphatidylinositol (4,5)-diphosphate (PtdIns(4,5)P<sub>2</sub>) to produce phosphatidylinositol (3,4,5)-triphosphate (PtdIns(3,4,5)P<sub>3</sub>).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> A number of studies have highlighted the correlation between PI3K-mediated PIP3 production and T cell cytokine release,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> mast cell degranulation,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> neutrophil chemotaxis,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and the production of reactive oxygen species.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> These cell behaviors have been implicated in the development of respiratory inflammation and a range of cancers. Of the known isoforms, PI3Kδ is found to be predominantly expressed in leucocytes, suggesting it is a promising target for the treatment of asthma,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> chronic obstructive pulmonary disease (COPD),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and autoimmune disorders.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> From a drug discovery perspective, selectivity among the isoforms is an important consideration. Both PI3Kδ and γ knockout mice are viable and display some impairments of immune cell functions;<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> however, PI3Kα and β knockouts have been shown to be embryonically lethal.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">We recently reported the discovery of an inhaled clinical candidate, GSK2292767 (<b>1</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), as a potent and selective PI3Kδ inhibitor with promising in vivo properties as a potential therapy for respiratory indications.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This compound is structurally related to GSK2269557, also an inhaled therapy and currently in Phase II trials for COPD and asthma. Orally bioavailable compounds such as IPI-145<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and GS-1101 (CAL-101, Idelalisib)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> have previously been reported and advanced through clinical studies for oncology indications. Compounds of a similar structural genus have also appeared more recently, for example, UCB-5857 and TGR-1202. All derive from the same chemical series which generally possesses mixed PI3Kδ/γ inhibition, and this lack of selectivity creates difficulties in delineating the role of either isoform in inflammatory disease. More recently still, researchers from Amgen reported potent, selective, and orally bioavailable PI3Kδ inhibitors for the treatment of inflammatory disorders (e.g., AM-8508, <b>2</b>),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and researchers from Novatis have progressed CDZ-173 into Phase III trials for the treatment of activated PI3K delta syndrome. Taken together, these events highlight the significant and continuing level of interest associated with this promising therapeutic target. In the current study, we disclose our early efforts toward the discovery of a series of PI3Kδ-selective, orally bioavailable compounds exemplified by the dihydroisobenzofuran derivative <b>3</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) derived from our existing inhaled asset <b>1</b> as a potential therapy for respiratory disorders. The aim of the study was to discover an alternative core with reduced clearance and increased bioavailability while retaining the potential to deliver the class-leading levels of selectivity demonstrated by compounds such as <b>1</b>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>1</b>, <b>2</b>, and <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our progenitor compound <b>1</b> was developed for delivery by the inhaled route and exhibited negligible oral bioavailability (<2%) with very low exposure (<i>C</i><sub>max</sub> < 2 ng/mL, 3 mg/kg p.o.), and only a small subset of the compounds prepared in this series possessed moderate bioavailability and clearance. With this in mind, we elected to pursue a four-stage approach in order to evolve a series more suited to oral adsorption: (1) Utilize all available information to guide future approaches. (2) Deconstruct the current series to identify key features and provide an efficiency baseline. (3) Replace or remove perceived vulnerable moieties in the deconstructed molecules to provide a wide range of future options. (4) Select options with distinct risk profiles for regrowth/optimization.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Step 1: Utilization of Legacy Information</h3><div class="NLM_p">Replacement of the indazole core was motivated in part by a desire to reduce the aromatic ring count<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> but primarily by contemporaneous literature reports that implicated the indazole group<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> as a target for time-dependent P450 inhibition. The general design strategy involved tuning of topological polar surface area (TPSA)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (<135 Å<sup>2</sup>) and limitation of molecular weight (MW) through consideration of ligand efficiency (LE).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> To further refine our approach, two proprietary data sets were inspected with a view to minimize oral dose. These were factors affecting clearance (in vitro and in vivo) and cellular potency/drop-off. While the clearance data presented no potentially transferable trends, the data from the cell assays provided significantly more insight. The difference between the primary assay and cellular whole blood (bio phase) assay was calculated, and this difference was modeled using a multivariate data analysis technique called partial least squares regression,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> involving a standard set of physicochemical descriptors. The model was used to identify and explore potential relationships between molecular properties and the measured difference. The loadings plot (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) explores the relationship between variables themselves and also between responses in question. An examination of the plot highlighted three clusters of variables, which led to assessment of which parameters were important. The associated coefficient plot summarizes the magnitude and direction of influence of each variable.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) PLS loadings plot demonstrating groups of coefficients. (b) PLS coefficient plot indicating magnitude, direction, and 95% confidence interval of the mean. Variables of interest: Var 5–8 (ACD Laboratories v11.logd at pH 2, 5.5, 6.5, and 7.4) and Var 9 (cLogP 481); Var 11 (positive ionizable center count) and Var 12 (total charge); Var 23 (estate.amideNH-sum), Var 24 (estate.amideNH-av), and Var 25 (estate.amideOtoNH-av). Note: Var 2 is PI3K delta potency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Three key trends emerged from the data: (i) Variables 5–9 are calculations of lipophilicity and appeared to be associated with a detrimental effect on drop-off between enzyme and whole blood potency. (ii) Variables 11 and 12 suggested that ionization, in particular addition of a basic center, was beneficial to minimizing the drop-off between enzyme and biofluid activity. (iii) The group of variables 23, 24, and 25 related to increased hydrogen bond donor count were detrimental to whole-cell activity. The impact of lipophilicity and basic centers was attributed primarily to modulation of protein binding, for which optimization was not a priority; however, the negative impact of hydrogen bond donors, but not acceptors, drew our attention and impacted on our subsequent design strategy (vide infra). It is interesting to note that PI3Kdelta potency (variable 2) positively correlates with cellular drop-off, albeit with very high variability, and it is not unlikely that this observation results from a relationship between lipophilicity and potency.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Step 2: Deconstruction</h3><div class="NLM_p">A deconstruction (D<sub>x</sub>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) of compound <b>1</b> was performed to establish the minimum necessary pharmacophore and maximal potential efficiency of the lead series. It was anticipated that scanning for replacement components at a reduced complexity level would be considerably more synthetically tractable. Furthermore, scanning with fully elaborated compounds runs the risk of small changes in optimal binding pose of the core preventing efficient binding of the entire molecule. For efficiency measurements we adopted binding efficiency index<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (BEI = 1000 × (pIC<sub>50</sub>/MW)) as our efficiency metric, given that in our hands it proved to be intuitive to use yet correlates<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> very well with the more widely used LE. The deconstruction was conducted with some knowledge of the binding of the molecule<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> gleaned from homology modeling prior to the later generation of a crystal structure. The indazole core fragment (red) occupied the kinase “hinge” region, and the pyridyl sulfonamide (blue) entered the lipid–kinase “back pocket”, while the oxazole/morpholino group (magenta) occupied a vector that delivered the majority of selectivity for PI3Kδ.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design strategy for oral series. The calculated potency is derived via the rearranged BEI calculation (cPI3Kδ pIC<sub>50</sub> = 320 × (BEI/1000)).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The parent pyridinesulfonamide back-pocket binder (blue) was chosen as a structural lock. BEI calculations suggested that truncate <b>4</b> should be significantly above the limit of detection of the assay (pIC<sub>50</sub> ≈ 5) assuming a BEI of 18–20, hence allowing replacement hinge binding groups to be profiled. Synthesis and evaluation of <b>4</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) confirmed the anticipated level of potency against PI3Kδ, validating its use as a benchmark for replacement groups.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Profile of Reduced Complexity Analogue <b>4</b> and Indazole Replacement <b>5</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0012.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0013.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">p<i>K</i><sub>i</sub> is quoted for compound <b>1</b>, marked with asterisk, instead of pIC<sub>50</sub>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Step 3: Identification of Replacement Hinge-Binding Groups</h3><div class="NLM_p last">A variety of potential hinge-binding groups were then scanned, and one of the most promising hits from this exercise was the dihydroisobenzofuran analogue <b>5</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) as a potentially novel replacement. This moiety increased solubility, which was perhaps surprising given the higher measured LogD of the compound. We reasoned that this may be the result of destabilization of the solid form as a consequence of reduced planarity and elimination of intermolecular hydrogen bonds. This observation, coupled with the previous analysis suggesting the benefit of reduced HBD count, encouraged us to re-institute the selectivity vector on this template to establish the potential for obtaining selectivity, whole blood efficacy, and favorable drug metabolism and pharmacokinetic (DMPK) parameters.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Step 4: Regrowth and Optimization</h3><div class="NLM_p">Having established the feasibility of replacing the indazole core, the subsequent phase of the optimization trajectory focused on re-establishing the selectivity vector at the 6-position of the dihydroisobenzofuran template. The design hypothesis at this stage focused on generating compounds that would facilitate a thorough comparison with the indazole series and lead to an understanding of how well the structure–activity relationship would transfer between the two series. To select the most appropriate functional groups for the 6-position, we considered the structures of PI3Kδ compounds previously synthesized in our laboratories, focusing on the key pyridylsulfonamide motif. The subset of compounds identified from this approach was further filtered by applying physicochemical property constraints that would be likely to furnish compounds with oral bioavailability. This analysis led to the identification of six potential substituents for inclusion at the 6-position of the dihydroisobenzofuran, which spanned a variety of different chemotypes and offered a range of PI3K class I selectivity profiles. The substituents of interest are shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> as part of the dihydroisobenzofuran motif, with calculated physicochemical parameters shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Target 6-position substituents in the dihydroisobenzofuran series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Calculated Physicochemical Properties for Compounds <b>6</b>–<b>10</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">compound</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">property</th><th class="colsep0 rowsep0" align="center"><b>6</b></th><th class="colsep0 rowsep0" align="center"><b>7</b></th><th class="colsep0 rowsep0" align="center"><b>8</b></th><th class="colsep0 rowsep0" align="center"><b>9</b></th><th class="colsep0 rowsep0" align="center"><b>3</b></th><th class="colsep0 rowsep0" align="center"><b>10</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="center">402</td><td class="colsep0 rowsep0" align="center">397</td><td class="colsep0 rowsep0" align="center">377</td><td class="colsep0 rowsep0" align="center">461</td><td class="colsep0 rowsep0" align="center">463</td><td class="colsep0 rowsep0" align="center">455</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cLogP</td><td class="colsep0 rowsep0" align="center">1.1</td><td class="colsep0 rowsep0" align="center">2.9</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">2.8</td><td class="colsep0 rowsep0" align="center">2.9</td><td class="colsep0 rowsep0" align="center">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TPSA</td><td class="colsep0 rowsep0" align="center">116</td><td class="colsep0 rowsep0" align="center">90</td><td class="colsep0 rowsep0" align="center">107</td><td class="colsep0 rowsep0" align="center">120</td><td class="colsep0 rowsep0" align="center">120</td><td class="colsep0 rowsep0" align="center">120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. Ar rings</td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. rotatable bonds</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center">6</td><td class="colsep0 rowsep0" align="center">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. H-bond donors</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">2</td></tr></tbody></table></div></div><div class="NLM_p last">The calculated physicochemical data are summarized in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. In addition to reduced hydrogen bond donor count, target compounds had lower TPSA than the progenitor inhaled compound <b>1</b>, and we anticipated that this could potentially translate into improved oral exposure.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Other aspects of the physicochemical profile, such as number of aromatic rings, are lower, leading to potential improvements in property forecast index (PFI), again increasing the probability of enhancing oral exposure.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The overall hydrogen bond donor count is included in the table; however, it is worth noting that all of the compounds contain one fewer donor than the corresponding progenitor indazoles.</div></div><div id="sec2_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Chemistry</h3><div class="NLM_p">Reduced complexity analogues <b>4</b> and <b>5</b> were prepared using a Suzuki–Miyaura coupling from the pinacol boronic ester <b>11</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) boronate ester <b>11</b>, 6-bromo-1<i>H</i>-indazole, Pd<sub>2</sub>(dba)<sub>3</sub>, <sup>t</sup>Bu<sub>3</sub>P·HBF<sub>4</sub>, KF, 2-Me-THF/water (3:1), 28%; (ii) boronate ester, 5-bromo-1,3-dihydroisobenzofuran, PdCl<sub>2</sub>(dppf)·DCM, CsOAc, KF, THF/water (20:1), 39%.</p></p></figure><div class="NLM_p">The fully elaborated dihydroisobenzofuran core was accessed in an efficient manner utilizing a ruthenium-mediated cyclotrimerization reaction as outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. The tethered [2+2+2] trimerization of terminal alkynes preferentially installs the required <i>meta</i> arrangement of R<sub>4</sub> and R<sub>6</sub>. Judicious selection of these groups allows excellent flexibility to the medicinal chemist and synthesis of a wide variety of targets in short order (4–6 steps). Literature reports<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> suggested that trimethylsilyl-tethered diynes (R<sub>6</sub> = TMS) exhibit excellent regiochemistry in this reaction, and <i>ipso</i> substitution of the resulting aryl silane to iodide is well known (vide infra). It is worth noting that the route also provides the opportunity to make other changes to the core framework. For example, use of nitriles (A = N) allows access to pyridyl analogues, and elaboration at R<sub>2</sub> and R<sub>7</sub> readily facilitates substitution adjacent to the hinge-binding oxygen atom. Therefore, the investment was made in enabling this potentially challenging chemistry.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Plan for the Utilization of [2+2+2] Trimerization Chemistry</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Alkyne <b>13</b> was prepared as indicated in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, and the TMS-protected bispropargyl ether <b>12</b> was prepared in one step from propargyl ether according to the literature procedure.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl (8 mol %), CuI (8 mol %), Et<sub>3</sub>N (4 equiv), 2-Me-THF, 80 °C, quantitative; (ii) KOH, <i>i</i>PrOH, reflux, 77%.</p></p></figure><div class="NLM_p">The synthesis of the target compounds is described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Optimization of cyclotrimerization conditions revealed that cyclopropyl methyl ether (CPME) was preferable to the commonly used dichloroethane as solvent.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The key arylsilane intermediate <b>14</b> was thus obtained in good yield with either a 1.2 equiv excess of <b>12</b> or a 2.0 equiv excess of <b>13</b>. <i>Ipso</i> substitution of <b>14</b> with iodine monochloride then provided the iodo derivative <b>15</b> in excellent yield. Palladium-mediated cross-coupling provided <b>6</b> and <b>7</b> using either a Negishi protocol<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> or modified Suzuki–Miyaura procedure,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> respectively. Copper-mediated amination of <b>15</b> provided aniline <b>16</b>, which was then converted to amides <b>3</b>, <b>8</b>, <b>9</b>, and <b>10</b>.</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) RuCp*(cod)Cl (10 mol %), CPME, rt, 64% (1.2 equiv of <b>12</b> or 2.0 equiv of <b>13</b>); (ii) ICl, CH<sub>2</sub>Cl<sub>2</sub>, 10→0 °C, 80%; (iii) CuI (20 mol %), <span class="smallcaps smallerCapital">l</span>-proline, Cs<sub>2</sub>CO<sub>3</sub>, DMSO:NH<sub>3</sub> (aq) (1:1), 110 °C, microwave, 77%; (iv) 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, Pd(OAc)<sub>2</sub> (1 mol %), Cs<sub>2</sub>CO<sub>3</sub>, dppf (20 mol %), CuCl (100 mol %), DMF, microwave, 100 °C, 10%; (v) (a) 2-methyl-1,3,4-oxadiazole, LiHMDS, ZnCl<sub>2</sub>, THF, −10 °C; (b) Pd(PPh<sub>3</sub>)<sub>4</sub> (10 mol %), Cs<sub>2</sub>CO<sub>3</sub>, microwave, 150 °C, 24%; (vi) RCO<sub>2</sub>H, HATU, DMF, rt, 21–28%.</p></p></figure><div class="NLM_p">The in vitro potencies of the target compounds were measured in a homogeneous time-resolved fluorescence assay as described previously.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The results from these assays (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) indicate good levels of potency against the PI3Kδ isoform, with pIC<sub>50</sub> values ranging from 6.4 to 8.3. The more structurally elaborated thiazole <b>9</b> and pyridine <b>10</b> display the most encouraging potency and selectivity profiles, providing support to the original hypothesis that functionalization at the 6-position of the dihydroisobenzofuran core would provide an enhancement of activity. In relation to PI3K class I selectivity, the majority of the analogues showed an encouraging profile in comparison to the progenitor dihydroisobenzofuran <b>5</b>, particularly compounds <b>9</b>, <b>3</b>, and <b>10</b>. In general, the isoform selectivity observed was lower than that of the fully optimized inhaled candidate molecule; however, comparison to the previously reported thiazole analogue <b>20</b> indicates similar selectivity is retained with the new hinge-binder. Accordingly, we reasoned that selectivity could be improved by further optimization of the 6-position vector.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Isolated Enzyme Assay Results for the PI3K Class I Isoforms<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0014.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">p<i>K</i><sub>i</sub> is quoted for compound <b>1</b>, marked with asterisk, instead of pIC<sub>50</sub>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></p></div></div><div></div></div><div class="NLM_p">Based on these promising initial data, and to more fully benchmark this nascent lead series, a selection of compounds was made for further profiling in both whole blood<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> to assess the cellular activity of each compound and DMPK<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> assays, as well as other developability screening. The results of these studies are summarized in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Further Profiling of Dihydroisobenzofuran Analogues<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0016.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0017.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">In vivo PK data were obtained in the CD Sprague male rat following administration of 1 mg/kg oral and i.v. doses. IVC = in vitro clearance. AUC<sub>0-<i>t</i></sub> is quoted for <b>10</b>, marked with asterisk, instead of AUC<sub>inf</sub>.</p></div></div><div></div></div><div class="NLM_p">Comparing the whole-blood potencies for the newly synthesized compounds shows a drop-off in cellular activity of at least 10-fold or greater for compounds <b>6</b> and <b>10</b>. By contrast, compound <b>3</b> exhibits only minimal attenuation in cellular potency compared to the isolated enzyme data. A likely contributor to this difference is protein binding, given that compound <b>3</b> has an estimated free fraction of 36%, whereas the other analogues examined have an estimated free fraction of 10% or less. It is worth noting that, while these compounds are substantially weaker than the inhaled lead in whole-blood cell assays, there is, however, a stronger imperative for potency for an inhaled molecule due to the necessity of a very low dose. The whole-blood activity of <b>3</b>, <b>6</b>, and <b>10</b> compares favorably with that of oral compounds in clinical development. For example, the PI3Kδ/γ inhibitor IPI-145 inhibits basophil degranulation with IC<sub>50</sub> = 96 nM (pIC<sub>50</sub> ≈ 7.0) in whole blood.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">All three compounds display much improved metabolic stability when compared to the inhaled lead <b>1</b> in both in vitro and in vivo studies. In vitro clearance levels in all species investigated are low to moderate, while rat in vivo clearance for compound <b>3</b> of less than 14 mL/min/kg equates to less than 20% liver blood flow (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). The slightly elevated observed clearance of morpholine <b>3</b> with respect to oxadiazole <b>6</b> and pyridine <b>10</b> could be attributed to the lower level of protein binding (HSA), which may increase the fraction of drug exposed to organs of metabolism and excretion. The relatively low volumes of distribution for compounds <b>6</b> and <b>3</b> result in lower half-lives compared to pyridine analogue <b>10</b>. It was reasoned that further optimization of the 6-position (e.g., modulation of the basic amine) could increase the volume of distribution and positively impact the half-life.</div><div class="NLM_p">Low bioavailability is observed for pyridine <b>10</b> despite its low systemic clearance and excellent in vitro passive permeability measured on MDCK cells. First-pass metabolism and poor absorption from the GI tract are therefore unlikely causes of the low bioavailability, and it is more likely that this is attributed to the low solubility of pyridine <b>10</b> (50 μg/mL) when compared to the other dihydroisobenzofuran analogues examined. Oxadiazole <b>6</b> and morpholine <b>3</b> show significantly higher bioavailability than the inhaled lead <b>1</b>, thus validating the initial design hypothesis in controlling physicochemical properties. Furthermore, morpholine <b>3</b> is among a paucity of compounds from this chemotype which exhibit both oral bioavailability and greater than 20-fold PI3K class I selectivity in isolated enzyme assays. In addition to this, compound <b>3</b> also exhibited excellent selectivity against a varied panel of kinases and other enzymes.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Based on all of the above, we believe that the dihydroisobenzofuran series represents a significant advance in the design of selective PI3Kδ compounds which are suitable for oral administration.</div><div class="NLM_p">Compound <b>3</b> was also successfully co-crystallized with PI3Kδ, which confirmed the proposed binding mode with the kinase (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). From our earlier studies, the indazole was shown to be a hinge-binding motif,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and this interaction is effectively maintained by the dihydroisobenzofuran, albeit that any interaction between the indazole NH and the hinge has been lost. The 6-position substituent forms a similar vector to that observed with the inhaled lead <b>1</b>; however, the core benzenoid ring appears to be rotationally displaced by approximately 15°, which suggests that the optimal 6-position groups could differ between the two series. It is also worth noting that the morpholine substituent does not reach the same region of the protein as that occupied by <b>1</b>, leading to the hypothesis that further selectivity can be obtained. Given the rotational displacement of the core, it is postulated that complete reoptimization of the linking group is required to allow the morpholine group to access the region occupied by <b>1</b>.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray structure of compound <b>3</b> (cyan) co-crystallized with PI3Kδ and overlaid with a crystal structure of compound <b>1</b> (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on its promising oral bioavailability and encouraging level of cellular potency, the morpholine analogue <b>3</b> was progressed to an in vivo pharmacodynamic assay to determine its efficacy in a disease-relevant animal model. In our previous report, a brown Norway rat acute ovalbumin (OVA) model of lung inflammation was used.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Compound <b>3</b> was assessed using this model, whereby OVA challenge is administered 30 min after oral delivery. Significant protection against eosinophil recruitment was achieved by compound <b>3</b> at 3 mg/kg p.o. (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>), whereas failure to achieve significance at 9 mg/kg is primarily attributed to two poorly responding rats in this group.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacodynamic testing of compound <b>3</b> in an acute model of lung inflammation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pharmacokinetic data from the study are presented in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>, along with the comparative data from the pilot pharmacokinetic study. Interestingly, <b>3</b> achieved lower exposure in the OVA study at 3 mg/kg when compared to the pilot study (1 mg/kg), which may result from strain dependency and/or differences in dose formulation. The blood concentrations of <b>3</b> 1 h after dosing, i.e., 30 min after OVA challenge, are 0.19 and 1.27 μM for the 3 and 9 mg/kg groups, respectively, which compare very favorably with the potency in human whole blood (pIC<sub>50</sub> = 6.6, 0.25 μM, vide supra). The estimated free drug concentrations at this time point are also provided.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Compiled Pharmacokinetic Data on Compound <b>3</b> from Pilot Rat PK and PKPD Studies</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char=" " /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">strain</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>inf</sub> (h·ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=" ">blood conc, 1 h (ng/mL (μM))</th><th class="colsep0 rowsep0" align="center" char=".">unbound conc,<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> 1 h (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">WH</td><td class="colsep0 rowsep0" align="char" char=".">673</td><td class="colsep0 rowsep0" align="char" char=".">–</td><td class="colsep0 rowsep0" align="char" char=" ">240 (0.52)</td><td class="colsep0 rowsep0" align="char" char=".">0.089</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">BN</td><td class="colsep0 rowsep0" align="char" char=".">454</td><td class="colsep0 rowsep0" align="char" char=".">10.6</td><td class="colsep0 rowsep0" align="char" char=" ">86.9 (0.19)</td><td class="colsep0 rowsep0" align="char" char=".">0.032</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">BN</td><td class="colsep0 rowsep0" align="char" char=".">2621</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=" ">586 (1.27)</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Unbound concentration calculated using an internal algorithm that estimates binding from HPLC columns coated with HSA and α-glycoprotein.</p></div></div></div><div class="NLM_p">From consideration of all the above data, morpholine <b>3</b> represents the inception of a promising series of PI3Kδ inhibitors with good oral bioavailability and robust levels of in vivo efficacy. This compares favorably to the benchmark set by the orally bioavailable dual PI3Kγ/δ dual inhibitor IPI-145, which demonstrates similar levels of in vivo efficacy in a related pharmacodynamic study and has recently completed a Phase 2a trial for asthma.</div><div class="NLM_p">These highly encouraging data provide additional validation for the design strategy adopted in developing a new hinge-binder, thereby providing confidence in further developing the dihydroisobenzofuran series to further optimize its selectivity and DMPK characteristics.</div><div class="NLM_p last">The data in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> were analyzed using an analysis of variance model with the log eosinophil numbers as the response, with treatment including the controls fitted as a categorical factor. The plotted intervals represent the 95% confidence interval of the mean response.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23082" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23082" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Beginning with an inhaled start point with negligible oral bioavailability, a novel series of selective PI3Kδ inhibitors has been identified with a significantly improved pharmacokinetic profile. Key template modifications focused on controlling important physicochemical parameters revealed from analysis of data in the target biophase, with particular emphasis on number of aromatic rings, PSA, and restricting hydrogen bond donors. Through a reduced complexity approach, the dihydroisobenzofuran chemotype was identified as a new hinge-binding motif and subsequently elaborated through the creative application of [2+2+2] cyclotrimerization chemistry. This approach efficiently and rapidly led to identification of compound <b>3</b>, which has good oral bioavailability and promising PI3K subtype selectivity, as well as highly encouraging levels of efficacy in vivo. Further evolution of this new series of PI3Kδ inhibitors will be reported in due course, with particular emphasis on enhancing the primary activity and selectivity profile, while maintaining acceptable pharmacokinetic properties.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62560" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62560" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div id="sec4_100" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General</h4><div class="NLM_p last">All solvents and reagents, unless otherwise stated, were commercially available from regular suppliers such as Sigma-Aldrich and Fluorochem and were used as purchased without further purification. Proton and carbon nuclear magnetic resonance (<sup>1</sup>H NMR and <sup>13</sup>C NMR) spectra were recorded on a Bruker AVI (400 MHz), Bruker Nano (400 MHz), or Bruker AVII+ (600 MHz) spectrometer (with cryoprobe) in the indicated solvent. Chemical shifts δ are reported in parts per million (ppm) relative to tetramethylsilane and are internally referenced to the residual solvent peak. Coupling constants (<i>J</i>) are given in hertz to the nearest 0.1 Hz. High-resolution mass spectra were obtained on a Micromass QTof Ultima hybrid quadrupole time-of-flight mass spectrometer, equipped with a Z-spray interface (ESI), over a mass range of 100–1100 Da, with a scan time of 0.9 s and an interscan delay of 0.1 s. Reserpine was used as the external mass calibrant ([M+H]<sup>+</sup> = 609.2812 Da). The Q-Tof Ultima mass spectrometer was operated in W reflectron mode to give a resolution (fwhm) of 16 000–20 000. Ionization was achieved with a spray voltage of 3.2 kV and a cone voltage of 50 V, with cone and desolvation gas flows of 10–20 and 600 L/h, respectively. The source block and desolvation temperatures were maintained at 120 and 250 °C, respectively. The elemental composition was calculated using MassLynx, version 4.1, for the [M+H]<sup>+</sup> and the mass error quoted as ppm. The purity of all compounds screened in the biological assays was examined by LCMS analysis and was found to be ≥95% unless otherwise specified.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>-(5-(1<i>H</i>-Indazol-6-yl)-2-methoxypyridin-3-yl)methanesulfonamide (<b>4</b>)</h4><div class="NLM_p"><i>N</i>-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanesulfonamide (218 mg, 0.66 mmol) and 6-bromo-1<i>H</i>-indazole (133 mg, 0.67 mmol) were introduced into a reaction tube, and 2-methyltetrahydrofuran (2-Me-THF, 1.5 mL) was added. Potassium fluoride (96.0 mg, 1.7 mmol) was dissolved in water (0.5 mL) and added into the mixture. The mixture was bubbled through with nitrogen for 4–5 min, and then tri-<i>tert</i>-butylphosphonium tetrafluoroborate (25 mg, 0.087 mmol) was mixed with tris(dibenzylidene-acetone)dipalladium(0) (30 mg, 0.033 mmol) and added to the mixture. After 1 h, further tri-<i>tert</i>-butylphosphonium tetrafluoroborate (29 mg, 0.100 mmol) was mixed with tris(dibenzylidene-acetone)dipalladium(0) (34 mg, 0.037 mmol) and added to the mixture. The resulting mixture was heated at reflux for 19 h before water (10 mL) and 2-Me-THF (10 mL) were added. The organic phase was collected using a hydrophilic cartridge and then loaded onto a strong cation exchange (SCX, 20 g) cartridge. This was eluted with MeOH (30 mL) and then 2 N NH<sub>3</sub>/MeOH (90 mL). The NH<sub>3</sub>/MeOH fraction was concentrated in vacuo. This sample was dissolved in DMSO (3 mL) and purified in 3 × 1 mL runs by mass-directed autopreparative (MDAP) chromatography on an Xbridge column using acetonitrile/water with a formic acid modifier. The relevant fractions were combined, and the solvent was removed under a stream of nitrogen to give <b>4</b> (59 mg, 28%).</div><div class="NLM_p last">LCMS (Method A): 0.74 min, [M+H]<sup>+</sup> 319 <i>m</i>/<i>z</i>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 13.16 (s, 1H), 9.35 (br s, 1H), 8.35 (d, <i>J</i> = 2.4, 1H), 8.08 (s, 1H), 7.94 (s, <i>J</i> =  2.4, 1H), 7.86 (s, <i>J</i> = 7.6, 1H), 7.71 (s, 1H), 7.39 (dd, <i>J</i> =  7.6, 1.5, 1H), 3.98 (s, 3H), 3.09 (s, 3H) ppm.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-(5-(1,3-Dihydroisobenzofuran-5-yl)-2-methoxypyridin-3-yl)methanesulfonamide (<b>5</b>)</h4><div class="NLM_p"><i>N</i>-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanesulfonamide (0.074 g, 0.23 mmol), 5-bromo-1,3-dihydroisobenzofuran (0.030 g, 0.15 mmol), PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub> adduct (2.5 mg, 3.00 μmol), and cesium carbonate (0.072 g, 0.38 mmol) were combined in THF (1 mL) and water (60 μL). The reaction vessel was sealed and heated in an Anton Parr microwave at 100 °C for 25 min. The solution was then loaded onto C18 SPE (preconditioned with MeCN/0.1%TFA) and flushed through with a further 3 mL of MeCN/0.1%TFA. Solvent was removed, and the residue was dissolved in DMSO (0.5 mL) and purified by MDAP chromatography on a Sunfire C18 column using acetonitrile/water with a formic acid modifier. The solvent was removed under a stream of nitrogen to give <b>5</b> (20.7 mg, 39%).</div><div class="NLM_p last">LCMS (Method A): 0.85 min, [M+H]<sup>+</sup> 321 <i>m</i>/<i>z</i>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.35 (br s, 1H), 8.26 (s, 1H), 7.83 (s, 1H), 7.57 (s, 1H), 7.53 (d, <i>J</i> = 7.6, 1H), 7.41 (d, <i>J</i> = 7.6, 1H), 5.09 (s, 2H), 5.05 (s, 2H), 3.95 (s, 3H), 3.06 (s, 3H) ppm.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-(5-(3-Hydroxy-3-methylbut-1-yn-1-yl)-2-methoxypyridin-3-yl)methanesulfonamide (<b>19</b>)</h4><div class="NLM_p"><i>N</i>-(5-Bromo-2-methoxypyridin-3-yl)methanesulfonamide (7.03 g, 25 mmol) and copper(I) iodide (0.381 g, 2.00 mmol) were dissolved in anhydrous 2-Me-THF (80 mL), and nitrogen was bubbled into the mixture during 10 min at room temperature. Then, 2-methylbut-3-yn-2-ol (3.63 mL, 37.5 mmol), bis(triphenylphosphine)palladium(II) chloride (1.05 g, 1.50 mmol), and triethylamine (13.9 mL, 100 mmol) were added, and the mixture was stirred and heated. After 28 h at 85 °C, the reaction exhibited approximately 60% conversion, and 2-methylbut-3-yn-2-ol (1.2 mL) and bis(triphenylphosphine)palladium(II) chloride (400 mg) were added and stirred at 85 °C for a further 17 h. Ammonium chloride (120 mL) and 2-Me-THF (80 mL) were added, and the mixture was filtered through Celite. The layers were separated, and the aqueous layer was extracted with further 2-Me-THF (2 × 80 mL). The combined organics were washed with brine, dried over sodium sulfate, and reduced in vacuo. The resulting residue was purified by column chromatography, eluting with 0–100% ethyl acetate in cyclohexane. The appropriate fractions were combined and reduced in vacuo to provide <b>19</b> (7.39 g, 104%, contained residual ethyl acetate).</div><div class="NLM_p last">LCMS (Method A): 0.73 min, [M+H]<sup>+</sup> 285 <i>m</i>/<i>z</i>. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ = 8.11 (br s, 1H), 7.97 (d, <i>J</i> = 2.4, 1H), 7.73 (d, <i>J</i> = 2.4, 1H), 4.49 (s, 1H), 3.97 (s, 3H), 3.10 (s, 3H), 1.55 (s, 6H) ppm.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-[5-Ethynyl-2-(methyloxy)-3-pyridinyl]methanesulfonamide (<b>13</b>)</h4><div class="NLM_p">Potassium hydroxide (9.87 g, 176 mmol) was dissolved in isopropanol (80 mL) at 50 °C over 10 min, and then <b>19</b> (10 g, 35.2 mmol) was added in isopropanol (80 mL + 40 mL wash). The mixture was heated to reflux (90 °C) for 4.5 h. Another 0.5 equiv of potassium hydroxide (0.968 g) was added, and the reaction was stirred under reflux (95 °C) for a further 4 h. The reaction was allowed to stand at room temperature for 18 h and then reduced in vacuo and partitioned between aqueous ammonium chloride (150 mL) and 2-Me-THF (100 mL). The aqueous layer was washed with 2-Me-THF (2 × 100 mL), and the combined organics were washed with brine, dried over sodium sulfate, and reduced in vacuo. The resulting residue was purified by column chromatography, eluting with 0–50% ethyl acetate in cyclohexane to give <b>13</b> (5.0 g, 60%).</div><div class="NLM_p last">LCMS (Method A): 0.74 min, [M+H]<sup>+</sup> 227 <i>m</i>/<i>z</i>. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz): δ = 8.5 (br s, 1H), 8.08 (d, <i>J</i> = 2.4, 1H), 7.82 (d, <i>J</i> = 2.4, 1H), 4.01 (s, 3H), 3.74 (s, 1H), 3.12 (s, 3H) ppm.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>N</i>-{2-(Methyloxy)-5-[7-(trimethylsilyl)-1,3-dihydro-2-benzofuran-5-yl]-3-pyridinyl}methanesulfonamide (<b>14</b>)</h4><div class="NLM_p">Proceedure A: To a nitrogen-degassed solution of chloro(pentamethylcyclopentadienyl)(cyclooctadiene)ruthenium(II) (38 mg, 0.1 mmol) and <i>N</i>-[5-ethynyl-2-(methyloxy)-3-pyridinyl]methanesulfonamide (226 mg, 1.0 mmol) in CPME (7.5 mL) was added a solution of <b>13</b> (200 mg, 1.20 mmol) in CPME (7.5 mL) sequentially, dropwise at room temperature. The mixture was then stirred at room temperature for 24 h. The mixture was concentrated under reduced pressure to afford a crude gum. The gum was loaded in minimal CH<sub>2</sub>Cl<sub>2</sub> onto a silica prepacked column (10 g) and eluted with 0–100% EtOAc in cyclohexane over 60 min. The combined relevant fractions were concentrated under reduced pressure to give <b>14</b> (250 mg, 64%) as a white solid.</div><div class="NLM_p">Proceedure B: To chloro(pentamethylcyclopentadienyl)(cyclooctadiene)ruthenium(II) (344 mg, 902 μmol) was added a solution of <b>13</b> (4.1 g, 18 mmol) in CPME (65 mL), and the mixture was degassed with three alternative applications of vacuum and nitrogen. To the mixture was added a solution of trimethyl[3-(2-propyn-1-yloxy)-1-propyn-1-yl]silane (1.5 g, 9.0 mmol) in CPME (40 mL) sequentially, dropwise at room temperature. The reaction mixture was then stirred at room temperature for 2 h. The reaction mixture was diluted with ethyl acetate (100 mL) and washed with brine (3 × 50 mL). The aqueous extracts were back-extracted with ethyl acetate (50 mL). The combined organic extracts were dried under reduced pressure to afford a crude gum. The gum was loaded in minimal CH<sub>2</sub>Cl<sub>2</sub> onto a silica prepacked column (340 g) and eluted with 0–10% EtOAc in CH<sub>2</sub>Cl<sub>2</sub> over 12 column volumes. The combined relevant fractions were concentrated under reduced pressure to give <b>14</b> (2.26 g, 5.76 mmol, 64% yield) as a yellow solid: mp 166–167 °C.</div><div class="NLM_p last">LCMS (Method A): 1.19 min, [M+H]<sup>+</sup> 393 <i>m</i>/<i>z</i>. IR (solid): 3171 (N–H stretch); 1327, 1137 (O═S═O) cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.33 (s, 1H), 8.28 (d, <i>J</i> = 2.3 Hz, 1H), 7.85 (d, <i>J</i> = 2.3 Hz, 1H), 7.57 (s, 1H), 7.54 (s, 1H), 5.09 (s, 2H), 5.05 (s, 2H), 3.97 (s, 3H), 3.08 (s, 3H), 0.30 (s, 9H) ppm. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 101 MHz): δ = 157.2, 144.5, 141.5, 140.3, 136.4, 134.2, 132.2, 132.1, 131.2, 122.4, 121.3, 73.9, 73.3, 54.8, 41.8, 0.0 ppm. HRMS (ESI): calcd for C<sub>18</sub>H<sub>25</sub>N<sub>2</sub>O<sub>4</sub>SSi [M+H]<sup>+</sup> 393.1299, found 393.1298.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-[5-(7-Iodo-1,3-dihydro-2-benzofuran-5-yl)-2-(methyloxy)-3-pyridinyl]methanesulfonamide (<b>15</b>)</h4><div class="NLM_p">Iodine monochloride in CH<sub>2</sub>Cl<sub>2</sub> (1 M, 4.33 mL, 4.33 mmol) was added dropwise to a solution of <b>14</b> (850 mg, 2.17 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) under nitrogen at −10 °C. The reaction mixture was allowed to warm to 0 °C and stirred for 5 min, during which a white solid precipitated from solution. Saturated sodium thiosulfate solution (50 mL) was added, and the resulting mixture was stirred at room temperature for 20 min. The reaction mixture was filtered under reduced pressure and washed with CH<sub>2</sub>Cl<sub>2</sub> (5 mL). The filtrate was poured onto CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and water (30 mL), and the separated aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 50 mL). The combined organic fractions were passed through a hydrophobic frit and then concentrated under vacuum to afford a yellow solid. The yellow solid and white solid were combined and triturated in methanol (5 mL). The mixture was filtered under reduced pressure, and the solid was dried in a vacuum oven for 2 h to afford <b>15</b> (774 mg, 1.73 mmol, 80%) as a white solid.</div><div class="NLM_p last">LCMS (Method A): 1.06 min, [M+H]<sup>+</sup> 447 <i>m</i>/<i>z</i>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.26–9.39 (m, 1H), 8.28 (d, <i>J</i> = 2.3 Hz, 1H), 7.89 (s, 1H), 7.85 (d, <i>J</i> = 2.3 Hz, 1H), 7.59 (s, 1H), 5.21 (s, 2H), 4.92 (s, 2H), 3.96 (s, 3H), 3.09 (s, 3H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 156.8, 143.2, 141.5, 141.1, 138.8, 134.3, 131.0, 128.8, 121.9, 119.8, 89.0, 76.9, 74.7, 54.3, 41.2 ppm.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-(5-(7-Amino-1,3-dihydroisobenzofuran-5-yl)-2-methoxypyridin-3-yl)methanesulfonamide (<b>16</b>)</h4><div class="NLM_p"><span class="smallcaps smallerCapital">l</span>-Proline (413 mg, 3.59 mmol), copper(I) iodide (68 mg, 0.36 mmol), cesium carbonate (1.75 g, 5.38 mmol), and <b>15</b> (800 mg, 1.79 mmol) were evenly charged over two microwave vials (2 × 20 mL). The vials was sealed and degassed before aqueous ammonia solution 0.88 (35%, 8.0 mL, 0.13 mol) and DMSO (8 mL) were added via syringe, and the vials were then heated and stirred in a Biotage microwave reactor at 50 °C for 2 h. After this time, aqueous ammonia solution 0.88 (35%, 2 × 4 mL, 0.2 mol) and cesium carbonate (2 × 500 mg, 1.53 mmol) were added via syringe to both vials, and the vials were heated and stirred at 110 °C for 6 h. The reaction mixtures were combined and filtered under reduced pressure and then washed with methanol. The filtrate was loaded directly onto an SCX cartridge (70 g) and flushed with methanol (200 mL) under reduced pressure. The column was then eluted with ammonia in methanol solution (7 M, 300 mL) under reduced pressure. The filtrate was concentrated under reduced pressure to afford a crude gum. The gum was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and washed three times with water. The combined organic fractions were filtered through a hydrophobic frit and concentrated under reduced pressure to afford <b>16</b> (460 mg, 1.37 mmol, 77%) as a white solid: mp 295–301 °C.</div><div class="NLM_p last">LCMS (Method A): 0.65 min, [M+H]<sup>+</sup> 336 <i>m</i>/<i>z</i>. IR (solid): 3467, 3377 (H–N–H stretch); 3049 (N–H stretch); 1303, 1138 (O═S═O) cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.28 (br s, 1H), 8.17 (d, <i>J</i> = 2.3 Hz, 1H), 7.77 (d, <i>J</i> = 2.3 Hz, 1H), 6.64–6.78 (m, 2H), 5.25 (s, 2H), 4.97 (s, 2H), 4.88 (s, 2H), 3.96 (s, 3H), 3.07 (s, 3H) ppm. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 101 MHz): δ = 155.8, 142.9, 140.8, 140.0, 137.1, 130.6, 130.5, 122.3, 121.1, 110.7, 106.6, 73.2, 71.5, 53.7, 40.6 ppm. HRMS (ESI) calcd for C<sub>15</sub>H<sub>18</sub>N<sub>3</sub>O<sub>4</sub>S [M+H]<sup>+</sup> 336.1013, found 336.1017.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-(2-Methoxy-5-(7-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-dihydroisobenzofuran-5-yl)pyridin-3-yl)methanesulfonamide (<b>6</b>)</h4><div class="NLM_p">A microwave vial was charged with 2-methyl-1,3,4-oxadiazole (45 mg, 0.54 mmol) and THF (1.5 mL). Zinc chloride (244 mg, 1.79 mmol) was added, and the mixture was degassed and cooled to −10 °C under nitrogen. A solution of lithium hexamethyldisilazide in THF (1 M, 810 μL, 810 μmol) was then added dropwise over 15 min at −10 °C. The resulting mixture was stirred at −10 °C (±5 °C) for 1 h. <b>15</b> (200 mg, 450 μmol), tetrakis(triphenylphosphine)palladium(0) (52 mg, 45 μmol), and cesium carbonate (146 mg, 448 μmol) were then added at −10 °C. The mixture was then degassed with three alternating applications of vacuum and nitrogen and then heated in a Biotage microwave at 150 °C for 1 h. The mixture was poured onto CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and then filtered under reduced pressure. The filtrate was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL), and the combined organic phase was treated with water (50 mL). The resulting mixture was filtered under reduced pressure and washed with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL). The filtrate was passed through a hydrophobic frit and then concentrated under reduced pressure to afford a yellow solid. The solid was loaded in DMSO (1 mL) and purified via MDAP chromatography using a Sunfire C18 column and an ammonium bicarbonate-modified MeCN/water gradient. The relevant combined fractions were concentrated under reduced pressure to give <b>6</b> (45 mg, 0.11 mmol, 24%) as a white solid.</div><div class="NLM_p last">LCMS (Method A): 0.78 min, [M+H]<sup>+</sup> 403. IR (solid): 2929 (N–H stretch); 1331, 1149 (O═S═O) cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.37 (s, 1H), 8.37 (d, <i>J</i> = 2.3 Hz, 1 H), 8.02 (d, <i>J</i> = 1.3 Hz, 1H), 7.94 (d, <i>J</i> = 2.3 Hz, 1H), 7.84 (s, 1H), 5.34 (s, 2H), 5.17 (s, 2H), 3.99 (s, 3H), 3.10 (s, 3H), 2.62 (s, 3H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 164.4, 163.3, 156.9, 142.7, 140.6, 137.8, 137.7, 130.6, 129.1, 123.7, 122.8, 122.6, 118.5, 73.9, 73.0, 54.3, 41.2, 11.1 ppm. HRMS (ESI): calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>5</sub>S [M+H]<sup>+</sup> 403.1071, found 403.1070.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-(2-Methoxy-5-(7-(pyridin-2-yl)-1,3-dihydroisobenzofuran-5-yl)pyridin-3-yl)methanesulfonamide (<b>7</b>)</h4><div class="NLM_p">A microwave vial was charged with <b>15</b> (70 mg, 0.16 mmol), 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (80 mg, 0.39 mmol), cesium carbonate (102 mg, 0.310 mmol), copper(I) chloride (16 mg, 0.16 mmol), palladium(II) acetate (0.5 mg, 2 μmol), 1,1′-bis(diphenylphosphino)ferrocene (dppf) (18 mg, 30 μmol), and DMF (1.5 mL). The vial was sealed, degassed, and then heated and stirred in a Biotage microwave reactor at 100 °C for 90 min. The mixture was poured onto water (20 mL) and EtOAc (20 mL) and then filtered under reduced pressure. The separated aqueous phase was extracted with EtOAc (3 × 20 mL), and the combined organic phase was filtered. The filtrate was concentrated under reduced pressure to afford a brown solid. The solid was loaded in DMSO/MeOH solution (1:1 (v/v) 1 mL) and purified via MDAP chromatography using a Sunfire C18 column and an ammonium bicarbonate-modified MeCN/water gradient. The relevant combined fractions were concentrated under reduced pressure to give <b>7</b> (6 mg, 0.02 mmol, 10%) as a white solid.</div><div class="NLM_p last">LCMS (Method A): 0.89 min, [M+H]<sup>+</sup> 398 <i>m</i>/<i>z</i>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.07–9.43 (m, 1H), 8.70 (d, <i>J</i> = 4.03 Hz, 1H), 8.41 (d, <i>J</i> = 2.01 Hz, 1H), 8.06 (s, 2H), 7.90–8.00 (m, 2H), 7.65 (s, 1H), 7.39 (dd, <i>J</i> = 5.16, 6.92 Hz, 1H), 5.38 (s, 2H), 5.11 (s, 2H), 3.99 (s, 3H), 3.09 (s, 3H) ppm.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-(6-(6-Methoxy-5-(methylsulfonamido)pyridin-3-yl)-1,3-dihydroisobenzofuran-4-yl)acetamide (<b>8</b>)</h4><div class="NLM_p">Acetic acid (10 μL, 0.15 mmol) was added dropwise to a stirred suspension of HATU (62 mg, 0.16 mmol) and DIPEA (50 μL, 0.30 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) at room temperature. The mixture was stirred for 10 min at room temperature, during which time the milky suspension turned into a yellow solution. A suspension of <b>16</b> (50 mg, 0.15 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was then added dropwise to the mixture at room temperature. DMF (10 μL) was added, and the solution was stirred for 16 h at room temperature. The solution was poured onto EtOAc (2 mL) and brine (3 mL), and the separated organic phase was washed with brine (2 × 3 mL). The combined organic phase was concentrated under a stream of nitrogen to give an orange gum. The gum was dissolved in DMSO/MeOH (1 mL, 1:1 v/v) and purified via MDAP chromatography using a Sunfire C18 column and an ammonium bicarbonate-modified MeCN/water gradient. The relevant combined fractions were concentrated under reduced pressure to give a white solid. Water (10 mL) and diethyl ether (10 mL) were added, the mixture was filtered, and the filter cake was dried under reduced pressure to give <b>8</b> (12 mg, 30 μmol, 21%) as a white solid, mp 225–228 °C.</div><div class="NLM_p last">LCMS (Method A): 0.67 min, [M+H]<sup>+</sup> 378 <i>m</i>/<i>z</i>. IR (solid) 3240 (N–H stretch): 3080 (N–H stretch); 1629 (C═O); 1321, 1144 (O═S═O) cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.77 (s, 1H), 9.37 (s, 1H), 8.23 (s, 1H), 7.81 (s, 1H), 7.65 (s, 1H), 7.34 (s, 1H), 5.05 (s, 2H), 4.96 (s, 2H), 3.96 (s, 3H), 3.07 (s, 3H), 2.07 (s, 3H) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 168.3, 156.1, 141.6, 140.3, 136.6, 132.9, 130.7, 130.4, 129.6, 121.3, 118.9, 115.0, 72.8, 72.1, 53.8, 40.7, 23.4 ppm. HRMS (ESI): calcd for C<sub>17</sub>H<sub>20</sub>N<sub>3</sub>O<sub>5</sub>S [M+H]<sup>+</sup> 378.1118, found 378.1120.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-(6-(6-Methoxy-5-(methylsulfonamido)pyridin-3-yl)-1,3-dihydroisobenzofuran-4-yl)-2-methylthiazole-4-carboxamide (<b>9</b>)</h4><div class="NLM_p">DIPEA (50 μL, 0.30 mmol) and HATU (62 mg, 0.16 mmol) were added sequentially to a stirred solution of 2-methyl-1,3-thiazole-4-carboxylic acid (34 mg, 24 μmol) in DMF (0.5 mL) at room temperature, and the solution was stirred for 10 min. A solution of <b>16</b> (50 mg, 0.15 mmol) in DMF (0.5 mL) was then added dropwise at room temperature, and the solution was stirred at room temperature for 16 h, during which time a white solid precipitated. The mixture was filtered under reduced pressure and washed with water (10 mL) and then diethyl ether (10 mL). The white solid was dried in a vacuum oven for 16 h to afford <b>9</b> (23.5 mg, 50.0 μmol, 21%) as a white solid, mp 274–277 °C.</div><div class="NLM_p last">LCMS (Method A): 0.89 min, [M+H]<sup>+</sup> 461 <i>m</i>/<i>z</i>. IR (solid) 3379 (N–H stretch): 3141 (N–H stretch); 1671 (C═O); 1324, 1136 (O═S═O) cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 10.30 (s, 1H), 9.39 (s, 1H), 8.25–8.44 (m, 2H), 7.93 (d, <i>J</i> = 2.3 Hz, 1H), 7.71 (s, 1H), 7.49 (s, 1H), 5.15 (s, 2H), 5.07 (s, 2H), 4.03 (s, 3H), 3.14 (s, 3H), 2.83 (s, 3H) ppm. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 101 MHz): δ = 166.2, 158.8, 156.0, 148.7, 142.1, 140.1, 136.9, 132.6, 132.1, 130.6, 129.3, 125.4, 121.5, 120.8, 115.8, 72.7, 72.2, 53.7, 40.7, 18.8 ppm. HRMS (ESI): calcd for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>5</sub>S<sub>2</sub> [M+H]<sup>+</sup> 461.0948, found 461.0951.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(6-(6-Methoxy-5-(methylsulfonamido)pyridin-3-yl)-1,3-dihydroisobenzofuran-4-yl)-2-morpholinoacetamide (<b>3</b>)</h4><div class="NLM_p">DIPEA (80 μL, 0.48 mmol) and HATU (100 mg, 260 μmol) were added sequentially to a stirred solution of morpholin-4-ylacetic acid (35 mg, 0.24 mmol) in DMF (0.5 mL) at room temperature. The reaction was stirred for 10 min at room temperature. A solution of <b>16</b> (80 mg, 0.24 mmol) in DMF (0.5 mL) was then added dropwise to the reaction mixture at room temperature, and the mixture was stirred at room temperature for 16 h. The mixture was poured onto EtOAc (2 mL) and brine (3 mL), and the separated organic phase was washed with brine (2 × 3 mL). The combined organic phase was concentrated under a stream of nitrogen to give an orange gum. The gum was dissolved in DMSO/MeOH (1 mL, 1:1 v/v) and purified via MDAP chromatography using a Sunfire C18 column and an ammonium bicarbonate-modified MeCN/water gradient. The relevant fractions were combined, and the volume was reduced by 70% under a stream of nitrogen. A white solid precipitated from the solution. The mixture was filtered under reduced pressure, washed with water (10 mL) and diethyl ether (10 mL), and then dried in a vacuum oven for 1 h to afford <b>3</b> (25 mg, 50 μmol, 22%) as a white solid, mp 218–220 °C.</div><div class="NLM_p last">LCMS (Method A): 0.54 min, [M+H]<sup>+</sup> 463 <i>m</i>/<i>z</i>. IR (solid) 3224 (N–H stretch): 2925 (N–H stretch); 2852 (C–H stretch); 1658 (C═O); 1318, 1142 (O═S═O) cm<sup>–1</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.63 (s, 1H), 9.24–9.46 (m, 1H), 8.24 (d, <i>J</i> = 2.3 Hz, 1H), 7.83 (d, <i>J</i> = 2.3 Hz, 1H), 7.67 (s, 1H), 7.37 (s, 1H), 5.07 (s, 2H), 4.98 (s, 2H), 3.96 (s, 3H), 3.65 (t, <i>J</i> = 4.5 Hz, 4H), 3.15 (s, 2H), 3.07 (s, 3H), 2.53 (t, <i>J</i> = 4.5 Hz, 4H) ppm. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 101 MHz): δ = 168.0, 156.1, 141.6, 140.3, 136.6, 133.1, 130.7, 130.4, 129.6, 121.3, 118.8, 115.0, 72.8, 72.1, 53.8, 40.7, 40.2, 38.9, 23.4 ppm. HRMS (ESI): calcd for C<sub>21</sub>H<sub>27</sub>N<sub>4</sub>O<sub>6</sub>S [M+H]<sup>+</sup> 463.1651, found 463.1656.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(6-(6-Methoxy-5-(methylsulfonamido)pyridin-3-yl)-1,3-dihydroisobenzofuran-4-yl)-6-methylpicolinamide (<b>10</b>)</h4><div class="NLM_p">DIPEA (50 μL, 0.30 mmol) and HATU (62 mg, 0.16 mmol) were added sequentially to a stirred solution of 6-methylpicolinic acid (33 mg, 0.24 mmol) in DMF (0.5 mL) at room temperature, and the solution was stirred for 10 min. A solution of <b>16</b> (50 mg, 0.15 mmol) in DMF (0.5 mL) was then added dropwise at room temperature, and the mixture was stirred at room temperature overnight. The reaction mixture was poured onto EtOAc (2 mL) and brine (3 mL), and the separated organic phase was washed with brine (2 × 3 mL). The combined organic phase was concentrated under a stream of nitrogen to give an orange gum. The gum was loaded in a solution of DMSO/MeOH (1 mL, 1:1 v/v) and purified via MDAP chromatography using a Sunfire C18 column and an ammonium bicarbonate-modified MeCN/water gradient. The relevant fractions were combined and concentrated under a stream of nitrogen to give <b>10</b> (30 mg, 60 μmol, 28%) as a white solid.</div><div class="NLM_p last">LCMS (Method A): 0.99 min, [M+H]<sup>+</sup> 455 <i>m</i>/<i>z</i>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 10.49 (s, 1H), 9.26–9.57 (br. s, 1H), 8.31 (d, <i>J</i> = 2.3 Hz, 1H), 7.94–7.99 (m, 2H), 7.89 (d, <i>J</i> = 2.3 Hz, 1H), 7.81 (s, 1H), 7.56 (dd, <i>J</i> = 6.2, 2.4 Hz, 1H), 7.46 (s, 1H), 5.11 (s, 2H), 5.07 (s, 2H), 3.98 (s, 3H), 3.09 (s, 3H), 2.64 (s, 3H) ppm.</div></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Biology</h3><div id="sec4_150" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> PI3Kα, -β, -γ, and -δ HTRF Assays</h4><div class="NLM_p last">Inhibition of PI3 kinase’s enzymatic activity was determined using a homogeneous time-resolved fluorescence (HTRF) kit assay format provided by Millipore. Reactions were performed in assay buffer containing 50 mM HEPES, pH 7.0, 150 mM NaCl, 10 mM MgCl<sub>2</sub>, <1% cholate (w/v), <1% CHAPS (w/v), 0.05% sodium azide (w/v), and 1 mM DTT. Enzymes were pre-incubated with compound and serially diluted 4-fold in 100% DMSO for 15 min prior to reaction initiation upon addition of substrate solution containing ATP at <i>K</i><sub>m</sub> for the specific isoform tested (α at 250 μM, β at 400 μM, δ at 80 μM, and γ at 15 μM), PIP2 at either 5 μM (PI3Kδ) or 8 μM (PI3Kα, -β, and -γ), and 10 nM biotin-PIP3. Assays were quenched after 60 min by addition of a quench/detection solution prepared in 50 mM HEPES, pH 7.0, 150 mM NaCl, <1% cholate, <1% Tween 20, 30 mM EDTA, 40 mM potassium fluoride, and 1 mM DTT containing 16.5 nM GRP-1 PH domain, 8.3 nM streptavidin-APC, and 2 nM europium-antiGST and were left for a further 60 min in the dark to equilibrate prior to reading using a BMG RubyStar plate reader. Ratio data were normalized to high (no compound) and low (no enzyme) controls prior to fitting using a logistical four-parameter equation to determine IC<sub>50</sub>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Peripheral Blood Mononuclear Cells (PBMC) Assay</h4><div class="NLM_p last">Reagents were purchased from Invitrogen Corporation Ltd. unless otherwise specified. PBMCs were prepared from heparinized human blood (using 1% v/v heparin sodium, 1000 U/mL endotoxin-free, Leo Laboratories Ltd.) using the Accuspin system Histopaque 1077 (Sigma-Aldrich Co. Ltd.). The cells were resuspended in RPMI1640 medium containing 10% fetal calf serum, 1% <span class="smallcaps smallerCapital">l</span>-glutamine, and 1% penicillin/streptomycin. The cells at a density of 5 × 105 viable cells/mL were incubated with 0.0156% (v/v) CytoStim (Miltenyi Biotech). The assay plate was then incubated at 37 °C, 5% CO<sub>2</sub>, for 20 h. The supernatant was removed, and the concentrations of IFNγ were determined by electrochemiluminescence assay using the Meso Scale Discovery (MSD) technology.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Brown Norway Rat Acute OVA Model of Th2-Driven Lung Inflammation</h4><div class="NLM_p last">All reagents, unless stated otherwise, were from Sigma-Aldrich. The models used in these studies conform to U.K. standards of animal care, as laid down by the Home Office. Procedures were carried out exactly as specified under GlaxoSmithKline’s Respiratory Diseases Project license (PPL 80/2361 and 80/1537). Male brown Norway (BN) rats weighing 250–300 g were sensitized by intraperitoneal injection of a 1 mL OVA solution containing 10 μg of OVA and 20 mg of Al(OH)<sub>3</sub> on days 1 and 7. On day 21 or 28, rats were challenged with 0.2 mL of intratracheal (i.t.) OVA solution under isoflurane (Abbott Laboratories) anesthesia. Compound in vehicle (0.2% Tween 80, water, pH 4.5) or vehicle alone was also dosed by i.t. route (0.2 mL volume) at <i>t</i> – 30 min and +24 h relative to i.t. OVA challenge; 48 h after i.t. OVA challenge, rats were sacrificed by anesthetic overdose. The trachea were exposed and lungs were lavaged with 5 mL of lavage fluid (0.1% BSA, 10 mM EDTA, and 1 protease inhibitor tablet, catalog no. 11873580001 from Roche, per 50 mL). Death was confirmed by cervical dislocation. Bronchoalveolar lavage fluid (BAL) was immediately transferred onto ice, and leucocytes were then quantified by flow cytometry. Briefly, samples were read on a BD FACSCANTO II 8 color flow cytometer. Lymphocytes, eosinophils, neutrophils, and macrophages were gated on FSC and SSC using morphological criteria. Threshold was set on FSC channel. In some studies the Amcyan channel was used to gate cells further using autofluorescence (intersecting gates). DAPI+ cells were excluded as dead. For cytokine analysis, mice were lavaged 24 h after OVA challenge. BAL was spun at 4 °C at 300<i>g</i> for 7 min and the supernatant stored at 20 °C prior to analysis. Data from repeat studies were average-standardized and pooled, and a four-parameter nonlinear logistic curve was fitted.</div></div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Pharmacokinetic Studies</h3><div class="NLM_p last">In vitro clearance was determined to assess metabolic stability of compounds in rat microsomes. Microsomes (190 μL, 0.5 mg of protein/mL) were prewarmed for 10 min at 37 °C. The incubation was initiated by addition of NADPH regeneration system (50 μL) and compound (10 μL, 12.5 μM), resulting in a final compound concentration of 0.5 μM in the incubation. Samples (20 μL) were removed at 0, 3, 6, 12, and 30 min, and the reaction was quenched by addition to acetonitrile (100 μL) containing internal standard (IS). Compound remaining was measured using specific LC-MS/MS methods as a ratio to the IS in the absence of a calibration curve. Peak area ratios (compound to IS) were fitted to an unweighted logarithmic decline in substrate. By use of the first-order rate constant, clearance was calculated by adjustment for protein concentration (0.5 mg/mL), volume of the incubation (250 μL), and hepatic scaling factor (52.5 mg of microsomal protein/g of liver). HSA binding was measured via chromatographic analysis according to the published methodology.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Passive membrane permeability was determined in MDCKII-MDR1 cells, at pH 7.4, in the presence of a potent P-glycoprotein inhibitor. Each compound was incubated in duplicate at a concentration of 3 mM on one test occasion. In this assay, the passive apparent permeability (<i>P</i><sub>app</sub>) is reported in nanometers per second (single test occasion). In vivo pharmacokinetics was tested in Sprague–Dawley male rats. Compounds were administered discretely by the oral and intravenous routes at dose levels of 3 and 1 mg/kg, respectively (<i>n</i> = 2 rats/route). Compounds were formulated as a solution in DMSO/PEG200/water (5:45:50 v/v/v) at a dose volume of 6 (oral) or 2 (intravenous) mL/kg. All animals were serially bled from the tail vein, and blood samples collected over a time course of 0–7 h were submitted to LC-MS/MS analysis for the quantification of the parent compound. The main pharmacokinetic parameters were estimated by non-compartmental analysis.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Chemiluminescent Nitrogen Detection (CLND) Solubility Determination</h3><div class="NLM_p">GSK in-house kinetic solubility assay involved the following: 5 mL of 10 mM DMSO stock solution diluted to 100 μL with pH 7.4 phosphate-buffered saline, equilibrated for 1 h at room temperature, filtered through Millipore Multiscreen HTS-PCF filter plates (MSSL BPC). The filtrate was quantified by suitably calibrated flow injection chemiluminescent nitrogen detection.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The standard error of the CLND solubility determination was ±30 μM, and the upper limit of the solubility is 500 μM when working from 10 mM DMSO stock solution.</div><div class="NLM_p last">All animal studies were ethically reviewed and carried out in accordance with Animals (Scientific Procedures) Act 1986 and the GSK Policy on the Care, Welfare and Treatment of Laboratory Animals. The human biological samples were sourced ethically, and their research use was in accord with the terms of the informed consents.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d42e2299-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00799">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00799" class="ext-link">10.1021/acs.jmedchem.6b00799</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00799/suppl_file/jm6b00799_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00799/suppl_file/jm6b00799_si_001.csv">jm6b00799_si_001.csv (1.28 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Compound <b>3</b> PDB accssion code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L72">5L72</a>. The authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b00799" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36330" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36330" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon Peace</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7c0f15111312524e520c191d1f193c1b0f17521f1311"><span class="__cf_email__" data-cfemail="5d2e34303233736f732d383c3e381d3a2e36733e3230">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Augustin Amour</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nick Barton</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony W. J. Cooper</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graham Inglis</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig Jamieson</span> - <span class="hlFld-Affiliation affiliation">Department
of Pure and Applied Chemistry, University
of Strathclyde, 295 Cathedral
Street, Glasgow G1 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher N. Luscombe</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josie Morrell</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Perez</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Rowland</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chris Tame</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sorif Uddin</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanni Vitulli</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natalie Wellaway</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
R&D, Gunnels Wood
Road, Stevenage SG1 2NY, U.K.</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08227" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08227" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Ghigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damilano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braccini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span> </span><span class="NLM_article-title">PI3K inhibition in inflammation: Toward tailored therapies for specific diseases</span> <span class="citation_source-journal">BioEssays</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1002/bies.200900150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1002%2Fbies.200900150" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=185-196&issue=3&author=A.+Ghigoauthor=F.+Damilanoauthor=L.+Bracciniauthor=E.+Hirsch&title=PI3K+inhibition+in+inflammation%3A+Toward+tailored+therapies+for+specific+diseases&doi=10.1002%2Fbies.200900150"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fbies.200900150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbies.200900150%26sid%3Dliteratum%253Aachs%26aulast%3DGhigo%26aufirst%3DA.%26aulast%3DDamilano%26aufirst%3DF.%26aulast%3DBraccini%26aufirst%3DL.%26aulast%3DHirsch%26aufirst%3DE.%26atitle%3DPI3K%2520inhibition%2520in%2520inflammation%253A%2520Toward%2520tailored%2520therapies%2520for%2520specific%2520diseases%26jtitle%3DBioEssays%26date%3D2010%26volume%3D32%26issue%3D3%26spage%3D185%26epage%3D196%26doi%3D10.1002%2Fbies.200900150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iribarren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. M.</span><span> </span><span class="NLM_article-title">The essential role of phosphoinositide 3-kinases (PI3Ks) in regulating pro-inflammatory responses and the progression of cancer</span> <span class="citation_source-journal">Cell. Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=16274621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSitrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=241-252&author=K.+Chenauthor=P.+Iribarrenauthor=W.+Gongauthor=J.+M.+Wang&title=The+essential+role+of+phosphoinositide+3-kinases+%28PI3Ks%29+in+regulating+pro-inflammatory+responses+and+the+progression+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The essential role of phosphoinositide 3-Kinases (PI3Ks) in regulating pro-inflammatory responses and the progression of cancer</span></div><div class="casAuthors">Chen, Keqiang; Iribarren, Pablo; Gong, Wanghua; Wang, Ji-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">241-252</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">Chinese Society of Immunology</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide 3-Kinases (PI3Ks) are proteins coupled to a variety of cell surface receptors and play a key role in signal transduction cascade regulating fundamental cellular functions such as transcription, proliferation, and survival.  PI3Ks also are important in disease processes such as inflammation and cancer.  The aim of this review is to outline current understandings of the PI3K family, mechanism of their activation, their role in inflammatory responses and the development of malignant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorKgtt4FcP87Vg90H21EOLACvtfcHk0li8FbLr5ORf8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSitrrF&md5=c1e52d6c3605cff390c534ad2ef166de</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%26aulast%3DIribarren%26aufirst%3DP.%26aulast%3DGong%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520essential%2520role%2520of%2520phosphoinositide%25203-kinases%2520%2528PI3Ks%2529%2520in%2520regulating%2520pro-inflammatory%2520responses%2520and%2520the%2520progression%2520of%2520cancer%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2005%26volume%3D2%26spage%3D241%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Paz-Ares, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco-Aparicio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Carbonero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span> </span><span class="NLM_article-title">Inhibiting PI3K as a therapeutic strategy against cancer</span> <span class="citation_source-journal">Clin. Transl. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">572</span><span class="NLM_x">–</span> <span class="NLM_lpage">579</span><span class="refDoi"> DOI: 10.1007/s12094-009-0407-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1007%2Fs12094-009-0407-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=19775996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Whur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=572-579&issue=9&author=L.+Paz-Aresauthor=C.+Blanco-Aparicioauthor=R.+Garcia-Carboneroauthor=A.+Carnero&title=Inhibiting+PI3K+as+a+therapeutic+strategy+against+cancer&doi=10.1007%2Fs12094-009-0407-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting PI3K as a therapeutic strategy against cancer</span></div><div class="casAuthors">Paz-Ares, Luis; Blanco-Aparicio, Carmen; Garcia-Carbonero, Rocio; Carnero, Amancio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Translational Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">572-579</span>CODEN:
                <span class="NLM_cas:coden">CTOLAM</span>;
        ISSN:<span class="NLM_cas:issn">1699-048X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Class I PI3K is composed of heterodimeric lipid kinases regulating essential cellular functions including proliferation, apoptosis and metab.  Class I PI3K isoforms are commonly amplified in different cancer types and the PI3Kα catalytic subunit, PIK3CA, has been found mutated in a variable proportion of tumors of different origin.  Furthermore, PI3K has been shown to mediate oncogenic signalling induced by several oncogenes such as HER2 or Ras.  These facts suggest that PI3K might be a good target for anticancer drug discovery.  Today, the rise of PI3K inhibitors and their first in vivo results have cleared much of the path for the development of PI3K inhibitors for anticancer therapy.  Here we will review the PI3K pathway and the pharmacol. results of PI3K inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdCYk5H3lNzrVg90H21EOLACvtfcHk0lgk10XcdPx5Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Whur3J&md5=558d5ae7e8b6ea38c82c8a90cfdce93e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs12094-009-0407-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-009-0407-x%26sid%3Dliteratum%253Aachs%26aulast%3DPaz-Ares%26aufirst%3DL.%26aulast%3DBlanco-Aparicio%26aufirst%3DC.%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DCarnero%26aufirst%3DA.%26atitle%3DInhibiting%2520PI3K%2520as%2520a%2520therapeutic%2520strategy%2520against%2520cancer%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2009%26volume%3D11%26issue%3D9%26spage%3D572%26epage%3D579%26doi%3D10.1007%2Fs12094-009-0407-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Czech, M. P.</span><span> </span><span class="NLM_article-title">PIP2 and PIP3: complex roles at the cell surface</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span><span class="refDoi"> DOI: 10.1016/S0092-8674(00)80696-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2FS0092-8674%2800%2980696-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10761925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFeksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=603-606&author=M.+P.+Czech&title=PIP2+and+PIP3%3A+complex+roles+at+the+cell+surface&doi=10.1016%2FS0092-8674%2800%2980696-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PIP2 and PIP3: complex roles at the cell surface</span></div><div class="casAuthors">Czech, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">603-606</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 22 refs.  Phosphatidylinositol (4,5)bisphosphate (PIP2) and phosphatidylinositol (3,4,5)trisphosphate (PIP3) represent less than 1 % of membrane phospholipids, yet they function in a remarkable no. of crucial cellular processes.  These low-abundance polyphosphoinositides direct two major independent signaling cascades.  PIP3 is the effector of multiple downstream targets of the phosphoinositide 3 kinase (P31K) pathway; PIP2 is the precursor of the mediators diacylglycerol and inositol(1,4,5)P3 following its hydrolysis by hormone-sensitive phospholipase C (PLC) enzymes.  New expts. are now revealing yet another signaling mode controlled by PIP2.  This novel cascade depends on intact PIP2 rather than products of its hydrolysis.  Recent work demonstrates not only new signaling functions of PIP2 but also intricate regulation of membrane phospholipids.  New insights on these events highlight the cell surface membrane as a major site of action of both PIP2 and PIP3 and reveal unexpected cross-talk between these polyphosphoinositides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQekjpcNonwLVg90H21EOLACvtfcHk0lgk10XcdPx5Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFeksrs%253D&md5=372b17fe8ea614a9c72a44e61d0eab37</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980696-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980696-0%26sid%3Dliteratum%253Aachs%26aulast%3DCzech%26aufirst%3DM.%2BP.%26atitle%3DPIP2%2520and%2520PIP3%253A%2520complex%2520roles%2520at%2520the%2520cell%2520surface%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D603%26epage%3D606%26doi%3D10.1016%2FS0092-8674%2800%2980696-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Soond, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørgo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moltu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, V. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torgersen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galleway, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twomey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaston, JS. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskén, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunyard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span> </span><span class="NLM_article-title">PI3K p110δ regulates T cell cytokine production during primary and secondary immune responses in mice and humans</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2213</span><span class="refDoi"> DOI: 10.1182/blood-2009-07-232330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1182%2Fblood-2009-07-232330" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=2203-2213&author=D.+R.+Soondauthor=E.+Bj%C3%B8rgoauthor=K.+Moltuauthor=V.+Q.+Daleauthor=D.+T.+Pattonauthor=K.+M.+Torgersenauthor=F.+Gallewayauthor=B.+Twomeyauthor=J.+Clarkauthor=JS.+H.+Gastonauthor=K.+Task%C3%A9nauthor=P.+Bunyardauthor=K.+Okkenhaug&title=PI3K+p110%CE%B4+regulates+T+cell+cytokine+production+during+primary+and+secondary+immune+responses+in+mice+and+humans&doi=10.1182%2Fblood-2009-07-232330"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-07-232330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-07-232330%26sid%3Dliteratum%253Aachs%26aulast%3DSoond%26aufirst%3DD.%2BR.%26aulast%3DBj%25C3%25B8rgo%26aufirst%3DE.%26aulast%3DMoltu%26aufirst%3DK.%26aulast%3DDale%26aufirst%3DV.%2BQ.%26aulast%3DPatton%26aufirst%3DD.%2BT.%26aulast%3DTorgersen%26aufirst%3DK.%2BM.%26aulast%3DGalleway%26aufirst%3DF.%26aulast%3DTwomey%26aufirst%3DB.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DGaston%26aufirst%3DJS.%2BH.%26aulast%3DTask%25C3%25A9n%26aufirst%3DK.%26aulast%3DBunyard%26aufirst%3DP.%26aulast%3DOkkenhaug%26aufirst%3DK.%26atitle%3DPI3K%2520p110%25CE%25B4%2520regulates%2520T%2520cell%2520cytokine%2520production%2520during%2520primary%2520and%2520secondary%2520immune%2520responses%2520in%2520mice%2520and%2520humans%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D2203%26epage%3D2213%26doi%3D10.1182%2Fblood-2009-07-232330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Brown, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalfe, D. D.</span><span> </span><span class="NLM_article-title">The mast cell and allergic diseases: role in pathogenesis and implications for therapy</span> <span class="citation_source-journal">Clin. Exp. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1111/j.1365-2222.2007.02886.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1111%2Fj.1365-2222.2007.02886.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=18031566" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2007&pages=4-18&author=J.+M.+Brownauthor=T.+M.+Wilsonauthor=D.+D.+Metcalfe&title=The+mast+cell+and+allergic+diseases%3A+role+in+pathogenesis+and+implications+for+therapy&doi=10.1111%2Fj.1365-2222.2007.02886.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2222.2007.02886.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2222.2007.02886.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DT.%2BM.%26aulast%3DMetcalfe%26aufirst%3DD.%2BD.%26atitle%3DThe%2520mast%2520cell%2520and%2520allergic%2520diseases%253A%2520role%2520in%2520pathogenesis%2520and%2520implications%2520for%2520therapy%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2007%26volume%3D38%26spage%3D4%26epage%3D18%26doi%3D10.1111%2Fj.1365-2222.2007.02886.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sadhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masinovsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowell, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staunton, D. E.</span><span> </span><span class="NLM_article-title">Essential role of phosphoinositide 3-kinase δ in neutrophil directional movement</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span><span class="refDoi"> DOI: 10.4049/jimmunol.170.5.2647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.4049%2Fjimmunol.170.5.2647" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=2647-2654&author=C.+Sadhuauthor=B.+Masinovskyauthor=K.+Dickauthor=C.+G.+Sowellauthor=D.+E.+Staunton&title=Essential+role+of+phosphoinositide+3-kinase+%CE%B4+in+neutrophil+directional+movement&doi=10.4049%2Fjimmunol.170.5.2647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.170.5.2647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.170.5.2647%26sid%3Dliteratum%253Aachs%26aulast%3DSadhu%26aufirst%3DC.%26aulast%3DMasinovsky%26aufirst%3DB.%26aulast%3DDick%26aufirst%3DK.%26aulast%3DSowell%26aufirst%3DC.%2BG.%26aulast%3DStaunton%26aufirst%3DD.%2BE.%26atitle%3DEssential%2520role%2520of%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520in%2520neutrophil%2520directional%2520movement%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26spage%3D2647%26epage%3D2654%26doi%3D10.4049%2Fjimmunol.170.5.2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Condliffe, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crabbe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilvers, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span> </span><span class="NLM_article-title">Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1432</span><span class="NLM_x">–</span> <span class="NLM_lpage">1440</span><span class="refDoi"> DOI: 10.1182/blood-2005-03-0944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1182%2Fblood-2005-03-0944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=15878979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXosVejtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=1432-1440&author=A.+M.+Condliffeauthor=K.+Davidsonauthor=K.+E.+Andersonauthor=C.+D.+Ellsonauthor=T.+Crabbeauthor=K.+Okkenhaugauthor=B.+Vanhaesebroeckauthor=M.+Turnerauthor=L.+Webbauthor=M.+P.+Wymannauthor=E.+Hirschauthor=T.+Ruckleauthor=M.+Campsauthor=C.+Rommelauthor=S.+P.+Jacksonauthor=E.+R.+Chilversauthor=L.+R.+Stephensauthor=P.+T.+Hawkins&title=Sequential+activation+of+class+IB+and+class+IA+PI3K+is+important+for+the+primed+respiratory+burst+of+human+but+not+murine+neutrophils&doi=10.1182%2Fblood-2005-03-0944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils</span></div><div class="casAuthors">Condliffe, Alison M.; Davidson, Keith; Anderson, Karen E.; Ellson, Chris D.; Crabbe, Tom; Okkenhaug, Klaus; Vanhaesebroeck, Bart; Turner, Martin; Webb, Louise; Wymann, Matthias P.; Hirsch, Emilio; Ruckle, Thomas; Camps, Montserrat; Rommel, Christian; Jackson, Shaun P.; Chilvers, Edwin R.; Stephens, Len R.; Hawkins, Phillip T.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1432-1440</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">It is well established that preexposure of human neutrophils to proinflammatory cytokines markedly augments the prodn. of reactive oxygen species (ROS) to subsequent stimuli.  This priming event is thought to be crit. for localizing ROS to the vicinity of the inflammation, maximizing their role in the resoln. of the inflammation, and minimizing the damage to surrounding tissue.  We have used a new generation of isoform-selective phosphoinositide 3-kinase (PI3K) inhibitors to show that ROS prodn. under these circumstances is regulated by temporal control of class I PI3K activity.  Stimulation of tumor necrosis factor-α (TNF-α)-primed human neutrophils with N-formylmethionyl-leucyl-phenylalanine (fMLP) results in biphasic activation of PI3K; the first phase is largely dependent on PI3Kγ, and the second phase is largely dependent on PI3Kδ.  The second phase of PI3K activation requires the first phase; it is this second phase that is augmented by TNF-α priming and that regulates parallel activation of ROS prodn.  Surprisingly, although TNF-α-primed mouse bone marrow-derived neutrophils exhibit superficially similar patterns of PI3K activation and ROS prodn. in response to fMLP, these responses are substantially lower and largely dependent on PI3Kγ alone.  These results start to define which PI3K isoforms are responsible for modulating neutrophil responsiveness to infection and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1vJNjX8qhzbVg90H21EOLACvtfcHk0lgMrTUdrmjN1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXosVejtLs%253D&md5=9487e1ec99df95d037ca180b1f5b4810</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-03-0944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-03-0944%26sid%3Dliteratum%253Aachs%26aulast%3DCondliffe%26aufirst%3DA.%2BM.%26aulast%3DDavidson%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DEllson%26aufirst%3DC.%2BD.%26aulast%3DCrabbe%26aufirst%3DT.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DL.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DChilvers%26aufirst%3DE.%2BR.%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26atitle%3DSequential%2520activation%2520of%2520class%2520IB%2520and%2520class%2520IA%2520PI3K%2520is%2520important%2520for%2520the%2520primed%2520respiratory%2520burst%2520of%2520human%2520but%2520not%2520murine%2520neutrophils%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D1432%26epage%3D1440%26doi%3D10.1182%2Fblood-2005-03-0944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Rowan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affleck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amour, A.</span><span> </span><span class="NLM_article-title">Targeting phosphoinositide 3-kinase δ for allergic asthma</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1042/BST20110665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1042%2FBST20110665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=22260698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=240-245&author=W.+C.+Rowanauthor=J.+L.+Smithauthor=K.+Affleckauthor=A.+Amour&title=Targeting+phosphoinositide+3-kinase+%CE%B4+for+allergic+asthma&doi=10.1042%2FBST20110665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phosphoinositide 3-kinase δ for allergic asthma</span></div><div class="casAuthors">Rowan, Wendy C.; Smith, Janet L.; Affleck, Karen; Amour, Augustin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-245</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic inflammation in the lung has long been linked to the pathogenesis of asthma.  Central to this airway inflammation is a T-cell response to allergens, with Th2 cytokines driving the differentiation, survival and function of the major inflammatory cells involved in the allergic cascade.  PI3Kδ (phosphoinositide 3-kinase δ) is a lipid kinase, expressed predominantly in leukocytes, where it plays a crit. role in immune receptor signalling.  A selective PI3Kδ inhibitor is predicted to block T-cell activation in the lung, reducing the prodn. of pro-inflammatory Th2 cytokines.  PI3Kδ is also involved in B-cell and mast cell activation.  Therefore the inhibition of PI3Kδ should dampen down the inflammatory cascade involved in the asthmatic response through a wide breadth of pharmacol.  Current anti-inflammatory therapies, which are based on corticosteroids, are effective in controlling inflammation in mild asthmatics, but moderate/severe asthmatic patients remain poorly controlled, experiencing recurrent exacerbations.  Corticosteroids have no effect on mast cell degranulation and do not act directly on B-cells, so, overall, a PI3Kδ inhibitor has the potential to deliver improvements in onset of action, efficacy and reduced exacerbations in moderate/severe asthmatics.  Addnl., PI3Kδ inhibition is expected to block effects of Th17 cells, which are increasingly implicated in steroid-insensitive asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKwu2SYlFjDbVg90H21EOLACvtfcHk0lgMrTUdrmjN1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGjs7s%253D&md5=db36bc8f79c70e0817e00fb9b04f10ff</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1042%2FBST20110665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110665%26sid%3Dliteratum%253Aachs%26aulast%3DRowan%26aufirst%3DW.%2BC.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DAmour%26aufirst%3DA.%26atitle%3DTargeting%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520for%2520allergic%2520asthma%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D240%26epage%3D245%26doi%3D10.1042%2FBST20110665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Sriskantharajah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamblin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worsley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calver, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessel, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amour, A.</span><span> </span><span class="NLM_article-title">Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1280</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1111/nyas.12039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1111%2Fnyas.12039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=23551101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1280&publication_year=2013&pages=35-39&author=S.+Sriskantharajahauthor=N.+Hamblinauthor=S.+Worsleyauthor=A.+R.+Calverauthor=E.+M.+Hesselauthor=A.+Amour&title=Targeting+phosphoinositide+3-kinase+%CE%B4+for+the+treatment+of+respiratory+diseases&doi=10.1111%2Fnyas.12039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases</span></div><div class="casAuthors">Sriskantharajah, Srividya; Hamblin, Nicole; Worsley, Sally; Calver, Andrew R.; Hessel, Edith M.; Amour, Augustin</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1280</span>
        (<span class="NLM_cas:issue">Inositol Phospholipid Signaling in Physiology and Disease</span>),
    <span class="NLM_cas:pages">35-39</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Asthma and chronic obstructive pulmonary disease (COPD) are characterized in their pathogenesis by chronic inflammation in the airways.  Phosphoinositide 3-kinase δ (PI3Kδ), a lipid kinase expressed predominantly in leukocytes, is thought to hold much promise as a therapeutic target for such inflammatory conditions.  Of particular interest for the treatment of severe respiratory disease is the observation that inhibition of PI3Kδ may restore steroid effectiveness under conditions of oxidative stress.  PI3Kδ inhibition may also prevent recruitment of inflammatory cells, including T lymphocytes and neutrophils, as well as the release of proinflammatory mediators, such as cytokines, chemokines, reactive oxygen species, and proteolytic enzymes.  In addn., targeting the PI3Kδ pathway could reduce the incidence of pathogen-induced exacerbations by improving macrophage-mediated bacterial clearance.  In this review, we discuss the potential and highlight the unknowns of targeting PI3Kδ for the treatment of respiratory disease, focusing on recent developments in the role of the PI3Kδ pathway in inflammatory cell types believed to be crit. to the pathogenesis of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFa4PRY73w17Vg90H21EOLACvtfcHk0lgLr7ie-3o83g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWgtL0%253D&md5=51549242bdf01d3373ded21565656f1d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fnyas.12039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.12039%26sid%3Dliteratum%253Aachs%26aulast%3DSriskantharajah%26aufirst%3DS.%26aulast%3DHamblin%26aufirst%3DN.%26aulast%3DWorsley%26aufirst%3DS.%26aulast%3DCalver%26aufirst%3DA.%2BR.%26aulast%3DHessel%26aufirst%3DE.%2BM.%26aulast%3DAmour%26aufirst%3DA.%26atitle%3DTargeting%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520for%2520the%2520treatment%2520of%2520respiratory%2520diseases%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2013%26volume%3D1280%26spage%3D35%26epage%3D39%26doi%3D10.1111%2Fnyas.12039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ball, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span> </span><span class="NLM_article-title">PI3K inhibitors as potential therapeutics for autoimmune disease</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2Fj.drudis.2014.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=24735732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVWkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1195-1199&author=J.+Ballauthor=S.+Archerauthor=S.+Ward&title=PI3K+inhibitors+as+potential+therapeutics+for+autoimmune+disease&doi=10.1016%2Fj.drudis.2014.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K inhibitors as potential therapeutics for autoimmune disease</span></div><div class="casAuthors">Ball, Jennifer; Archer, Sophie; Ward, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1195-1199</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Aberrant overactivation of the immune system can give rise to chronic and persistent self-attack, culminating in autoimmune disease.  This is currently managed therapeutically using potent immunosuppressive and anti-inflammatory drugs.  Class I phosphoinositide 3-kinases (PI3Ks) have been identified as ideal therapeutic targets for autoimmune diseases given their wide-ranging roles in immunol. processes.  Recent studies into the function of selective PI3K inhibitors in vitro and in vivo have yielded encouraging results, allowing progression into the clinic.  Here, we review their recent progress across a range of autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxxinvi1jaCbVg90H21EOLACvtfcHk0lgLr7ie-3o83g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVWkuro%253D&md5=68b502511b94de36aff58f8017427de4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DBall%26aufirst%3DJ.%26aulast%3DArcher%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DS.%26atitle%3DPI3K%2520inhibitors%2520as%2520potential%2520therapeutics%2520for%2520autoimmune%2520disease%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1195%26epage%3D1199%26doi%3D10.1016%2Fj.drudis.2014.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilancio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geering, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foukas, L. C.</span><span> </span><span class="NLM_article-title">Signalling by PI3K isoforms: insights from gene-targeted mice</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1016/j.tibs.2005.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2Fj.tibs.2005.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=15817396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVyqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2005&pages=194-204&author=B.+Vanhaesebroeckauthor=K.+Aliauthor=A.+Bilancioauthor=B.+Geeringauthor=L.+C.+Foukas&title=Signalling+by+PI3K+isoforms%3A+insights+from+gene-targeted+mice&doi=10.1016%2Fj.tibs.2005.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling by PI3K isoforms: insights from gene-targeted mice</span></div><div class="casAuthors">Vanhaesebroeck, Bart; Ali, Khaled; Bilancio, Antonio; Geering, Barbara; Foukas, Lazaros C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">194-204</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide 3-kinases (PI3Ks) generate lipids that control a wide variety of intracellular signaling pathways.  Part of this diversity in PI3K actions stems from the broad range of protein effectors of the PI3K lipids.  A further layer of complexity is added by the existence of multiple isoforms of PI3K.  Gene-targeting studies in the mouse have recently uncovered key roles for specific PI3K isoforms in immunity, metab. and cardiac function.  Remarkably, some of these actions do not require PI3K catalytic activity.  In addn., loss-of-expression of certain PI3K genes leads to increased PI3K signaling following insulin stimulation.  PI3K gene targeting has, in many cases, led to altered expression of the non-targeted PI3K subunits, making it difficult to exclude that some of the reported phenotypes result from knock-on' effects of PI3K gene deletion.  Targeting strategies that take into account the complex interplay between members of the PI3K family will be crucial to gain a full understanding of the physiol. roles of the isoforms of PI3K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc_FGLImCtxLVg90H21EOLACvtfcHk0lgLr7ie-3o83g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVyqsrw%253D&md5=d9222d98fa5cfb845290cf17cda50ff8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2005.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2005.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DAli%26aufirst%3DK.%26aulast%3DBilancio%26aufirst%3DA.%26aulast%3DGeering%26aufirst%3DB.%26aulast%3DFoukas%26aufirst%3DL.%2BC.%26atitle%3DSignalling%2520by%2520PI3K%2520isoforms%253A%2520insights%2520from%2520gene-targeted%2520mice%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2005%26volume%3D30%26spage%3D194%26epage%3D204%26doi%3D10.1016%2Fj.tibs.2005.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rückle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span> </span><span class="NLM_article-title">PI3Kγ inhibition: towards an ’aspirin of the 21st century’?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1038/nrd2145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1038%2Fnrd2145" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=903-18&author=T.+R%C3%BCckleauthor=M.+K.+Schwarzauthor=C.+Rommel&title=PI3K%CE%B3+inhibition%3A+towards+an+%E2%80%99aspirin+of+the+21st+century%E2%80%99%3F&doi=10.1038%2Fnrd2145"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd2145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2145%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DRommel%26aufirst%3DC.%26atitle%3DPI3K%25CE%25B3%2520inhibition%253A%2520towards%2520an%2520%25E2%2580%2599aspirin%2520of%2520the%252021st%2520century%25E2%2580%2599%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D903%26epage%3D18%26doi%3D10.1038%2Fnrd2145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Down, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, A. J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deakin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felton, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntrip, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeling, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunniss, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitulli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washio, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamblin, J. N.</span><span> </span><span class="NLM_article-title">Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7381</span><span class="NLM_x">–</span> <span class="NLM_lpage">7399</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00767</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00767" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyjsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7381-7399&author=K.+Downauthor=A.+Amourauthor=I.+R.+Baldwinauthor=A.+J.+W.+Cooperauthor=A.+M.+Deakinauthor=L.+M.+Feltonauthor=S.+B.+Guntripauthor=C.+Hardyauthor=Z.+A.+Harrisonauthor=K.+L.+Jonesauthor=P.+Jonesauthor=S.+E.+Keelingauthor=J.+Leauthor=S.+Liviaauthor=F.+Lucasauthor=C.+J.+Lunnissauthor=N.+J.+Parrauthor=E.+Robinsonauthor=P.+Rowlandauthor=S.+Smithauthor=D.+A.+Thomasauthor=G.+Vitulliauthor=Y.+Washioauthor=J.+N.+Hamblin&title=Optimization+of+Novel+Indazoles+as+Highly+Potent+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B4+for+the+Treatment+of+Respiratory+Disease&doi=10.1021%2Facs.jmedchem.5b00767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease</span></div><div class="casAuthors">Down, Kenneth; Amour, Augustin; Baldwin, Ian R.; Cooper, Anthony W. J.; Deakin, Angela M.; Felton, Leigh M.; Guntrip, Stephen B.; Hardy, Charlotte; Harrison, Zoe A.; Jones, Katherine L.; Jones, Paul; Keeling, Suzanne E.; Le, Joelle; Livia, Stefano; Lucas, Fiona; Lunniss, Christopher J.; Parr, Nigel J.; Robinson, Ed; Rowland, Paul; Smith, Sarah; Thomas, Daniel A.; Vitulli, Giovanni; Washio, Yoshiaki; Hamblin, J. Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7381-7399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of lead compd., through extensive use of structure-based design and a focus on PI3Kδ potency, isoform selectivity, and inhaled PK properties, led to the discovery of clin. candidates I (GSK2269557) and II (GSK2292767) for the treatment of respiratory indications via inhalation.  Compds. I and II are both highly selective for PI3Kδ over the closely related isoforms and are active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUYzpPxn_ArbVg90H21EOLACvtfcHk0lgB9QAlr0meHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyjsrvJ&md5=2fe8e51a64e6f7c798bdcb63781d02ad</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00767%26sid%3Dliteratum%253Aachs%26aulast%3DDown%26aufirst%3DK.%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DBaldwin%26aufirst%3DI.%2BR.%26aulast%3DCooper%26aufirst%3DA.%2BJ.%2BW.%26aulast%3DDeakin%26aufirst%3DA.%2BM.%26aulast%3DFelton%26aufirst%3DL.%2BM.%26aulast%3DGuntrip%26aufirst%3DS.%2BB.%26aulast%3DHardy%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DZ.%2BA.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKeeling%26aufirst%3DS.%2BE.%26aulast%3DLe%26aufirst%3DJ.%26aulast%3DLivia%26aufirst%3DS.%26aulast%3DLucas%26aufirst%3DF.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DParr%26aufirst%3DN.%2BJ.%26aulast%3DRobinson%26aufirst%3DE.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWashio%26aufirst%3DY.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26atitle%3DOptimization%2520of%2520Novel%2520Indazoles%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%2520for%2520the%2520Treatment%2520of%2520Respiratory%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7381%26epage%3D7399%26doi%3D10.1021%2Facs.jmedchem.5b00767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Winkler, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faia, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiNitto, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proctor, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lussier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyt, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillotson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutok, J. L.</span><span> </span><span class="NLM_article-title">PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1364</span><span class="NLM_x">–</span> <span class="NLM_lpage">1374</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2013.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2Fj.chembiol.2013.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=24211136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslClsrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1364-1374&author=D.+G.+Winklerauthor=K.+L.+Faiaauthor=J.+P.+DiNittoauthor=J.+A.+Aliauthor=K.+F.+Whiteauthor=E.+E.+Brophyauthor=M.+M.+Pinkauthor=J.+L.+Proctorauthor=J.+Lussierauthor=C.+M.+Martinauthor=J.+G.+Hoytauthor=B.+Tillotsonauthor=E.+L.+Murphyauthor=A.+R.+Limauthor=B.+D.+Thomasauthor=J.+R.+MacDougallauthor=P.+Renauthor=Y.+Liuauthor=L.+S.+Liauthor=K.+A.+Jessenauthor=C.+C.+Fritzauthor=J.+L.+Dunbarauthor=J.+R.+Porterauthor=C.+Rommelauthor=V.+J.+Palombellaauthor=P.+S.+Changelianauthor=J.+L.+Kutok&title=PI3K-%CE%B4+and+PI3K-%CE%B3+inhibition+by+IPI-145+abrogates+immune+responses+and+suppresses+activity+in+autoimmune+and+inflammatory+disease+models&doi=10.1016%2Fj.chembiol.2013.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models</span></div><div class="casAuthors">Winkler, David G.; Faia, Kerrie L.; DiNitto, Jonathan P.; Ali, Janid A.; White, Kerry F.; Brophy, Erin E.; Pink, Melissa M.; Proctor, Jennifer L.; Lussier, Jennifer; Martin, Christian M.; Hoyt, Jennifer G.; Tillotson, Bonnie; Murphy, Erin L.; Lim, Alice R.; Thomas, Brian D.; MacDougall, John R.; Ren, Pingda; Liu, Yi; Li, Lian-Sheng; Jessen, Katti A.; Fritz, Christian C.; Dunbar, Joi L.; Porter, James R.; Rommel, Christian; Palombella, Vito J.; Changelian, Paul S.; Kutok, Jeffery L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1364-1374</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Phosphoinositide-3 kinase (PI3K)-δ and PI3K-γ are preferentially expressed in immune cells, and inhibitors targeting these isoforms are hypothesized to have anti-inflammatory activity by affecting the adaptive and innate immune response.  We report on a potent oral PI3K-δ and PI3K-γ inhibitor (IPI-145) and characterize this compd. in biochem., cellular, and in vivo assays.  These studies demonstrate that IPI-145 exerts profound effects on adaptive and innate immunity by inhibiting B and T cell proliferation, blocking neutrophil migration, and inhibiting basophil activation.  We explored the therapeutic value of combined PI3K-δ and PI3K-γ blockade, and IPI-145 showed potent activity in collagen-induced arthritis, ovalbumin-induced asthma, and systemic lupus erythematosus rodent models.  These findings support the hypothesis that inhibition of immune function can be achieved through PI3K-δ and PI3K-γ blockade, potentially leading to significant therapeutic effects in multiple inflammatory, autoimmune, and hematol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHLymau7LdZrVg90H21EOLACvtfcHk0lgB9QAlr0meHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslClsrvN&md5=b9fdfd9444ac255430ff6c8a0fb71ab9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DWinkler%26aufirst%3DD.%2BG.%26aulast%3DFaia%26aufirst%3DK.%2BL.%26aulast%3DDiNitto%26aufirst%3DJ.%2BP.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DWhite%26aufirst%3DK.%2BF.%26aulast%3DBrophy%26aufirst%3DE.%2BE.%26aulast%3DPink%26aufirst%3DM.%2BM.%26aulast%3DProctor%26aufirst%3DJ.%2BL.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DC.%2BM.%26aulast%3DHoyt%26aufirst%3DJ.%2BG.%26aulast%3DTillotson%26aufirst%3DB.%26aulast%3DMurphy%26aufirst%3DE.%2BL.%26aulast%3DLim%26aufirst%3DA.%2BR.%26aulast%3DThomas%26aufirst%3DB.%2BD.%26aulast%3DMacDougall%26aufirst%3DJ.%2BR.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DFritz%26aufirst%3DC.%2BC.%26aulast%3DDunbar%26aufirst%3DJ.%2BL.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26atitle%3DPI3K-%25CE%25B4%2520and%2520PI3K-%25CE%25B3%2520inhibition%2520by%2520IPI-145%2520abrogates%2520immune%2520responses%2520and%2520suppresses%2520activity%2520in%2520autoimmune%2520and%2520inflammatory%2520disease%2520models%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1364%26epage%3D1374%26doi%3D10.1016%2Fj.chembiol.2013.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Lannutti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashishian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span> </span><span class="NLM_article-title">CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1182/blood-2010-03-275305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1182%2Fblood-2010-03-275305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16i&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=20959606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1aqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=591-594&author=B.+J.+Lannuttiauthor=S.+A.+Meadowsauthor=S.+E.+Hermanauthor=A.+Kashishianauthor=B.+Steinerauthor=A.+J.+Johnsonauthor=J.+C.+Byrdauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=M.+Deiningerauthor=B.+J.+Drukerauthor=K.+D.+Puriauthor=R.+G.+Ulrichauthor=N.+A.+Giese&title=CAL-101%2C+a+p110delta+selective+phosphatidylinositol-3-kinase+inhibitor+for+the+treatment+of+B-cell+malignancies%2C+inhibits+PI3K+signaling+and+cellular+viability&doi=10.1182%2Fblood-2010-03-275305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16iR"><div class="casContent"><span class="casTitleNuber">16i</span><div class="casTitle"><span class="NLM_cas:atitle">CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability</span></div><div class="casAuthors">Lannutti, Brian J.; Meadows, Sarah A.; Herman, Sarah E. M.; Kashishian, Adam; Steiner, Bart; Johnson, Amy J.; Byrd, John C.; Tyner, Jeffrey W.; Loriaux, Marc M.; Deininger, Mike; Druker, Brian J.; Puri, Kamal D.; Ulrich, Roger G.; Giese, Neill A.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">591-594</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase p110δ serves as a central integration point for signaling from cell surface receptors known to promote malignant B-cell proliferation and survival.  This provides a rationale for the development of small mol. inhibitors that selectively target p110δ as a treatment approach for patients with B-cell malignancies.  We thus identified 5-fluoro-3-phenyl-2-[(S)-1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one (CAL-101), a highly selective and potent p110δ small mol. inhibitor (half-maximal effective concn. [EC50] = 8nM).  Using tumor cell lines and primary patient samples representing multiple B-cell malignancies, we have demonstrated that constitutive phosphatidylinositol-3-kinase pathway activation is p110δ-dependent.  CAL-101 blocked constitutive phosphatidylinositol-3-kinase signaling, resulting in decreased phosphorylation of Akt and other downstream effectors, an increase in poly(ADP-ribose) polymerase and caspase cleavage and an induction of apoptosis.  These effects have been obsd. across a broad range of immature and mature B-cell malignancies, thereby providing a rationale for the ongoing clin. evaluation of CAL-101.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrID8zgXRVmvbVg90H21EOLACvtfcHk0lgyPa_fmdYX6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1aqtro%253D&md5=423bf1fbea274424db3b818fdc6733b0</span></div><a href="/servlet/linkout?suffix=cit16i&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-03-275305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-03-275305%26sid%3Dliteratum%253Aachs%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26aulast%3DMeadows%26aufirst%3DS.%2BA.%26aulast%3DHerman%26aufirst%3DS.%2BE.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDeininger%26aufirst%3DM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26atitle%3DCAL-101%252C%2520a%2520p110delta%2520selective%2520phosphatidylinositol-3-kinase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520B-cell%2520malignancies%252C%2520inhibits%2520PI3K%2520signaling%2520and%2520cellular%2520viability%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26spage%3D591%26epage%3D594%26doi%3D10.1182%2Fblood-2010-03-275305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16ii"><span><span class="NLM_label">(ii) </span><span class="NLM_contrib-group">Furman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutre, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillmen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrientos, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelenetz, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipps, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flinn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eradat, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ervin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamanna, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coiffier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettitt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stilgenbauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahn, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansey, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. M.</span><span> </span><span class="NLM_article-title">Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span><span class="refDoi"> DOI: 10.1056/NEJMoa1315226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16ii&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1056%2FNEJMoa1315226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16ii&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=24450857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16ii&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVyqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=997-1007&author=R.+R.+Furmanauthor=J.+P.+Sharmanauthor=S.+E.+Coutreauthor=B.+D.+Chesonauthor=J.+M.+Pagelauthor=P.+Hillmenauthor=J.+C.+Barrientosauthor=A.+D.+Zelenetzauthor=T.+J.+Kippsauthor=I.+Flinnauthor=P.+Ghiaauthor=H.+Eradatauthor=T.+Ervinauthor=N.+Lamannaauthor=B.+Coiffierauthor=A.+R.+Pettittauthor=S.+Maauthor=S.+Stilgenbauerauthor=P.+Cramerauthor=M.+Aielloauthor=D.+M.+Johnsonauthor=L.+L.+Millerauthor=D.+Liauthor=T.+M.+Jahnauthor=R.+D.+Danseyauthor=M.+Hallekauthor=S.+M.+O%E2%80%99Brien&title=Idelalisib+and+Rituximab+in+Relapsed+Chronic+Lymphocytic+Leukemia&doi=10.1056%2FNEJMoa1315226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16iiR"><div class="casContent"><span class="casTitleNuber">16ii</span><div class="casTitle"><span class="NLM_cas:atitle">Idelalisib and rituximab in relapsed chronic lymphocytic leukemia</span></div><div class="casAuthors">Furman, Richard R.; Sharman, Jeff P.; Coutre, Steven E.; Cheson, Bruce D.; Pagel, John M.; Hillmen, Peter; Barrientos, Jacqueline C.; Zelenetz, Andrew D.; Kipps, Thomas J.; Flinn, Ian; Ghia, Paolo; Eradat, Herbert; Ervin, Thomas; Lamanna, Nicole; Coiffier, Bertrand; Pettitt, Andrew R.; Ma, Shuo; Stilgenbauer, Stephan; Cramer, Paula; Aiello, Maria; Johnson, Dave M.; Miller, Langdon L.; Li, Daniel; Jahn, Thomas M.; Dansey, Roger D.; Hallek, Michael; O'Brien, Susan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">997-1007</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Patients with relapsed chronic lymphocytic leukemia (CLL) who have clin. significant coexisting medical conditions are less able to undergo std. chemotherapy.  Effective therapies with acceptable side-effect profiles are needed for this patient population.  In this multicenter, randomized, double-blind, placebo-controlled, phase 3 study, the authors assessed the efficacy and safety of idelalisib, an oral inhibitor of the delta isoform of phosphatidylinositol 3-kinase, in combination with rituximab vs. rituximab plus placebo.  The authors randomly assigned 220 patients with decreased renal function, previous therapy-induced myelosuppression, or major coexisting illnesses to receive rituximab and either idelalisib (at a dose of 150 mg) or placebo twice daily.  The primary end point was progression-free survival.  At the first prespecified interim anal., the study was stopped early on the recommendation of the data and safety monitoring board owing to overwhelming efficacy.  The median progression-free survival was 5.5 mo in the placebo group and was not reached in the idelalisib group (hazard ratio for progression or death in the idelalisib group, 0.15; P<0.001).  Patients receiving idelalisib vs. those receiving placebo had improved rates of overall response (81% vs. 13%; odds ratio, 29.92; P<0.001) and overall survival at 12 mo (92% vs. 80%; hazard ratio for death, 0.28; P = 0.02).  Serious adverse events occurred in 40% of the patients receiving idelalisib and rituximab and in 35% of those receiving placebo and rituximab.  The combination of idelalisib and rituximab, as compared with placebo and rituximab, significantly improved progression-free survival, response rate, and overall survival among patients with relapsed CLL who were less able to undergo chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhnTsUaIOybVg90H21EOLACvtfcHk0lgyPa_fmdYX6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVyqtLs%253D&md5=4bce9ab0dae94360abfcd4f312691503</span></div><a href="/servlet/linkout?suffix=cit16ii&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1315226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1315226%26sid%3Dliteratum%253Aachs%26aulast%3DFurman%26aufirst%3DR.%2BR.%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DCoutre%26aufirst%3DS.%2BE.%26aulast%3DCheson%26aufirst%3DB.%2BD.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DHillmen%26aufirst%3DP.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DZelenetz%26aufirst%3DA.%2BD.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DFlinn%26aufirst%3DI.%26aulast%3DGhia%26aufirst%3DP.%26aulast%3DEradat%26aufirst%3DH.%26aulast%3DErvin%26aufirst%3DT.%26aulast%3DLamanna%26aufirst%3DN.%26aulast%3DCoiffier%26aufirst%3DB.%26aulast%3DPettitt%26aufirst%3DA.%2BR.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DStilgenbauer%26aufirst%3DS.%26aulast%3DCramer%26aufirst%3DP.%26aulast%3DAiello%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BM.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DJahn%26aufirst%3DT.%2BM.%26aulast%3DDansey%26aufirst%3DR.%2BD.%26aulast%3DHallek%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BM.%26atitle%3DIdelalisib%2520and%2520Rituximab%2520in%2520Relapsed%2520Chronic%2520Lymphocytic%2520Leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D997%26epage%3D1007%26doi%3D10.1056%2FNEJMoa1315226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Shin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchomel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vissinga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wannberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whoriskey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushing, T. D.</span><span> </span><span class="NLM_article-title">Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01651</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01651" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFylurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=431-447&author=Y.+Shinauthor=J.+Suchomelauthor=M.+Cardozoauthor=J.+Duquetteauthor=X.+Heauthor=K.+Henneauthor=Y.+L.+Huauthor=R.+C.+Kellyauthor=J.+McCarterauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=D.+Metzauthor=T.+San+Miguelauthor=M.+Mohnauthor=T.+Tranauthor=C.+Vissingaauthor=S.+Wongauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=J.+Whoriskeyauthor=G.+Yuauthor=L.+Zalamedaauthor=X.+Zhangauthor=T.+D.+Cushing&title=Discovery%2C+Optimization%2C+and+in+Vivo+Evaluation+of+Benzimidazole+Derivatives+AM-8508+and+AM-9635+as+Potent+and+Selective+PI3K%CE%B4+Inhibitors&doi=10.1021%2Facs.jmedchem.5b01651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors</span></div><div class="casAuthors">Shin, Youngsook; Suchomel, Julia; Cardozo, Mario; Duquette, Jason; He, Xiao; Henne, Kirk; Hu, Yi-Ling; Kelly, Ron C.; McCarter, John; McGee, Lawrence R.; Medina, Julio C.; Metz, Daniela; San Miguel, Tisha; Mohn, Deanna; Tran, Thuy; Vissinga, Christine; Wong, Simon; Wannberg, Sharon; Whittington, Douglas A.; Whoriskey, John; Yu, Gang; Zalameda, Leeanne; Zhang, Xuxia; Cushing, Timothy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">431-447</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lead optimization efforts resulted in the discovery of two potent, selective, and orally bioavailable PI3Kδ inhibitors, 1 (AM-8508) and 2 (AM-9635), with good pharmacokinetic properties.  The compds. inhibit B cell receptor (BCR)-mediated AKT phosphorylation (pAKT) in PI3Kδ-dependent in vitro cell based assays.  These compds. which share a benzimidazole bicycle are effective when administered in vivo at unbound concns. consistent with their in vitro cell potency as a consequence of improved unbound drug concn. with lower unbound clearance.  Furthermore, the compds. demonstrated efficacy in a Keyhole Limpet Hemocyanin (KLH) study in rats, where the blockade of PI3Kδ activity by inhibitors 1 and 2 led to effective inhibition of antigen-specific IgG and IgM formation after immunization with KLH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr81OyYoamY1rVg90H21EOLACvtfcHk0liqEiELAG_91g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFylurnP&md5=258ce4cf8c13cf799f342ebab3137264</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01651%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DY.%26aulast%3DSuchomel%26aufirst%3DJ.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHenne%26aufirst%3DK.%26aulast%3DHu%26aufirst%3DY.%2BL.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohn%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DVissinga%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWhoriskey%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26atitle%3DDiscovery%252C%2520Optimization%252C%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520Benzimidazole%2520Derivatives%2520AM-8508%2520and%2520AM-9635%2520as%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D431%26epage%3D447%26doi%3D10.1021%2Facs.jmedchem.5b01651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=21129497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.; Young, Robert J.; Pickett, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of carboarom., heteroarom., carboaliph. and heteroaliph. ring counts and fused arom. ring count on several developability measures (soly., lipophilicity, protein binding, P 450 inhibition and hERG binding) is the topic for this review article.  Recent results indicate that increasing ring counts have detrimental effects on developability in the order carboaroms. » heteroaroms. > carboaliphatics > heteroaliphatics, with heteroaliphatics exerting a beneficial effect in many cases.  Increasing arom. ring count exerts effects on several developability parameters that are lipophilicity- and size-independent, and fused arom. systems have a beneficial effect relative to their nonfused counterparts.  Increasing arom. ring count has a detrimental effect on human bioavailability parameters, and heteroarom. ring count (but not other ring counts) has increased over time in marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYPC7hkoyv7Vg90H21EOLACvtfcHk0liqEiELAG_91g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D&md5=8e2d0e4e499d2f07d66ca2f385defb2d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Zientek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayscue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klug-McLeod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekins, S.</span><span> </span><span class="NLM_article-title">Integrated in silico-in vitro strategy for addressing cytochrome P450 3A4 time-dependent inhibition<i>Chem</i></span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1021/tx900417f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx900417f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=664-676&author=M.+Zientekauthor=C.+Stonerauthor=R.+Ayscueauthor=J.+Klug-McLeodauthor=Y.+Jiangauthor=M.+Westauthor=C.+Collinsauthor=S.+Ekins&title=Integrated+in+silico-in+vitro+strategy+for+addressing+cytochrome+P450+3A4+time-dependent+inhibitionChem&doi=10.1021%2Ftx900417f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Ftx900417f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx900417f%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DStoner%26aufirst%3DC.%26aulast%3DAyscue%26aufirst%3DR.%26aulast%3DKlug-McLeod%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DWest%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DEkins%26aufirst%3DS.%26atitle%3DIntegrated%2520in%2520silico-in%2520vitro%2520strategy%2520for%2520addressing%2520cytochrome%2520P450%25203A4%2520time-dependent%2520inhibitionChem%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2010%26volume%3D23%26spage%3D664%26epage%3D676%26doi%3D10.1021%2Ftx900417f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span><span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0liqEiELAG_91g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lgRLReA76cxWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, L.</span><span> </span><span class="NLM_article-title">PLS-regression: a basic tool of chemometrics</span> <span class="citation_source-journal">Chemom. Intell. Lab. Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1016/S0169-7439(01)00155-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2FS0169-7439%2801%2900155-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=109-130&author=S.+Woldauthor=M.+Sj%C3%B6str%C3%B6mauthor=L.+Eriksson&title=PLS-regression%3A+a+basic+tool+of+chemometrics&doi=10.1016%2FS0169-7439%2801%2900155-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">PLS-regression: a basic tool of chemometrics</span></div><div class="casAuthors">Wold, Svante; Sjostrom, Michael; Eriksson, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Chemometrics and Intelligent Laboratory Systems</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-130</span>CODEN:
                <span class="NLM_cas:coden">CILSEN</span>;
        ISSN:<span class="NLM_cas:issn">0169-7439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review on PLS-regression (PLSR) as a std. tool in chemometrics and used in chem. and engineering.  The underlying model and its assumption and commonly used diagnostics are discussed, together with the interpretation of resulting parameters.  Two examples are used as illustrations: first, a Quant. Structure-Activity Relationship (QSAR)/Quant. Structure Property Relationship (QSPR) data set of peptides is used to outline the development, interpretation, and refinement of a PLSR model.  Second, a data set from the manufg. of recycled paper is analyzed to illustrate time series modeling of process data by means of PLSR and time-lagged X-variables.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIKGNtaZZXqbVg90H21EOLACvtfcHk0lgRLReA76cxWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLw%253D&md5=2d7fd1e946600e138ac92699ebcc7e29</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0169-7439%2801%2900155-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-7439%252801%252900155-1%26sid%3Dliteratum%253Aachs%26aulast%3DWold%26aufirst%3DS.%26aulast%3DSj%25C3%25B6str%25C3%25B6m%26aufirst%3DM.%26aulast%3DEriksson%26aufirst%3DL.%26atitle%3DPLS-regression%253A%2520a%2520basic%2520tool%2520of%2520chemometrics%26jtitle%3DChemom.%2520Intell.%2520Lab.%2520Syst.%26date%3D2001%26volume%3D58%26spage%3D109%26epage%3D130%26doi%3D10.1016%2FS0169-7439%2801%2900155-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices for effective drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1517/17460441.2.4.469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1517%2F17460441.2.4.469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=23484756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=469-488&author=C.+Abad-Zapatero&title=Ligand+efficiency+indices+for+effective+drug+discovery&doi=10.1517%2F17460441.2.4.469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices for effective drug discovery</span></div><div class="casAuthors">Abad-Zapatero, Cele</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-488</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Successful drug discovery requires the optimization of a large no. of variables ranging from strictly physicochem. parameters such as mol. wt. to more complex parameters related to toxicity and bioavailability.  Presently, structure-based methodologies influence many aspects of the drug discovery process from lead discovery to the final preclin. characterization.  However, crit. biol. issues along the path to the market have diminished the impact and power of this methodol.  The physicochem. properties of the novel chem. entities designed and guided by structural methods have become the subject of intense scrutiny from lead discovery to drug candidate.  The idea of ligand efficiency (binding energy/non-hydrogen atoms) has recently emerged as a useful guide to optimize fragment and lead selection in the discovery process.  More generalized concepts of ligand efficiency, related to efficiency per dalton and per unit of polar surface area, have also been introduced and will be discussed in the broader context.  Preliminary results and trends obtained using ligand efficiencies as guides are reviewed and their future application to guide drug discovery will be discussed, as well as their integration into the structure-based drug design methods to make them more effective and numerically robust.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmKduo41JcS7Vg90H21EOLACvtfcHk0lgRLReA76cxWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D&md5=a1682fbc4545d8eab3a44417c0e88869</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.4.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.4.469%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520effective%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D469%26epage%3D488%26doi%3D10.1517%2F17460441.2.4.469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Tanaka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiyo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusunose, N.</span><span> </span><span class="NLM_article-title">A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">857</span><span class="refDoi"> DOI: 10.1021/jm101273e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101273e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=851-857&author=D.+Tanakaauthor=Y.+Tsudaauthor=R.+Shiyamaauthor=T.+Nishimuraauthor=N.+Chiyoauthor=Y.+Tominagaauthor=N.+Sawadaauthor=T.+Mimotoauthor=N.+Kusunose&title=A+practical+use+of+ligand+efficiency+indices+out+of+the+fragment-based+approach%3A+ligand+efficiency-guided+lead+identification+of+soluble+epoxide+hydrolase+inhibitors&doi=10.1021%2Fjm101273e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm101273e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101273e%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DD.%26aulast%3DTsuda%26aufirst%3DY.%26aulast%3DShiyama%26aufirst%3DR.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DChiyo%26aufirst%3DN.%26aulast%3DTominaga%26aufirst%3DY.%26aulast%3DSawada%26aufirst%3DN.%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DKusunose%26aufirst%3DN.%26atitle%3DA%2520practical%2520use%2520of%2520ligand%2520efficiency%2520indices%2520out%2520of%2520the%2520fragment-based%2520approach%253A%2520ligand%2520efficiency-guided%2520lead%2520identification%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D851%26epage%3D857%26doi%3D10.1021%2Fjm101273e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span> </span><span class="NLM_article-title">Ruthenium(II)-Catalyzed Selective Intramolecular [2 + 2 + 2] Alkyne Cyclotrimerizations</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">12143</span><span class="NLM_x">–</span> <span class="NLM_lpage">12160</span><span class="refDoi"> DOI: 10.1021/ja0358697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0358697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1KlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=12143-12160&author=Y.+Yamamotoauthor=T.+Arakawaauthor=R.+Ogawaauthor=K.+Itoh&title=Ruthenium%28II%29-Catalyzed+Selective+Intramolecular+%5B2+%2B+2+%2B+2%5D+Alkyne+Cyclotrimerizations&doi=10.1021%2Fja0358697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II)-Catalyzed Selective Intramolecular [2 + 2 + 2] Alkyne Cyclotrimerizations</span></div><div class="casAuthors">Yamamoto, Yoshihiko; Arakawa, Takayasu; Ogawa, Ryuji; Itoh, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">12143-12160</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the presence of a catalytic amt. of Cp*RuCl(cod), 1,6-diynes chemoselectively reacted with monoalkynes at ambient temp. to afford the desired bicyclic benzene derivs. in good yields.  A wide variety of diynes and monoynes contg. functional groups such as ester, ketone, nitrile, amine, alc., sulfide, etc. can be used for the present ruthenium catalysis.  The most significant advantage of this protocol is that the cycloaddn. of unsym. 1,6-diynes with one internal alkyne moiety regioselectively gave rise to meta-substituted products with excellent regioselectivity.  Completely intramol. alkyne cyclotrimerization was also accomplished using triyne substrates to obtain tricyclic arom. compds. fused with 5-7-membered rings.  A ruthenabicycle complex relevant to these cyclotrimerizations was synthesized from Cp*RuCl(cod) and O(CH2C≡CPh)2, and its structure was unambiguously detd. by X-ray anal.  The intermediacy of such a ruthenacycle was further confirmed by its reaction with acetylene, giving rise to the expected cycloadduct.  The d. functional study on the cyclotrimerization mechanism elucidated that the cyclotrimerization proceeds via oxidative cyclization, producing a ruthenacycle intermediate and subsequent alkyne insertion initiated by the formal [2 + 2] cycloaddn. of the resultant ruthenacycle with an alkyne.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLZ9c8K_KBi7Vg90H21EOLACvtfcHk0limeXz1CbL3og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1KlsLk%253D&md5=7048fb116105ae68e359b6d1e6218562</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja0358697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0358697%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DArakawa%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DR.%26aulast%3DItoh%26aufirst%3DK.%26atitle%3DRuthenium%2528II%2529-Catalyzed%2520Selective%2520Intramolecular%2520%255B2%2520%252B%25202%2520%252B%25202%255D%2520Alkyne%2520Cyclotrimerizations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D12143%26epage%3D12160%26doi%3D10.1021%2Fja0358697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Trost, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomerantz, A. E.</span><span> </span><span class="NLM_article-title">Regioselectivity control in a ruthenium-catalyzed cycloisomerization of diyne-ols</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4235</span><span class="NLM_x">–</span> <span class="NLM_lpage">4238</span><span class="refDoi"> DOI: 10.1021/ol048351w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol048351w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4235-4238&author=B.+Trostauthor=M.+T.+Ruddauthor=M.+G.+Costaauthor=P.+I.+Leeauthor=A.+E.+Pomerantz&title=Regioselectivity+control+in+a+ruthenium-catalyzed+cycloisomerization+of+diyne-ols&doi=10.1021%2Fol048351w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fol048351w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol048351w%26sid%3Dliteratum%253Aachs%26aulast%3DTrost%26aufirst%3DB.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DCosta%26aufirst%3DM.%2BG.%26aulast%3DLee%26aufirst%3DP.%2BI.%26aulast%3DPomerantz%26aufirst%3DA.%2BE.%26atitle%3DRegioselectivity%2520control%2520in%2520a%2520ruthenium-catalyzed%2520cycloisomerization%2520of%2520diyne-ols%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4235%26epage%3D4238%26doi%3D10.1021%2Fol048351w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Tame, C.</span> Ph.D. thesis.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tame%2C+C.+Ph.D.+thesis."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTame%26aufirst%3DC." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Erdik, E.</span><span> </span><span class="NLM_article-title">Use of activation methods for organozinc reagents</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2212</span><span class="refDoi"> DOI: 10.1016/S0040-4020(01)86803-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2FS0040-4020%2801%2986803-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADyaL2sXkslKquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=2203-2212&author=E.+Erdik&title=Use+of+activation+methods+for+organozinc+reagents&doi=10.1016%2FS0040-4020%2801%2986803-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Use of activation methods for organozinc reagents</span></div><div class="casAuthors">Erdik, Ender</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2203-12</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">A review with 56 refs. on the activation of organozinc reagents by chem. or ultrasonic methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJy7oAxVwo5LVg90H21EOLACvtfcHk0limeXz1CbL3og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXkslKquro%253D&md5=3e0483a714e838d0178075c6f4eadfdb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2986803-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252986803-4%26sid%3Dliteratum%253Aachs%26aulast%3DErdik%26aufirst%3DE.%26atitle%3DUse%2520of%2520activation%2520methods%2520for%2520organozinc%2520reagents%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D2203%26epage%3D2212%26doi%3D10.1016%2FS0040-4020%2801%2986803-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Deng, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paone, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginnetti, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreher, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgey, C. S.</span><span> </span><span class="NLM_article-title">Copper-facilitated Suzuki reactions: application to 2-heterocyclic boronate</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span><span class="refDoi"> DOI: 10.1021/ol802556f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol802556f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=345-347&author=J.+Z.+Dengauthor=D.+V.+Paoneauthor=A.+T.+Ginnettiauthor=H.+Kuriharaauthor=S.+D.+Dreherauthor=S.+A.+Weissmanauthor=S.+R.+Staufferauthor=C.+S.+Burgey&title=Copper-facilitated+Suzuki+reactions%3A+application+to+2-heterocyclic+boronate&doi=10.1021%2Fol802556f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fol802556f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol802556f%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DJ.%2BZ.%26aulast%3DPaone%26aufirst%3DD.%2BV.%26aulast%3DGinnetti%26aufirst%3DA.%2BT.%26aulast%3DKurihara%26aufirst%3DH.%26aulast%3DDreher%26aufirst%3DS.%2BD.%26aulast%3DWeissman%26aufirst%3DS.%2BA.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26atitle%3DCopper-facilitated%2520Suzuki%2520reactions%253A%2520application%2520to%25202-heterocyclic%2520boronate%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D345%26epage%3D347%26doi%3D10.1021%2Fol802556f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">All animal studies were ethically reviewed and carried out in accordance with Animals (Scientific Procedures) Act 1986 and the GSK Policy on the Care, Welfare and Treatment of Animals.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">Compound <b>3</b>: pIC<sub>50</sub> < 5.0 against a panel of kinases comprised of ASK1, Aurora A, Aurora B, BTK, CHKB, Choline Kinase α, DAG Kinase, DAG Kinase Zeta, EGFR (HER1), FRAP1, GSK3B, IKK1, IKK2, ITK, JAK2, JAK3, LCK, LRRK2, PI4K2A, PIK3C2B, PIK4A, PIL4B, PIP4K2A, ROCK1, SPHK1, SPHK2, and SYK; also pIC<sub>50</sub> < 5.0 against p38a and PDE4B. DNA-PK apparent pIC<sub>50</sub> = 5.6, and equivocal data were reported in assays related to VPS34 inhibition.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Valko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunhuck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D. P.</span><span> </span><span class="NLM_article-title">Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">2236</span><span class="NLM_x">–</span> <span class="NLM_lpage">2248</span><span class="refDoi"> DOI: 10.1002/jps.10494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1002%2Fjps.10494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=14603509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFCrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=2236-2248&author=K.+Valkoauthor=S.+Nunhuckauthor=C.+Bevanauthor=M.+H.+Abrahamauthor=D.+P.+Reynolds&title=Fast+gradient+HPLC+method+to+determine+compounds+binding+to+human+serum+albumin.+Relationships+with+octanol%2Fwater+and+immobilized+artificial+membrane+lipophilicity&doi=10.1002%2Fjps.10494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity</span></div><div class="casAuthors">Valko, Klara; Nunhuck, Shenaz; Bevan, Chris; Abraham, Michael H.; Reynolds, Derek P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2236-2248</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A fast gradient HPLC method (cycle time 15 min) has been developed to det. Human Serum Albumin (HSA) binding of discovery compds. using chem. bonded protein stationary phases.  The HSA binding values were derived from the gradient retention times that were converted to the logarithm of the equil. consts. (logK HSA) using data from a calibration set of mols.  The method has been validated using literature plasma protein binding data of 68 known drug mols.  The method is fully automated, and has been used for lead optimization in more than 20 company projects.  The HSA binding data obtained for more than 4000 compds. were suitable to set up global and project specific quant. structure binding relationships that helped compd. design in early drug discovery.  The obtained HSA binding of known drug mols. were compared to the Immobilizd Artificial Membrane binding data (CHI IAM) obtained by our previously described HPLC-based method.  The solvation equation approach has been used to characterize the normal binding ability of HSA, and this relationship shows that compd. lipophilicity is a significant factor.  It was found that the selectivity of the "baseline" lipophilicity governing HSA binding, membrane interaction, and octanol/water partition are very similar.  However, the effect of the presence of pos. or neg. charges have very different effects.  It was found that neg. charged compds. bind more strongly to HSA than it would be expected from the lipophilicity of the ionized species at pH 7.4.  Several compds. showed stronger HSA binding than can be expected from their lipophilicity alone, and comparison between predicted and exptl. binding affinity allows the identification of compds. that have good complementarities with any of the known binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr1LUBLdv-t7Vg90H21EOLACvtfcHk0ljQmYzyjiQB1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFCrs7Y%253D&md5=14eb1e0f0ad616846a2b5d1428133fa9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fjps.10494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10494%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DNunhuck%26aufirst%3DS.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DReynolds%26aufirst%3DD.%2BP.%26atitle%3DFast%2520gradient%2520HPLC%2520method%2520to%2520determine%2520compounds%2520binding%2520to%2520human%2520serum%2520albumin.%2520Relationships%2520with%2520octanol%252Fwater%2520and%2520immobilized%2520artificial%2520membrane%2520lipophilicity%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D2236%26epage%3D2248%26doi%3D10.1002%2Fjps.10494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Bhattachar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seadeek, C.</span><span> </span><span class="NLM_article-title">Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discovery</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span><span class="refDoi"> DOI: 10.1016/j.jpba.2005.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2Fj.jpba.2005.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=16364585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ent7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=152-157&author=S.+N.+Bhattacharauthor=J.+A.+Wesleyauthor=C.+Seadeek&title=Evaluation+of+the+chemiluminescent+nitrogen+detector+for+solubility+determinations+to+support+drug+discovery&doi=10.1016%2Fj.jpba.2005.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discovery</span></div><div class="casAuthors">Bhattachar, Shobha N.; Wesley, James A.; Seadeek, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-157</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Soly. measurements using chemiluminescent nitrogen detection (CLND) has advantages of reduced compd. requirement and increased throughput compared to UV-spectrophotometric and HPLC-based measurements.  CLND with direct flow injection was evaluated for the measurement of thermodn. soly. to support drug discovery.  The limit of quantitation (LOQ), accuracy, and day-to-day reproducibility of the detector were measured.  Measurements made on CLND were compared to those obtained from UV spectrophotometry and HPLC.  Based on the results obtained, it was concluded that the CLND performs satisfactorily for discovery stage thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI5WHL9BI2NLVg90H21EOLACvtfcHk0ljQmYzyjiQB1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ent7s%253D&md5=c11f76d20d59b740e9d2b1d7942f2f24</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2005.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2005.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DWesley%26aufirst%3DJ.%2BA.%26aulast%3DSeadeek%26aufirst%3DC.%26atitle%3DEvaluation%2520of%2520the%2520chemiluminescent%2520nitrogen%2520detector%2520for%2520solubility%2520determinations%2520to%2520support%2520drug%2520discovery%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2006%26volume%3D41%26spage%3D152%26epage%3D157%26doi%3D10.1016%2Fj.jpba.2005.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16i','cit16ii'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':[],'ref31':[],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Feng Li, Xiaofei Liang, Zongru Jiang, Aoli Wang, Junjie Wang, Cheng Chen, Wenliang Wang, Fengming Zou, Ziping Qi, Qingwang Liu, Zhenquan Hu, Jiangyan Cao, Hong Wu, Beilei Wang, Li Wang, Jing Liu, <span class="NLM_string-name hlFld-ContribAuthor">Qingsong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13973-13993. <a href="https://doi.org/10.1021/acs.jmedchem.0c01544" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01544%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528S%252529-2-%2525281-%2525284-Amino-3-%2525283-fluoro-4-methoxyphenyl%252529-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidin-1-yl%252529propyl%252529-3-cyclopropyl-5-fluoroquinazolin-4%2525283H%252529-one%252B%252528IHMT-PI3K%2525CE%2525B4-372%252529%252Bas%252Ba%252BPotent%252Band%252BSelective%252BPI3K%2525CE%2525B4%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BObstructive%252BPulmonary%252BDisease%26aulast%3DLi%26aufirst%3DFeng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03092020%26date%3D12112020%26volume%3D63%26issue%3D22%26spage%3D13973%26epage%3D13993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zoë A. Henley, Augustin Amour, Nick Barton, Marcus Bantscheff, Giovanna Bergamini, Sophie M. Bertrand, Máire Convery, Kenneth Down, Birgit Dümpelfeld, Chris D. Edwards, Paola Grandi, Paul M. Gore, Steve Keeling, Stefano Livia, David Mallett, Aoife Maxwell, Mark Price, Christina Rau, Friedrich B. M. Reinhard, James Rowedder, Paul Rowland, Jonathan A. Taylor, Daniel A. Thomas, Edith M. Hessel, <span class="NLM_string-name hlFld-ContribAuthor">J. Nicole Hamblin</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 638-655. <a href="https://doi.org/10.1021/acs.jmedchem.9b01585" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01585%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BOrally%252BBioavailable%252BPI3K%2525CE%2525B4%252BInhibitors%252Band%252BIdentification%252Bof%252BVps34%252Bas%252Ba%252BKey%252BSelectivity%252BTarget%26aulast%3DHenley%26aufirst%3DZo%25C3%25AB%2BA.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D23092019%26date%3D08012020%26date%3D19122019%26volume%3D63%26issue%3D2%26spage%3D638%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lydia Barnes, Hollie Blaber, David T. K. Brooks, Lewis Byers, Daniel Buckley, Zoe C. Byron, Richard G. Chilvers, Liam Cochrane, Edward Cooney, Heather A. Damian, Luke Francis, Daniel Fu He, Jack M. J. Grace, Harley J. Green, Edmund J. P. Hogarth, Leyla Jusu, C. Elizabeth Killalea, Oliver King, Joseph Lambert, Zoe J. Lee, Nuria S. Lima, Christina L. Long, May-Li Mackinnon, Shusha Mahdy, Jolyon Matthews-Wright, Makenzie J. Millward, Matthew F. Meehan, Christopher Merrett, Lisa Morrison, Hal R. I. Parke, Charlotte Payne, Lawrence Payne, Craig Pike, Alexander Seal, Aaron J. Senior, Keenan M. Smith, Kamile Stanelyte, Joe Stillibrand, Rachel Szpara, Freya F. H. Taday, Antony M. Threadgould, Rohan J. Trainor, Jordan Waters, Oliver Williams, Carrie K. W. Wong, Katherine Wood, Nick Barton, Anna Gruszka, Zoe Henley, James E. Rowedder, Rosa Cookson, Katherine L. Jones, Alan Nadin, Ian E. Smith, Simon J. F. Macdonald, <span class="NLM_string-name hlFld-ContribAuthor">Andrew Nortcliffe</span>. </span><span class="cited-content_cbyCitation_article-title">Free–Wilson Analysis of Comprehensive Data on Phosphoinositide-3-kinase (PI3K) Inhibitors Reveals Importance of N-Methylation for PI3Kδ Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (22)
                                     , 10402-10422. <a href="https://doi.org/10.1021/acs.jmedchem.9b01499" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01499%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFree%2525E2%252580%252593Wilson%252BAnalysis%252Bof%252BComprehensive%252BData%252Bon%252BPhosphoinositide-3-kinase%252B%252528PI3K%252529%252BInhibitors%252BReveals%252BImportance%252Bof%252BN-Methylation%252Bfor%252BPI3K%2525CE%2525B4%252BActivity%26aulast%3DBarnes%26aufirst%3DLydia%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D11092019%26date%3D06112019%26date%3D24102019%26volume%3D62%26issue%3D22%26spage%3D10402%26epage%3D10422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Heather Hobbs, Gianpaolo Bravi, Ian Campbell, Maire Convery, Hannah Davies, Graham Inglis, Sandeep Pal, Simon Peace, Joanna Redmond, <span class="NLM_string-name hlFld-ContribAuthor">Declan Summers</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-Oxabicyclo[4.1.0]heptane, a Non-nitrogen Containing Morpholine Isostere, and Its Application in Novel Inhibitors of the PI3K-AKT-mTOR Pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 6972-6984. <a href="https://doi.org/10.1021/acs.jmedchem.9b00348" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00348%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-Oxabicyclo%25255B4.1.0%25255Dheptane%25252C%252Ba%252BNon-nitrogen%252BContaining%252BMorpholine%252BIsostere%25252C%252Band%252BIts%252BApplication%252Bin%252BNovel%252BInhibitors%252Bof%252Bthe%252BPI3K-AKT-mTOR%252BPathway%26aulast%3DHobbs%26aufirst%3DHeather%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25022019%26date%3D23072019%26date%3D08072019%26volume%3D62%26issue%3D15%26spage%3D6972%26epage%3D6984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Huihui Ti, Yang Zhou, Xue Liang, Runfeng Li, Ke Ding, <span class="NLM_string-name hlFld-ContribAuthor">Xin Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (13)
                                     , 5944-5978. <a href="https://doi.org/10.1021/acs.jmedchem.8b01520" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01520%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeted%252BTreatments%252Bfor%252BChronic%252BObstructive%252BPulmonary%252BDisease%252B%252528COPD%252529%252BUsing%252BLow-Molecular-Weight%252BDrugs%252B%252528LMWDs%252529%26aulast%3DTi%26aufirst%3DHuihui%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D30092018%26date%3D12022019%26date%3D25012019%26volume%3D62%26issue%3D13%26spage%3D5944%26epage%3D5978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew W. D. Perry, Raolat Abdulai, Mickael Mogemark, Jens Petersen, Matthew J. Thomas, Barbara Valastro, <span class="NLM_string-name hlFld-ContribAuthor">Annika Westin Eriksson</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 4783-4814. <a href="https://doi.org/10.1021/acs.jmedchem.8b01298" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01298%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvolution%252Bof%252BPI3K%2525CE%2525B3%252Band%252B%2525CE%2525B4%252BInhibitors%252Bfor%252BInflammatory%252Band%252BAutoimmune%252BDiseases%26aulast%3DPerry%26aufirst%3DMatthew%2BW.%2BD.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D16082018%26date%3D24122018%26volume%3D62%26issue%3D10%26spage%3D4783%26epage%3D4814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nick Barton, Máire Convery, Anthony W. J. Cooper, Kenneth Down, J. Nicole Hamblin, Graham Inglis, Simon Peace, James Rowedder, Paul Rowland, Jonathan A. Taylor, <span class="NLM_string-name hlFld-ContribAuthor">Natalie Wellaway</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (24)
                                     , 11061-11073. <a href="https://doi.org/10.1021/acs.jmedchem.8b01556" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01556</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01556%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%25252C%252BEfficient%25252C%252Band%252BSelective%252BInhibitors%252Bof%252BPhosphoinositide%252B3-Kinase%252B%2525CE%2525B4%252Bthrough%252Ba%252BDeconstruction%252Band%252BRegrowth%252BApproach%26aulast%3DBarton%26aufirst%3DNick%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05102018%26date%3D21122018%26date%3D11122018%26volume%3D61%26issue%3D24%26spage%3D11061%26epage%3D11073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingjie  Liu</span>, <span class="hlFld-ContribAuthor ">Qing  Shi</span>, <span class="hlFld-ContribAuthor ">David  Marcoux</span>, <span class="hlFld-ContribAuthor ">Douglas G.  Batt</span>, <span class="hlFld-ContribAuthor ">Lyndon  Cornelius</span>, <span class="hlFld-ContribAuthor ">Lan-Ying  Qin</span>, <span class="hlFld-ContribAuthor ">Zheming  Ruan</span>, <span class="hlFld-ContribAuthor ">James  Neels</span>, <span class="hlFld-ContribAuthor ">Myra  Beaudoin-Bertrand</span>, <span class="hlFld-ContribAuthor ">Anurag S.  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">Robert J.  Cherney</span>, <span class="hlFld-ContribAuthor ">Hua  Gong</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Carolyn  Weigelt</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Gillooly</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Jenny H.  Xie</span>, <span class="hlFld-ContribAuthor ">Mary T.  Obermeier</span>, <span class="hlFld-ContribAuthor ">Aberra  Fura</span>, <span class="hlFld-ContribAuthor ">Bogdan  Sleczka</span>, <span class="hlFld-ContribAuthor ">Kevin  Stefanski</span>, <span class="hlFld-ContribAuthor ">R. M.  Fancher</span>, <span class="hlFld-ContribAuthor ">Shweta  Padmanabhan</span>, <span class="hlFld-ContribAuthor ">Thatipamula  RP</span>, <span class="hlFld-ContribAuthor ">Ipsit  Kundu</span>, <span class="hlFld-ContribAuthor ">Kallem  Rajareddy</span>, <span class="hlFld-ContribAuthor ">Rodney  Smith</span>, <span class="hlFld-ContribAuthor ">James K.  Hennan</span>, <span class="hlFld-ContribAuthor ">Dezhi  Xing</span>, <span class="hlFld-ContribAuthor ">Jingsong  Fan</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Qian  Ruan</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Donna  Pedicord</span>, <span class="hlFld-ContribAuthor ">Jie  Pan</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Hao  Lu</span>, <span class="hlFld-ContribAuthor ">Jonathan  Lippy</span>, <span class="hlFld-ContribAuthor ">Christine  Goldstine</span>, <span class="hlFld-ContribAuthor ">Stacey  Skala</span>, <span class="hlFld-ContribAuthor ">Richard A.  Rampulla</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Anuradha  Gupta</span>, <span class="hlFld-ContribAuthor ">Pirama Nayagam  Arunachalam</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Jodi K.  Muckelbauer</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Luisa M.  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Rajeev S.  Bhide</span>, <span class="hlFld-ContribAuthor ">Michael A.  Poss</span>, <span class="hlFld-ContribAuthor ">John  Hynes</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, <span class="hlFld-ContribAuthor ">Stefan  Ruepp</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, and <span class="hlFld-ContribAuthor ">Joseph A.  Tino</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (12)
                                     , 5193-5208. <a href="https://doi.org/10.1021/acs.jmedchem.7b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BEfficacious%252BPhosphatidylinositol%252B3-Kinase%252B%2525CE%2525B4%252B%252528PI3K%2525CE%2525B4%252529%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BImmunological%252BDisorders%26aulast%3DLiu%26aufirst%3DQingjie%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27042017%26date%3D05062017%26date%3D22062017%26date%3D25052017%26volume%3D60%26issue%3D12%26spage%3D5193%26epage%3D5208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omar A.  El-Khouly</span>, <span class="hlFld-ContribAuthor ">Morkos A.  Henen</span>, <span class="hlFld-ContribAuthor ">Magda A.-A.  El-Sayed</span>, <span class="hlFld-ContribAuthor ">Mona I.  Shabaan</span>, <span class="hlFld-ContribAuthor ">Shahenda M.  El-Messery</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, anticancer and antimicrobial evaluation of new benzofuran based derivatives: PI3K inhibition, quorum sensing and molecular modeling study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>31 </em>, 115976. <a href="https://doi.org/10.1016/j.bmc.2020.115976" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115976%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Banticancer%252Band%252Bantimicrobial%252Bevaluation%252Bof%252Bnew%252Bbenzofuran%252Bbased%252Bderivatives%25253A%252BPI3K%252Binhibition%25252C%252Bquorum%252Bsensing%252Band%252Bmolecular%252Bmodeling%252Bstudy%26aulast%3DEl-Khouly%26aufirst%3DOmar%2BA.%26date%3D2021%26volume%3D31%26spage%3D115976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiajia  Sun</span>, <span class="hlFld-ContribAuthor ">Yifan  Feng</span>, <span class="hlFld-ContribAuthor ">Yuan  Huang</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Minhang  Xin</span>. </span><span class="cited-content_cbyCitation_article-title">Research advances on selective phosphatidylinositol 3 kinase δ (PI3Kδ) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (19)
                                     , 127457. <a href="https://doi.org/10.1016/j.bmcl.2020.127457" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127457%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DResearch%252Badvances%252Bon%252Bselective%252Bphosphatidylinositol%252B3%252Bkinase%252B%2525CE%2525B4%252B%252528PI3K%2525CE%2525B4%252529%252Binhibitors%26aulast%3DSun%26aufirst%3DJiajia%26date%3D2020%26volume%3D30%26issue%3D19%26spage%3D127457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Cai</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Ullmann‐Ma
              Reaction: Development, Scope and Applications in Organic Synthesis
              †. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2020,</strong> <em>38 </em>
                                    (8)
                                     , 879-893. <a href="https://doi.org/10.1002/cjoc.202000075" title="DOI URL">https://doi.org/10.1002/cjoc.202000075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.202000075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.202000075%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DUllmann%2525E2%252580%252590Ma%252BReaction%25253A%252BDevelopment%25252C%252BScope%252Band%252BApplications%252Bin%252BOrganic%252BSynthesis%252B%2525E2%252580%2525A0%26aulast%3DCai%26aufirst%3DQian%26date%3D2020%26date%3D2020%26volume%3D38%26issue%3D8%26spage%3D879%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua  Zhou</span>, <span class="hlFld-ContribAuthor ">Meredeth A.  McGowan</span>, <span class="hlFld-ContribAuthor ">Kathryn  Lipford</span>, <span class="hlFld-ContribAuthor ">Matthew  Christopher</span>, <span class="hlFld-ContribAuthor ">Xavier  Fradera</span>, <span class="hlFld-ContribAuthor ">David  Witter</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Chaomin  Li</span>, <span class="hlFld-ContribAuthor ">Joey L.  Methot</span>, <span class="hlFld-ContribAuthor ">John  Lampe</span>, <span class="hlFld-ContribAuthor ">Abdelghani  Achab</span>, <span class="hlFld-ContribAuthor ">Lynsey  Shaffer</span>, <span class="hlFld-ContribAuthor ">Peter  Goldenblatt</span>, <span class="hlFld-ContribAuthor ">Sanjiv  Shah</span>, <span class="hlFld-ContribAuthor ">Alan  Bass</span>, <span class="hlFld-ContribAuthor ">Gottfried  Schroeder</span>, <span class="hlFld-ContribAuthor ">Dapeng  Chen</span>, <span class="hlFld-ContribAuthor ">Haoyu  Zeng</span>, <span class="hlFld-ContribAuthor ">Martin A.  Augustin</span>, <span class="hlFld-ContribAuthor ">Jason D.  Katz</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (1)
                                     , 126715. <a href="https://doi.org/10.1016/j.bmcl.2019.126715" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126715</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126715%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bheteroaryl%252Bpiperazines%252Bas%252Bpotent%252Band%252Bselective%252BPI3K%2525CE%2525B4%252Binhibitors%26aulast%3DZhou%26aufirst%3DHua%26date%3D2020%26volume%3D30%26issue%3D1%26spage%3D126715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xavier  Fradera</span>, <span class="hlFld-ContribAuthor ">Joey L.  Methot</span>, <span class="hlFld-ContribAuthor ">Abdelghani  Achab</span>, <span class="hlFld-ContribAuthor ">Matthew  Christopher</span>, <span class="hlFld-ContribAuthor ">Michael D.  Altman</span>, <span class="hlFld-ContribAuthor ">Hua  Zhou</span>, <span class="hlFld-ContribAuthor ">Meredeth A.  McGowan</span>, <span class="hlFld-ContribAuthor ">Sam D.  Kattar</span>, <span class="hlFld-ContribAuthor ">Kevin  Wilson</span>, <span class="hlFld-ContribAuthor ">Yudith  Garcia</span>, <span class="hlFld-ContribAuthor ">Martin A.  Augustin</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Sanjiv  Shah</span>, <span class="hlFld-ContribAuthor ">Peter  Goldenblatt</span>, <span class="hlFld-ContribAuthor ">Jason D.  Katz</span>. </span><span class="cited-content_cbyCitation_article-title">Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2575-2580. <a href="https://doi.org/10.1016/j.bmcl.2019.08.004" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Bof%252Bselective%252BPI3K%2525CE%2525B4%252Binhibitors%252Busing%252Ban%252Biterative%252Bscaffold-hopping%252Bworkflow%26aulast%3DFradera%26aufirst%3DXavier%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2575%26epage%3D2580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Jun  Wei</span>, <span class="hlFld-ContribAuthor ">Chang  Wang</span>, <span class="hlFld-ContribAuthor ">Dongyan  Gu</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>, <span class="hlFld-ContribAuthor ">Rong  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel benzothiadiazine derivatives as potent PI3Kδ-selective inhibitors for treating B-cell-mediated malignancies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>170 </em>, 112-125. <a href="https://doi.org/10.1016/j.ejmech.2019.03.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bbenzothiadiazine%252Bderivatives%252Bas%252Bpotent%252BPI3K%2525CE%2525B4-selective%252Binhibitors%252Bfor%252Btreating%252BB-cell-mediated%252Bmalignancies%26aulast%3DMa%26aufirst%3DXiaodong%26date%3D2019%26volume%3D170%26spage%3D112%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluigi  Albano</span>, <span class="hlFld-ContribAuthor ">Laura Antonella  Aronica</span>. </span><span class="cited-content_cbyCitation_article-title">Potentiality and Synthesis of O- and N-Heterocycles: Pd-Catalyzed Cyclocarbonylative Sonogashira Coupling as a Valuable Route to Phthalans, Isochromans, and Isoindolines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (48)
                                     , 7204-7221. <a href="https://doi.org/10.1002/ejoc.201701041" title="DOI URL">https://doi.org/10.1002/ejoc.201701041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPotentiality%252Band%252BSynthesis%252Bof%252BO-%252Band%252BN-Heterocycles%25253A%252BPd-Catalyzed%252BCyclocarbonylative%252BSonogashira%252BCoupling%252Bas%252Ba%252BValuable%252BRoute%252Bto%252BPhthalans%25252C%252BIsochromans%25252C%252Band%252BIsoindolines%26aulast%3DAlbano%26aufirst%3DGianluigi%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D48%26spage%3D7204%26epage%3D7221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Klemens  Hoegenauer</span>, <span class="hlFld-ContribAuthor ">Nicolas  Soldermann</span>, <span class="hlFld-ContribAuthor ">Christina  Hebach</span>, <span class="hlFld-ContribAuthor ">Gregory J.  Hollingworth</span>, <span class="hlFld-ContribAuthor ">Ian  Lewis</span>, <span class="hlFld-ContribAuthor ">Anette  von Matt</span>, <span class="hlFld-ContribAuthor ">Alexander B.  Smith</span>, <span class="hlFld-ContribAuthor ">Romain M.  Wolf</span>, <span class="hlFld-ContribAuthor ">Rainer  Wilcken</span>, <span class="hlFld-ContribAuthor ">Dorothea  Haasen</span>, <span class="hlFld-ContribAuthor ">Christoph  Burkhart</span>, <span class="hlFld-ContribAuthor ">Frédéric  Zécri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (23)
                                     , 5657-5662. <a href="https://doi.org/10.1016/j.bmcl.2016.10.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.10.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.10.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.10.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bpyrrolidineoxy-substituted%252Bheteroaromatics%252Bas%252Bpotent%252Band%252Bselective%252BPI3K%252Bdelta%252Binhibitors%252Bwith%252Bimproved%252Bphysicochemical%252Bproperties%26aulast%3DHoegenauer%26aufirst%3DKlemens%26date%3D2016%26volume%3D26%26issue%3D23%26spage%3D5657%26epage%3D5662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>1</b>, <b>2</b>, and <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) PLS loadings plot demonstrating groups of coefficients. (b) PLS coefficient plot indicating magnitude, direction, and 95% confidence interval of the mean. Variables of interest: Var 5–8 (ACD Laboratories v11.logd at pH 2, 5.5, 6.5, and 7.4) and Var 9 (cLogP 481); Var 11 (positive ionizable center count) and Var 12 (total charge); Var 23 (estate.amideNH-sum), Var 24 (estate.amideNH-av), and Var 25 (estate.amideOtoNH-av). Note: Var 2 is PI3K delta potency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design strategy for oral series. The calculated potency is derived via the rearranged BEI calculation (cPI3Kδ pIC<sub>50</sub> = 320 × (BEI/1000)).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Target 6-position substituents in the dihydroisobenzofuran series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) boronate ester <b>11</b>, 6-bromo-1<i>H</i>-indazole, Pd<sub>2</sub>(dba)<sub>3</sub>, <sup>t</sup>Bu<sub>3</sub>P·HBF<sub>4</sub>, KF, 2-Me-THF/water (3:1), 28%; (ii) boronate ester, 5-bromo-1,3-dihydroisobenzofuran, PdCl<sub>2</sub>(dppf)·DCM, CsOAc, KF, THF/water (20:1), 39%.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Plan for the Utilization of [2+2+2] Trimerization Chemistry</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl (8 mol %), CuI (8 mol %), Et<sub>3</sub>N (4 equiv), 2-Me-THF, 80 °C, quantitative; (ii) KOH, <i>i</i>PrOH, reflux, 77%.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) RuCp*(cod)Cl (10 mol %), CPME, rt, 64% (1.2 equiv of <b>12</b> or 2.0 equiv of <b>13</b>); (ii) ICl, CH<sub>2</sub>Cl<sub>2</sub>, 10→0 °C, 80%; (iii) CuI (20 mol %), <span class="smallcaps smallerCapital">l</span>-proline, Cs<sub>2</sub>CO<sub>3</sub>, DMSO:NH<sub>3</sub> (aq) (1:1), 110 °C, microwave, 77%; (iv) 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, Pd(OAc)<sub>2</sub> (1 mol %), Cs<sub>2</sub>CO<sub>3</sub>, dppf (20 mol %), CuCl (100 mol %), DMF, microwave, 100 °C, 10%; (v) (a) 2-methyl-1,3,4-oxadiazole, LiHMDS, ZnCl<sub>2</sub>, THF, −10 °C; (b) Pd(PPh<sub>3</sub>)<sub>4</sub> (10 mol %), Cs<sub>2</sub>CO<sub>3</sub>, microwave, 150 °C, 24%; (vi) RCO<sub>2</sub>H, HATU, DMF, rt, 21–28%.</p></p></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray structure of compound <b>3</b> (cyan) co-crystallized with PI3Kδ and overlaid with a crystal structure of compound <b>1</b> (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/medium/jm-2016-007993_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacodynamic testing of compound <b>3</b> in an acute model of lung inflammation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-15/acs.jmedchem.6b00799/20160811/images/large/jm-2016-007993_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00799&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Ghigo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damilano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braccini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span> </span><span class="NLM_article-title">PI3K inhibition in inflammation: Toward tailored therapies for specific diseases</span> <span class="citation_source-journal">BioEssays</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1002/bies.200900150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1002%2Fbies.200900150" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=185-196&issue=3&author=A.+Ghigoauthor=F.+Damilanoauthor=L.+Bracciniauthor=E.+Hirsch&title=PI3K+inhibition+in+inflammation%3A+Toward+tailored+therapies+for+specific+diseases&doi=10.1002%2Fbies.200900150"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fbies.200900150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbies.200900150%26sid%3Dliteratum%253Aachs%26aulast%3DGhigo%26aufirst%3DA.%26aulast%3DDamilano%26aufirst%3DF.%26aulast%3DBraccini%26aufirst%3DL.%26aulast%3DHirsch%26aufirst%3DE.%26atitle%3DPI3K%2520inhibition%2520in%2520inflammation%253A%2520Toward%2520tailored%2520therapies%2520for%2520specific%2520diseases%26jtitle%3DBioEssays%26date%3D2010%26volume%3D32%26issue%3D3%26spage%3D185%26epage%3D196%26doi%3D10.1002%2Fbies.200900150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iribarren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. M.</span><span> </span><span class="NLM_article-title">The essential role of phosphoinositide 3-kinases (PI3Ks) in regulating pro-inflammatory responses and the progression of cancer</span> <span class="citation_source-journal">Cell. Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=16274621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSitrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=241-252&author=K.+Chenauthor=P.+Iribarrenauthor=W.+Gongauthor=J.+M.+Wang&title=The+essential+role+of+phosphoinositide+3-kinases+%28PI3Ks%29+in+regulating+pro-inflammatory+responses+and+the+progression+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The essential role of phosphoinositide 3-Kinases (PI3Ks) in regulating pro-inflammatory responses and the progression of cancer</span></div><div class="casAuthors">Chen, Keqiang; Iribarren, Pablo; Gong, Wanghua; Wang, Ji-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">241-252</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">Chinese Society of Immunology</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide 3-Kinases (PI3Ks) are proteins coupled to a variety of cell surface receptors and play a key role in signal transduction cascade regulating fundamental cellular functions such as transcription, proliferation, and survival.  PI3Ks also are important in disease processes such as inflammation and cancer.  The aim of this review is to outline current understandings of the PI3K family, mechanism of their activation, their role in inflammatory responses and the development of malignant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorKgtt4FcP87Vg90H21EOLACvtfcHk0li5op0-p22lYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSitrrF&md5=c1e52d6c3605cff390c534ad2ef166de</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%26aulast%3DIribarren%26aufirst%3DP.%26aulast%3DGong%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520essential%2520role%2520of%2520phosphoinositide%25203-kinases%2520%2528PI3Ks%2529%2520in%2520regulating%2520pro-inflammatory%2520responses%2520and%2520the%2520progression%2520of%2520cancer%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2005%26volume%3D2%26spage%3D241%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Paz-Ares, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco-Aparicio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Carbonero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span> </span><span class="NLM_article-title">Inhibiting PI3K as a therapeutic strategy against cancer</span> <span class="citation_source-journal">Clin. Transl. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">572</span><span class="NLM_x">–</span> <span class="NLM_lpage">579</span><span class="refDoi"> DOI: 10.1007/s12094-009-0407-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1007%2Fs12094-009-0407-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=19775996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Whur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=572-579&issue=9&author=L.+Paz-Aresauthor=C.+Blanco-Aparicioauthor=R.+Garcia-Carboneroauthor=A.+Carnero&title=Inhibiting+PI3K+as+a+therapeutic+strategy+against+cancer&doi=10.1007%2Fs12094-009-0407-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting PI3K as a therapeutic strategy against cancer</span></div><div class="casAuthors">Paz-Ares, Luis; Blanco-Aparicio, Carmen; Garcia-Carbonero, Rocio; Carnero, Amancio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Translational Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">572-579</span>CODEN:
                <span class="NLM_cas:coden">CTOLAM</span>;
        ISSN:<span class="NLM_cas:issn">1699-048X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Class I PI3K is composed of heterodimeric lipid kinases regulating essential cellular functions including proliferation, apoptosis and metab.  Class I PI3K isoforms are commonly amplified in different cancer types and the PI3Kα catalytic subunit, PIK3CA, has been found mutated in a variable proportion of tumors of different origin.  Furthermore, PI3K has been shown to mediate oncogenic signalling induced by several oncogenes such as HER2 or Ras.  These facts suggest that PI3K might be a good target for anticancer drug discovery.  Today, the rise of PI3K inhibitors and their first in vivo results have cleared much of the path for the development of PI3K inhibitors for anticancer therapy.  Here we will review the PI3K pathway and the pharmacol. results of PI3K inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdCYk5H3lNzrVg90H21EOLACvtfcHk0li5op0-p22lYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Whur3J&md5=558d5ae7e8b6ea38c82c8a90cfdce93e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs12094-009-0407-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-009-0407-x%26sid%3Dliteratum%253Aachs%26aulast%3DPaz-Ares%26aufirst%3DL.%26aulast%3DBlanco-Aparicio%26aufirst%3DC.%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DCarnero%26aufirst%3DA.%26atitle%3DInhibiting%2520PI3K%2520as%2520a%2520therapeutic%2520strategy%2520against%2520cancer%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2009%26volume%3D11%26issue%3D9%26spage%3D572%26epage%3D579%26doi%3D10.1007%2Fs12094-009-0407-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Czech, M. P.</span><span> </span><span class="NLM_article-title">PIP2 and PIP3: complex roles at the cell surface</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span><span class="refDoi"> DOI: 10.1016/S0092-8674(00)80696-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2FS0092-8674%2800%2980696-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10761925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFeksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=603-606&author=M.+P.+Czech&title=PIP2+and+PIP3%3A+complex+roles+at+the+cell+surface&doi=10.1016%2FS0092-8674%2800%2980696-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PIP2 and PIP3: complex roles at the cell surface</span></div><div class="casAuthors">Czech, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">603-606</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 22 refs.  Phosphatidylinositol (4,5)bisphosphate (PIP2) and phosphatidylinositol (3,4,5)trisphosphate (PIP3) represent less than 1 % of membrane phospholipids, yet they function in a remarkable no. of crucial cellular processes.  These low-abundance polyphosphoinositides direct two major independent signaling cascades.  PIP3 is the effector of multiple downstream targets of the phosphoinositide 3 kinase (P31K) pathway; PIP2 is the precursor of the mediators diacylglycerol and inositol(1,4,5)P3 following its hydrolysis by hormone-sensitive phospholipase C (PLC) enzymes.  New expts. are now revealing yet another signaling mode controlled by PIP2.  This novel cascade depends on intact PIP2 rather than products of its hydrolysis.  Recent work demonstrates not only new signaling functions of PIP2 but also intricate regulation of membrane phospholipids.  New insights on these events highlight the cell surface membrane as a major site of action of both PIP2 and PIP3 and reveal unexpected cross-talk between these polyphosphoinositides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQekjpcNonwLVg90H21EOLACvtfcHk0li5op0-p22lYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFeksrs%253D&md5=372b17fe8ea614a9c72a44e61d0eab37</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980696-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980696-0%26sid%3Dliteratum%253Aachs%26aulast%3DCzech%26aufirst%3DM.%2BP.%26atitle%3DPIP2%2520and%2520PIP3%253A%2520complex%2520roles%2520at%2520the%2520cell%2520surface%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D603%26epage%3D606%26doi%3D10.1016%2FS0092-8674%2800%2980696-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Soond, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjørgo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moltu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, V. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torgersen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galleway, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twomey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaston, JS. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskén, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunyard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span> </span><span class="NLM_article-title">PI3K p110δ regulates T cell cytokine production during primary and secondary immune responses in mice and humans</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2213</span><span class="refDoi"> DOI: 10.1182/blood-2009-07-232330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1182%2Fblood-2009-07-232330" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=2203-2213&author=D.+R.+Soondauthor=E.+Bj%C3%B8rgoauthor=K.+Moltuauthor=V.+Q.+Daleauthor=D.+T.+Pattonauthor=K.+M.+Torgersenauthor=F.+Gallewayauthor=B.+Twomeyauthor=J.+Clarkauthor=JS.+H.+Gastonauthor=K.+Task%C3%A9nauthor=P.+Bunyardauthor=K.+Okkenhaug&title=PI3K+p110%CE%B4+regulates+T+cell+cytokine+production+during+primary+and+secondary+immune+responses+in+mice+and+humans&doi=10.1182%2Fblood-2009-07-232330"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-07-232330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-07-232330%26sid%3Dliteratum%253Aachs%26aulast%3DSoond%26aufirst%3DD.%2BR.%26aulast%3DBj%25C3%25B8rgo%26aufirst%3DE.%26aulast%3DMoltu%26aufirst%3DK.%26aulast%3DDale%26aufirst%3DV.%2BQ.%26aulast%3DPatton%26aufirst%3DD.%2BT.%26aulast%3DTorgersen%26aufirst%3DK.%2BM.%26aulast%3DGalleway%26aufirst%3DF.%26aulast%3DTwomey%26aufirst%3DB.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DGaston%26aufirst%3DJS.%2BH.%26aulast%3DTask%25C3%25A9n%26aufirst%3DK.%26aulast%3DBunyard%26aufirst%3DP.%26aulast%3DOkkenhaug%26aufirst%3DK.%26atitle%3DPI3K%2520p110%25CE%25B4%2520regulates%2520T%2520cell%2520cytokine%2520production%2520during%2520primary%2520and%2520secondary%2520immune%2520responses%2520in%2520mice%2520and%2520humans%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D2203%26epage%3D2213%26doi%3D10.1182%2Fblood-2009-07-232330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Brown, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalfe, D. D.</span><span> </span><span class="NLM_article-title">The mast cell and allergic diseases: role in pathogenesis and implications for therapy</span> <span class="citation_source-journal">Clin. Exp. Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1111/j.1365-2222.2007.02886.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1111%2Fj.1365-2222.2007.02886.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=18031566" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2007&pages=4-18&author=J.+M.+Brownauthor=T.+M.+Wilsonauthor=D.+D.+Metcalfe&title=The+mast+cell+and+allergic+diseases%3A+role+in+pathogenesis+and+implications+for+therapy&doi=10.1111%2Fj.1365-2222.2007.02886.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2222.2007.02886.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2222.2007.02886.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DT.%2BM.%26aulast%3DMetcalfe%26aufirst%3DD.%2BD.%26atitle%3DThe%2520mast%2520cell%2520and%2520allergic%2520diseases%253A%2520role%2520in%2520pathogenesis%2520and%2520implications%2520for%2520therapy%26jtitle%3DClin.%2520Exp.%2520Allergy%26date%3D2007%26volume%3D38%26spage%3D4%26epage%3D18%26doi%3D10.1111%2Fj.1365-2222.2007.02886.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sadhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masinovsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowell, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staunton, D. E.</span><span> </span><span class="NLM_article-title">Essential role of phosphoinositide 3-kinase δ in neutrophil directional movement</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span><span class="refDoi"> DOI: 10.4049/jimmunol.170.5.2647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.4049%2Fjimmunol.170.5.2647" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=2647-2654&author=C.+Sadhuauthor=B.+Masinovskyauthor=K.+Dickauthor=C.+G.+Sowellauthor=D.+E.+Staunton&title=Essential+role+of+phosphoinositide+3-kinase+%CE%B4+in+neutrophil+directional+movement&doi=10.4049%2Fjimmunol.170.5.2647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.170.5.2647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.170.5.2647%26sid%3Dliteratum%253Aachs%26aulast%3DSadhu%26aufirst%3DC.%26aulast%3DMasinovsky%26aufirst%3DB.%26aulast%3DDick%26aufirst%3DK.%26aulast%3DSowell%26aufirst%3DC.%2BG.%26aulast%3DStaunton%26aufirst%3DD.%2BE.%26atitle%3DEssential%2520role%2520of%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520in%2520neutrophil%2520directional%2520movement%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26spage%3D2647%26epage%3D2654%26doi%3D10.4049%2Fjimmunol.170.5.2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Condliffe, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crabbe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilvers, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span> </span><span class="NLM_article-title">Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1432</span><span class="NLM_x">–</span> <span class="NLM_lpage">1440</span><span class="refDoi"> DOI: 10.1182/blood-2005-03-0944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1182%2Fblood-2005-03-0944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=15878979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXosVejtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=1432-1440&author=A.+M.+Condliffeauthor=K.+Davidsonauthor=K.+E.+Andersonauthor=C.+D.+Ellsonauthor=T.+Crabbeauthor=K.+Okkenhaugauthor=B.+Vanhaesebroeckauthor=M.+Turnerauthor=L.+Webbauthor=M.+P.+Wymannauthor=E.+Hirschauthor=T.+Ruckleauthor=M.+Campsauthor=C.+Rommelauthor=S.+P.+Jacksonauthor=E.+R.+Chilversauthor=L.+R.+Stephensauthor=P.+T.+Hawkins&title=Sequential+activation+of+class+IB+and+class+IA+PI3K+is+important+for+the+primed+respiratory+burst+of+human+but+not+murine+neutrophils&doi=10.1182%2Fblood-2005-03-0944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils</span></div><div class="casAuthors">Condliffe, Alison M.; Davidson, Keith; Anderson, Karen E.; Ellson, Chris D.; Crabbe, Tom; Okkenhaug, Klaus; Vanhaesebroeck, Bart; Turner, Martin; Webb, Louise; Wymann, Matthias P.; Hirsch, Emilio; Ruckle, Thomas; Camps, Montserrat; Rommel, Christian; Jackson, Shaun P.; Chilvers, Edwin R.; Stephens, Len R.; Hawkins, Phillip T.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1432-1440</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">It is well established that preexposure of human neutrophils to proinflammatory cytokines markedly augments the prodn. of reactive oxygen species (ROS) to subsequent stimuli.  This priming event is thought to be crit. for localizing ROS to the vicinity of the inflammation, maximizing their role in the resoln. of the inflammation, and minimizing the damage to surrounding tissue.  We have used a new generation of isoform-selective phosphoinositide 3-kinase (PI3K) inhibitors to show that ROS prodn. under these circumstances is regulated by temporal control of class I PI3K activity.  Stimulation of tumor necrosis factor-α (TNF-α)-primed human neutrophils with N-formylmethionyl-leucyl-phenylalanine (fMLP) results in biphasic activation of PI3K; the first phase is largely dependent on PI3Kγ, and the second phase is largely dependent on PI3Kδ.  The second phase of PI3K activation requires the first phase; it is this second phase that is augmented by TNF-α priming and that regulates parallel activation of ROS prodn.  Surprisingly, although TNF-α-primed mouse bone marrow-derived neutrophils exhibit superficially similar patterns of PI3K activation and ROS prodn. in response to fMLP, these responses are substantially lower and largely dependent on PI3Kγ alone.  These results start to define which PI3K isoforms are responsible for modulating neutrophil responsiveness to infection and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1vJNjX8qhzbVg90H21EOLACvtfcHk0lhfkJaQAOrLfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXosVejtLs%253D&md5=9487e1ec99df95d037ca180b1f5b4810</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-03-0944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-03-0944%26sid%3Dliteratum%253Aachs%26aulast%3DCondliffe%26aufirst%3DA.%2BM.%26aulast%3DDavidson%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DK.%2BE.%26aulast%3DEllson%26aufirst%3DC.%2BD.%26aulast%3DCrabbe%26aufirst%3DT.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DWebb%26aufirst%3DL.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DJackson%26aufirst%3DS.%2BP.%26aulast%3DChilvers%26aufirst%3DE.%2BR.%26aulast%3DStephens%26aufirst%3DL.%2BR.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26atitle%3DSequential%2520activation%2520of%2520class%2520IB%2520and%2520class%2520IA%2520PI3K%2520is%2520important%2520for%2520the%2520primed%2520respiratory%2520burst%2520of%2520human%2520but%2520not%2520murine%2520neutrophils%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D1432%26epage%3D1440%26doi%3D10.1182%2Fblood-2005-03-0944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Rowan, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affleck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amour, A.</span><span> </span><span class="NLM_article-title">Targeting phosphoinositide 3-kinase δ for allergic asthma</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1042/BST20110665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1042%2FBST20110665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=22260698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=240-245&author=W.+C.+Rowanauthor=J.+L.+Smithauthor=K.+Affleckauthor=A.+Amour&title=Targeting+phosphoinositide+3-kinase+%CE%B4+for+allergic+asthma&doi=10.1042%2FBST20110665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phosphoinositide 3-kinase δ for allergic asthma</span></div><div class="casAuthors">Rowan, Wendy C.; Smith, Janet L.; Affleck, Karen; Amour, Augustin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">240-245</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic inflammation in the lung has long been linked to the pathogenesis of asthma.  Central to this airway inflammation is a T-cell response to allergens, with Th2 cytokines driving the differentiation, survival and function of the major inflammatory cells involved in the allergic cascade.  PI3Kδ (phosphoinositide 3-kinase δ) is a lipid kinase, expressed predominantly in leukocytes, where it plays a crit. role in immune receptor signalling.  A selective PI3Kδ inhibitor is predicted to block T-cell activation in the lung, reducing the prodn. of pro-inflammatory Th2 cytokines.  PI3Kδ is also involved in B-cell and mast cell activation.  Therefore the inhibition of PI3Kδ should dampen down the inflammatory cascade involved in the asthmatic response through a wide breadth of pharmacol.  Current anti-inflammatory therapies, which are based on corticosteroids, are effective in controlling inflammation in mild asthmatics, but moderate/severe asthmatic patients remain poorly controlled, experiencing recurrent exacerbations.  Corticosteroids have no effect on mast cell degranulation and do not act directly on B-cells, so, overall, a PI3Kδ inhibitor has the potential to deliver improvements in onset of action, efficacy and reduced exacerbations in moderate/severe asthmatics.  Addnl., PI3Kδ inhibition is expected to block effects of Th17 cells, which are increasingly implicated in steroid-insensitive asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKwu2SYlFjDbVg90H21EOLACvtfcHk0li9Ia6lxSB8zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGjs7s%253D&md5=db36bc8f79c70e0817e00fb9b04f10ff</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1042%2FBST20110665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110665%26sid%3Dliteratum%253Aachs%26aulast%3DRowan%26aufirst%3DW.%2BC.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DAffleck%26aufirst%3DK.%26aulast%3DAmour%26aufirst%3DA.%26atitle%3DTargeting%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520for%2520allergic%2520asthma%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D240%26epage%3D245%26doi%3D10.1042%2FBST20110665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Sriskantharajah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamblin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worsley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calver, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessel, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amour, A.</span><span> </span><span class="NLM_article-title">Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1280</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1111/nyas.12039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1111%2Fnyas.12039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=23551101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1280&publication_year=2013&pages=35-39&author=S.+Sriskantharajahauthor=N.+Hamblinauthor=S.+Worsleyauthor=A.+R.+Calverauthor=E.+M.+Hesselauthor=A.+Amour&title=Targeting+phosphoinositide+3-kinase+%CE%B4+for+the+treatment+of+respiratory+diseases&doi=10.1111%2Fnyas.12039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases</span></div><div class="casAuthors">Sriskantharajah, Srividya; Hamblin, Nicole; Worsley, Sally; Calver, Andrew R.; Hessel, Edith M.; Amour, Augustin</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1280</span>
        (<span class="NLM_cas:issue">Inositol Phospholipid Signaling in Physiology and Disease</span>),
    <span class="NLM_cas:pages">35-39</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Asthma and chronic obstructive pulmonary disease (COPD) are characterized in their pathogenesis by chronic inflammation in the airways.  Phosphoinositide 3-kinase δ (PI3Kδ), a lipid kinase expressed predominantly in leukocytes, is thought to hold much promise as a therapeutic target for such inflammatory conditions.  Of particular interest for the treatment of severe respiratory disease is the observation that inhibition of PI3Kδ may restore steroid effectiveness under conditions of oxidative stress.  PI3Kδ inhibition may also prevent recruitment of inflammatory cells, including T lymphocytes and neutrophils, as well as the release of proinflammatory mediators, such as cytokines, chemokines, reactive oxygen species, and proteolytic enzymes.  In addn., targeting the PI3Kδ pathway could reduce the incidence of pathogen-induced exacerbations by improving macrophage-mediated bacterial clearance.  In this review, we discuss the potential and highlight the unknowns of targeting PI3Kδ for the treatment of respiratory disease, focusing on recent developments in the role of the PI3Kδ pathway in inflammatory cell types believed to be crit. to the pathogenesis of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFa4PRY73w17Vg90H21EOLACvtfcHk0li9Ia6lxSB8zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWgtL0%253D&md5=51549242bdf01d3373ded21565656f1d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fnyas.12039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.12039%26sid%3Dliteratum%253Aachs%26aulast%3DSriskantharajah%26aufirst%3DS.%26aulast%3DHamblin%26aufirst%3DN.%26aulast%3DWorsley%26aufirst%3DS.%26aulast%3DCalver%26aufirst%3DA.%2BR.%26aulast%3DHessel%26aufirst%3DE.%2BM.%26aulast%3DAmour%26aufirst%3DA.%26atitle%3DTargeting%2520phosphoinositide%25203-kinase%2520%25CE%25B4%2520for%2520the%2520treatment%2520of%2520respiratory%2520diseases%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2013%26volume%3D1280%26spage%3D35%26epage%3D39%26doi%3D10.1111%2Fnyas.12039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ball, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span> </span><span class="NLM_article-title">PI3K inhibitors as potential therapeutics for autoimmune disease</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1195</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2Fj.drudis.2014.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=24735732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsVWkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1195-1199&author=J.+Ballauthor=S.+Archerauthor=S.+Ward&title=PI3K+inhibitors+as+potential+therapeutics+for+autoimmune+disease&doi=10.1016%2Fj.drudis.2014.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K inhibitors as potential therapeutics for autoimmune disease</span></div><div class="casAuthors">Ball, Jennifer; Archer, Sophie; Ward, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1195-1199</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Aberrant overactivation of the immune system can give rise to chronic and persistent self-attack, culminating in autoimmune disease.  This is currently managed therapeutically using potent immunosuppressive and anti-inflammatory drugs.  Class I phosphoinositide 3-kinases (PI3Ks) have been identified as ideal therapeutic targets for autoimmune diseases given their wide-ranging roles in immunol. processes.  Recent studies into the function of selective PI3K inhibitors in vitro and in vivo have yielded encouraging results, allowing progression into the clinic.  Here, we review their recent progress across a range of autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxxinvi1jaCbVg90H21EOLACvtfcHk0li9Ia6lxSB8zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsVWkuro%253D&md5=68b502511b94de36aff58f8017427de4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DBall%26aufirst%3DJ.%26aulast%3DArcher%26aufirst%3DS.%26aulast%3DWard%26aufirst%3DS.%26atitle%3DPI3K%2520inhibitors%2520as%2520potential%2520therapeutics%2520for%2520autoimmune%2520disease%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1195%26epage%3D1199%26doi%3D10.1016%2Fj.drudis.2014.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilancio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geering, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foukas, L. C.</span><span> </span><span class="NLM_article-title">Signalling by PI3K isoforms: insights from gene-targeted mice</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1016/j.tibs.2005.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2Fj.tibs.2005.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=15817396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtVyqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2005&pages=194-204&author=B.+Vanhaesebroeckauthor=K.+Aliauthor=A.+Bilancioauthor=B.+Geeringauthor=L.+C.+Foukas&title=Signalling+by+PI3K+isoforms%3A+insights+from+gene-targeted+mice&doi=10.1016%2Fj.tibs.2005.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling by PI3K isoforms: insights from gene-targeted mice</span></div><div class="casAuthors">Vanhaesebroeck, Bart; Ali, Khaled; Bilancio, Antonio; Geering, Barbara; Foukas, Lazaros C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">194-204</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Phosphoinositide 3-kinases (PI3Ks) generate lipids that control a wide variety of intracellular signaling pathways.  Part of this diversity in PI3K actions stems from the broad range of protein effectors of the PI3K lipids.  A further layer of complexity is added by the existence of multiple isoforms of PI3K.  Gene-targeting studies in the mouse have recently uncovered key roles for specific PI3K isoforms in immunity, metab. and cardiac function.  Remarkably, some of these actions do not require PI3K catalytic activity.  In addn., loss-of-expression of certain PI3K genes leads to increased PI3K signaling following insulin stimulation.  PI3K gene targeting has, in many cases, led to altered expression of the non-targeted PI3K subunits, making it difficult to exclude that some of the reported phenotypes result from knock-on' effects of PI3K gene deletion.  Targeting strategies that take into account the complex interplay between members of the PI3K family will be crucial to gain a full understanding of the physiol. roles of the isoforms of PI3K.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc_FGLImCtxLVg90H21EOLACvtfcHk0lhQx8_r6KqA7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtVyqsrw%253D&md5=d9222d98fa5cfb845290cf17cda50ff8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2005.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2005.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26aulast%3DAli%26aufirst%3DK.%26aulast%3DBilancio%26aufirst%3DA.%26aulast%3DGeering%26aufirst%3DB.%26aulast%3DFoukas%26aufirst%3DL.%2BC.%26atitle%3DSignalling%2520by%2520PI3K%2520isoforms%253A%2520insights%2520from%2520gene-targeted%2520mice%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2005%26volume%3D30%26spage%3D194%26epage%3D204%26doi%3D10.1016%2Fj.tibs.2005.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rückle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span> </span><span class="NLM_article-title">PI3Kγ inhibition: towards an ’aspirin of the 21st century’?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span><span class="refDoi"> DOI: 10.1038/nrd2145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1038%2Fnrd2145" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=903-18&author=T.+R%C3%BCckleauthor=M.+K.+Schwarzauthor=C.+Rommel&title=PI3K%CE%B3+inhibition%3A+towards+an+%E2%80%99aspirin+of+the+21st+century%E2%80%99%3F&doi=10.1038%2Fnrd2145"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd2145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2145%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DRommel%26aufirst%3DC.%26atitle%3DPI3K%25CE%25B3%2520inhibition%253A%2520towards%2520an%2520%25E2%2580%2599aspirin%2520of%2520the%252021st%2520century%25E2%2580%2599%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D903%26epage%3D18%26doi%3D10.1038%2Fnrd2145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Down, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, A. J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deakin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felton, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guntrip, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeling, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunniss, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitulli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washio, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamblin, J. N.</span><span> </span><span class="NLM_article-title">Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7381</span><span class="NLM_x">–</span> <span class="NLM_lpage">7399</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00767</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00767" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyjsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7381-7399&author=K.+Downauthor=A.+Amourauthor=I.+R.+Baldwinauthor=A.+J.+W.+Cooperauthor=A.+M.+Deakinauthor=L.+M.+Feltonauthor=S.+B.+Guntripauthor=C.+Hardyauthor=Z.+A.+Harrisonauthor=K.+L.+Jonesauthor=P.+Jonesauthor=S.+E.+Keelingauthor=J.+Leauthor=S.+Liviaauthor=F.+Lucasauthor=C.+J.+Lunnissauthor=N.+J.+Parrauthor=E.+Robinsonauthor=P.+Rowlandauthor=S.+Smithauthor=D.+A.+Thomasauthor=G.+Vitulliauthor=Y.+Washioauthor=J.+N.+Hamblin&title=Optimization+of+Novel+Indazoles+as+Highly+Potent+and+Selective+Inhibitors+of+Phosphoinositide+3-Kinase+%CE%B4+for+the+Treatment+of+Respiratory+Disease&doi=10.1021%2Facs.jmedchem.5b00767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease</span></div><div class="casAuthors">Down, Kenneth; Amour, Augustin; Baldwin, Ian R.; Cooper, Anthony W. J.; Deakin, Angela M.; Felton, Leigh M.; Guntrip, Stephen B.; Hardy, Charlotte; Harrison, Zoe A.; Jones, Katherine L.; Jones, Paul; Keeling, Suzanne E.; Le, Joelle; Livia, Stefano; Lucas, Fiona; Lunniss, Christopher J.; Parr, Nigel J.; Robinson, Ed; Rowland, Paul; Smith, Sarah; Thomas, Daniel A.; Vitulli, Giovanni; Washio, Yoshiaki; Hamblin, J. Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7381-7399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of lead compd., through extensive use of structure-based design and a focus on PI3Kδ potency, isoform selectivity, and inhaled PK properties, led to the discovery of clin. candidates I (GSK2269557) and II (GSK2292767) for the treatment of respiratory indications via inhalation.  Compds. I and II are both highly selective for PI3Kδ over the closely related isoforms and are active in a disease relevant brown Norway rat acute OVA model of Th2-driven lung inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUYzpPxn_ArbVg90H21EOLACvtfcHk0lhQx8_r6KqA7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyjsrvJ&md5=2fe8e51a64e6f7c798bdcb63781d02ad</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00767%26sid%3Dliteratum%253Aachs%26aulast%3DDown%26aufirst%3DK.%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DBaldwin%26aufirst%3DI.%2BR.%26aulast%3DCooper%26aufirst%3DA.%2BJ.%2BW.%26aulast%3DDeakin%26aufirst%3DA.%2BM.%26aulast%3DFelton%26aufirst%3DL.%2BM.%26aulast%3DGuntrip%26aufirst%3DS.%2BB.%26aulast%3DHardy%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DZ.%2BA.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKeeling%26aufirst%3DS.%2BE.%26aulast%3DLe%26aufirst%3DJ.%26aulast%3DLivia%26aufirst%3DS.%26aulast%3DLucas%26aufirst%3DF.%26aulast%3DLunniss%26aufirst%3DC.%2BJ.%26aulast%3DParr%26aufirst%3DN.%2BJ.%26aulast%3DRobinson%26aufirst%3DE.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DVitulli%26aufirst%3DG.%26aulast%3DWashio%26aufirst%3DY.%26aulast%3DHamblin%26aufirst%3DJ.%2BN.%26atitle%3DOptimization%2520of%2520Novel%2520Indazoles%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Phosphoinositide%25203-Kinase%2520%25CE%25B4%2520for%2520the%2520Treatment%2520of%2520Respiratory%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7381%26epage%3D7399%26doi%3D10.1021%2Facs.jmedchem.5b00767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Winkler, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faia, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiNitto, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brophy, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proctor, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lussier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyt, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillotson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutok, J. L.</span><span> </span><span class="NLM_article-title">PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1364</span><span class="NLM_x">–</span> <span class="NLM_lpage">1374</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2013.09.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2Fj.chembiol.2013.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=24211136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslClsrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1364-1374&author=D.+G.+Winklerauthor=K.+L.+Faiaauthor=J.+P.+DiNittoauthor=J.+A.+Aliauthor=K.+F.+Whiteauthor=E.+E.+Brophyauthor=M.+M.+Pinkauthor=J.+L.+Proctorauthor=J.+Lussierauthor=C.+M.+Martinauthor=J.+G.+Hoytauthor=B.+Tillotsonauthor=E.+L.+Murphyauthor=A.+R.+Limauthor=B.+D.+Thomasauthor=J.+R.+MacDougallauthor=P.+Renauthor=Y.+Liuauthor=L.+S.+Liauthor=K.+A.+Jessenauthor=C.+C.+Fritzauthor=J.+L.+Dunbarauthor=J.+R.+Porterauthor=C.+Rommelauthor=V.+J.+Palombellaauthor=P.+S.+Changelianauthor=J.+L.+Kutok&title=PI3K-%CE%B4+and+PI3K-%CE%B3+inhibition+by+IPI-145+abrogates+immune+responses+and+suppresses+activity+in+autoimmune+and+inflammatory+disease+models&doi=10.1016%2Fj.chembiol.2013.09.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models</span></div><div class="casAuthors">Winkler, David G.; Faia, Kerrie L.; DiNitto, Jonathan P.; Ali, Janid A.; White, Kerry F.; Brophy, Erin E.; Pink, Melissa M.; Proctor, Jennifer L.; Lussier, Jennifer; Martin, Christian M.; Hoyt, Jennifer G.; Tillotson, Bonnie; Murphy, Erin L.; Lim, Alice R.; Thomas, Brian D.; MacDougall, John R.; Ren, Pingda; Liu, Yi; Li, Lian-Sheng; Jessen, Katti A.; Fritz, Christian C.; Dunbar, Joi L.; Porter, James R.; Rommel, Christian; Palombella, Vito J.; Changelian, Paul S.; Kutok, Jeffery L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1364-1374</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Phosphoinositide-3 kinase (PI3K)-δ and PI3K-γ are preferentially expressed in immune cells, and inhibitors targeting these isoforms are hypothesized to have anti-inflammatory activity by affecting the adaptive and innate immune response.  We report on a potent oral PI3K-δ and PI3K-γ inhibitor (IPI-145) and characterize this compd. in biochem., cellular, and in vivo assays.  These studies demonstrate that IPI-145 exerts profound effects on adaptive and innate immunity by inhibiting B and T cell proliferation, blocking neutrophil migration, and inhibiting basophil activation.  We explored the therapeutic value of combined PI3K-δ and PI3K-γ blockade, and IPI-145 showed potent activity in collagen-induced arthritis, ovalbumin-induced asthma, and systemic lupus erythematosus rodent models.  These findings support the hypothesis that inhibition of immune function can be achieved through PI3K-δ and PI3K-γ blockade, potentially leading to significant therapeutic effects in multiple inflammatory, autoimmune, and hematol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHLymau7LdZrVg90H21EOLACvtfcHk0lihZI5E7qU2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslClsrvN&md5=b9fdfd9444ac255430ff6c8a0fb71ab9</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2013.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2013.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DWinkler%26aufirst%3DD.%2BG.%26aulast%3DFaia%26aufirst%3DK.%2BL.%26aulast%3DDiNitto%26aufirst%3DJ.%2BP.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DWhite%26aufirst%3DK.%2BF.%26aulast%3DBrophy%26aufirst%3DE.%2BE.%26aulast%3DPink%26aufirst%3DM.%2BM.%26aulast%3DProctor%26aufirst%3DJ.%2BL.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DC.%2BM.%26aulast%3DHoyt%26aufirst%3DJ.%2BG.%26aulast%3DTillotson%26aufirst%3DB.%26aulast%3DMurphy%26aufirst%3DE.%2BL.%26aulast%3DLim%26aufirst%3DA.%2BR.%26aulast%3DThomas%26aufirst%3DB.%2BD.%26aulast%3DMacDougall%26aufirst%3DJ.%2BR.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DJessen%26aufirst%3DK.%2BA.%26aulast%3DFritz%26aufirst%3DC.%2BC.%26aulast%3DDunbar%26aufirst%3DJ.%2BL.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26atitle%3DPI3K-%25CE%25B4%2520and%2520PI3K-%25CE%25B3%2520inhibition%2520by%2520IPI-145%2520abrogates%2520immune%2520responses%2520and%2520suppresses%2520activity%2520in%2520autoimmune%2520and%2520inflammatory%2520disease%2520models%26jtitle%3DChem.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1364%26epage%3D1374%26doi%3D10.1016%2Fj.chembiol.2013.09.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Lannutti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashishian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span> </span><span class="NLM_article-title">CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1182/blood-2010-03-275305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1182%2Fblood-2010-03-275305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16i&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=20959606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1aqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=591-594&author=B.+J.+Lannuttiauthor=S.+A.+Meadowsauthor=S.+E.+Hermanauthor=A.+Kashishianauthor=B.+Steinerauthor=A.+J.+Johnsonauthor=J.+C.+Byrdauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=M.+Deiningerauthor=B.+J.+Drukerauthor=K.+D.+Puriauthor=R.+G.+Ulrichauthor=N.+A.+Giese&title=CAL-101%2C+a+p110delta+selective+phosphatidylinositol-3-kinase+inhibitor+for+the+treatment+of+B-cell+malignancies%2C+inhibits+PI3K+signaling+and+cellular+viability&doi=10.1182%2Fblood-2010-03-275305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16iR"><div class="casContent"><span class="casTitleNuber">16i</span><div class="casTitle"><span class="NLM_cas:atitle">CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability</span></div><div class="casAuthors">Lannutti, Brian J.; Meadows, Sarah A.; Herman, Sarah E. M.; Kashishian, Adam; Steiner, Bart; Johnson, Amy J.; Byrd, John C.; Tyner, Jeffrey W.; Loriaux, Marc M.; Deininger, Mike; Druker, Brian J.; Puri, Kamal D.; Ulrich, Roger G.; Giese, Neill A.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">591-594</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase p110δ serves as a central integration point for signaling from cell surface receptors known to promote malignant B-cell proliferation and survival.  This provides a rationale for the development of small mol. inhibitors that selectively target p110δ as a treatment approach for patients with B-cell malignancies.  We thus identified 5-fluoro-3-phenyl-2-[(S)-1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one (CAL-101), a highly selective and potent p110δ small mol. inhibitor (half-maximal effective concn. [EC50] = 8nM).  Using tumor cell lines and primary patient samples representing multiple B-cell malignancies, we have demonstrated that constitutive phosphatidylinositol-3-kinase pathway activation is p110δ-dependent.  CAL-101 blocked constitutive phosphatidylinositol-3-kinase signaling, resulting in decreased phosphorylation of Akt and other downstream effectors, an increase in poly(ADP-ribose) polymerase and caspase cleavage and an induction of apoptosis.  These effects have been obsd. across a broad range of immature and mature B-cell malignancies, thereby providing a rationale for the ongoing clin. evaluation of CAL-101.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrID8zgXRVmvbVg90H21EOLACvtfcHk0lihZI5E7qU2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1aqtro%253D&md5=423bf1fbea274424db3b818fdc6733b0</span></div><a href="/servlet/linkout?suffix=cit16i&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-03-275305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-03-275305%26sid%3Dliteratum%253Aachs%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26aulast%3DMeadows%26aufirst%3DS.%2BA.%26aulast%3DHerman%26aufirst%3DS.%2BE.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDeininger%26aufirst%3DM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26atitle%3DCAL-101%252C%2520a%2520p110delta%2520selective%2520phosphatidylinositol-3-kinase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520B-cell%2520malignancies%252C%2520inhibits%2520PI3K%2520signaling%2520and%2520cellular%2520viability%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26spage%3D591%26epage%3D594%26doi%3D10.1182%2Fblood-2010-03-275305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16ii"><span><span class="NLM_label">(ii) </span><span class="NLM_contrib-group">Furman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutre, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillmen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrientos, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelenetz, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kipps, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flinn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eradat, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ervin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamanna, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coiffier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettitt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stilgenbauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahn, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansey, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, S. M.</span><span> </span><span class="NLM_article-title">Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span><span class="refDoi"> DOI: 10.1056/NEJMoa1315226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16ii&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1056%2FNEJMoa1315226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16ii&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=24450857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16ii&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkvVyqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=997-1007&author=R.+R.+Furmanauthor=J.+P.+Sharmanauthor=S.+E.+Coutreauthor=B.+D.+Chesonauthor=J.+M.+Pagelauthor=P.+Hillmenauthor=J.+C.+Barrientosauthor=A.+D.+Zelenetzauthor=T.+J.+Kippsauthor=I.+Flinnauthor=P.+Ghiaauthor=H.+Eradatauthor=T.+Ervinauthor=N.+Lamannaauthor=B.+Coiffierauthor=A.+R.+Pettittauthor=S.+Maauthor=S.+Stilgenbauerauthor=P.+Cramerauthor=M.+Aielloauthor=D.+M.+Johnsonauthor=L.+L.+Millerauthor=D.+Liauthor=T.+M.+Jahnauthor=R.+D.+Danseyauthor=M.+Hallekauthor=S.+M.+O%E2%80%99Brien&title=Idelalisib+and+Rituximab+in+Relapsed+Chronic+Lymphocytic+Leukemia&doi=10.1056%2FNEJMoa1315226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16iiR"><div class="casContent"><span class="casTitleNuber">16ii</span><div class="casTitle"><span class="NLM_cas:atitle">Idelalisib and rituximab in relapsed chronic lymphocytic leukemia</span></div><div class="casAuthors">Furman, Richard R.; Sharman, Jeff P.; Coutre, Steven E.; Cheson, Bruce D.; Pagel, John M.; Hillmen, Peter; Barrientos, Jacqueline C.; Zelenetz, Andrew D.; Kipps, Thomas J.; Flinn, Ian; Ghia, Paolo; Eradat, Herbert; Ervin, Thomas; Lamanna, Nicole; Coiffier, Bertrand; Pettitt, Andrew R.; Ma, Shuo; Stilgenbauer, Stephan; Cramer, Paula; Aiello, Maria; Johnson, Dave M.; Miller, Langdon L.; Li, Daniel; Jahn, Thomas M.; Dansey, Roger D.; Hallek, Michael; O'Brien, Susan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">997-1007</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Patients with relapsed chronic lymphocytic leukemia (CLL) who have clin. significant coexisting medical conditions are less able to undergo std. chemotherapy.  Effective therapies with acceptable side-effect profiles are needed for this patient population.  In this multicenter, randomized, double-blind, placebo-controlled, phase 3 study, the authors assessed the efficacy and safety of idelalisib, an oral inhibitor of the delta isoform of phosphatidylinositol 3-kinase, in combination with rituximab vs. rituximab plus placebo.  The authors randomly assigned 220 patients with decreased renal function, previous therapy-induced myelosuppression, or major coexisting illnesses to receive rituximab and either idelalisib (at a dose of 150 mg) or placebo twice daily.  The primary end point was progression-free survival.  At the first prespecified interim anal., the study was stopped early on the recommendation of the data and safety monitoring board owing to overwhelming efficacy.  The median progression-free survival was 5.5 mo in the placebo group and was not reached in the idelalisib group (hazard ratio for progression or death in the idelalisib group, 0.15; P<0.001).  Patients receiving idelalisib vs. those receiving placebo had improved rates of overall response (81% vs. 13%; odds ratio, 29.92; P<0.001) and overall survival at 12 mo (92% vs. 80%; hazard ratio for death, 0.28; P = 0.02).  Serious adverse events occurred in 40% of the patients receiving idelalisib and rituximab and in 35% of those receiving placebo and rituximab.  The combination of idelalisib and rituximab, as compared with placebo and rituximab, significantly improved progression-free survival, response rate, and overall survival among patients with relapsed CLL who were less able to undergo chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhnTsUaIOybVg90H21EOLACvtfcHk0lihZI5E7qU2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkvVyqtLs%253D&md5=4bce9ab0dae94360abfcd4f312691503</span></div><a href="/servlet/linkout?suffix=cit16ii&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1315226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1315226%26sid%3Dliteratum%253Aachs%26aulast%3DFurman%26aufirst%3DR.%2BR.%26aulast%3DSharman%26aufirst%3DJ.%2BP.%26aulast%3DCoutre%26aufirst%3DS.%2BE.%26aulast%3DCheson%26aufirst%3DB.%2BD.%26aulast%3DPagel%26aufirst%3DJ.%2BM.%26aulast%3DHillmen%26aufirst%3DP.%26aulast%3DBarrientos%26aufirst%3DJ.%2BC.%26aulast%3DZelenetz%26aufirst%3DA.%2BD.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DFlinn%26aufirst%3DI.%26aulast%3DGhia%26aufirst%3DP.%26aulast%3DEradat%26aufirst%3DH.%26aulast%3DErvin%26aufirst%3DT.%26aulast%3DLamanna%26aufirst%3DN.%26aulast%3DCoiffier%26aufirst%3DB.%26aulast%3DPettitt%26aufirst%3DA.%2BR.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DStilgenbauer%26aufirst%3DS.%26aulast%3DCramer%26aufirst%3DP.%26aulast%3DAiello%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DD.%2BM.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DJahn%26aufirst%3DT.%2BM.%26aulast%3DDansey%26aufirst%3DR.%2BD.%26aulast%3DHallek%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DS.%2BM.%26atitle%3DIdelalisib%2520and%2520Rituximab%2520in%2520Relapsed%2520Chronic%2520Lymphocytic%2520Leukemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D997%26epage%3D1007%26doi%3D10.1056%2FNEJMoa1315226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Shin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchomel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vissinga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wannberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whoriskey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushing, T. D.</span><span> </span><span class="NLM_article-title">Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">447</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01651</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01651" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFylurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=431-447&author=Y.+Shinauthor=J.+Suchomelauthor=M.+Cardozoauthor=J.+Duquetteauthor=X.+Heauthor=K.+Henneauthor=Y.+L.+Huauthor=R.+C.+Kellyauthor=J.+McCarterauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=D.+Metzauthor=T.+San+Miguelauthor=M.+Mohnauthor=T.+Tranauthor=C.+Vissingaauthor=S.+Wongauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=J.+Whoriskeyauthor=G.+Yuauthor=L.+Zalamedaauthor=X.+Zhangauthor=T.+D.+Cushing&title=Discovery%2C+Optimization%2C+and+in+Vivo+Evaluation+of+Benzimidazole+Derivatives+AM-8508+and+AM-9635+as+Potent+and+Selective+PI3K%CE%B4+Inhibitors&doi=10.1021%2Facs.jmedchem.5b01651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors</span></div><div class="casAuthors">Shin, Youngsook; Suchomel, Julia; Cardozo, Mario; Duquette, Jason; He, Xiao; Henne, Kirk; Hu, Yi-Ling; Kelly, Ron C.; McCarter, John; McGee, Lawrence R.; Medina, Julio C.; Metz, Daniela; San Miguel, Tisha; Mohn, Deanna; Tran, Thuy; Vissinga, Christine; Wong, Simon; Wannberg, Sharon; Whittington, Douglas A.; Whoriskey, John; Yu, Gang; Zalameda, Leeanne; Zhang, Xuxia; Cushing, Timothy D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">431-447</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lead optimization efforts resulted in the discovery of two potent, selective, and orally bioavailable PI3Kδ inhibitors, 1 (AM-8508) and 2 (AM-9635), with good pharmacokinetic properties.  The compds. inhibit B cell receptor (BCR)-mediated AKT phosphorylation (pAKT) in PI3Kδ-dependent in vitro cell based assays.  These compds. which share a benzimidazole bicycle are effective when administered in vivo at unbound concns. consistent with their in vitro cell potency as a consequence of improved unbound drug concn. with lower unbound clearance.  Furthermore, the compds. demonstrated efficacy in a Keyhole Limpet Hemocyanin (KLH) study in rats, where the blockade of PI3Kδ activity by inhibitors 1 and 2 led to effective inhibition of antigen-specific IgG and IgM formation after immunization with KLH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr81OyYoamY1rVg90H21EOLACvtfcHk0lg2oveEw8dBGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFylurnP&md5=258ce4cf8c13cf799f342ebab3137264</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01651%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DY.%26aulast%3DSuchomel%26aufirst%3DJ.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHenne%26aufirst%3DK.%26aulast%3DHu%26aufirst%3DY.%2BL.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohn%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DVissinga%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWhoriskey%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCushing%26aufirst%3DT.%2BD.%26atitle%3DDiscovery%252C%2520Optimization%252C%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520Benzimidazole%2520Derivatives%2520AM-8508%2520and%2520AM-9635%2520as%2520Potent%2520and%2520Selective%2520PI3K%25CE%25B4%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D431%26epage%3D447%26doi%3D10.1021%2Facs.jmedchem.5b01651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=21129497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.; Young, Robert J.; Pickett, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of carboarom., heteroarom., carboaliph. and heteroaliph. ring counts and fused arom. ring count on several developability measures (soly., lipophilicity, protein binding, P 450 inhibition and hERG binding) is the topic for this review article.  Recent results indicate that increasing ring counts have detrimental effects on developability in the order carboaroms. » heteroaroms. > carboaliphatics > heteroaliphatics, with heteroaliphatics exerting a beneficial effect in many cases.  Increasing arom. ring count exerts effects on several developability parameters that are lipophilicity- and size-independent, and fused arom. systems have a beneficial effect relative to their nonfused counterparts.  Increasing arom. ring count has a detrimental effect on human bioavailability parameters, and heteroarom. ring count (but not other ring counts) has increased over time in marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYPC7hkoyv7Vg90H21EOLACvtfcHk0lg2oveEw8dBGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D&md5=8e2d0e4e499d2f07d66ca2f385defb2d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Zientek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayscue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klug-McLeod, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekins, S.</span><span> </span><span class="NLM_article-title">Integrated in silico-in vitro strategy for addressing cytochrome P450 3A4 time-dependent inhibition<i>Chem</i></span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1021/tx900417f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx900417f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=664-676&author=M.+Zientekauthor=C.+Stonerauthor=R.+Ayscueauthor=J.+Klug-McLeodauthor=Y.+Jiangauthor=M.+Westauthor=C.+Collinsauthor=S.+Ekins&title=Integrated+in+silico-in+vitro+strategy+for+addressing+cytochrome+P450+3A4+time-dependent+inhibitionChem&doi=10.1021%2Ftx900417f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Ftx900417f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx900417f%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DStoner%26aufirst%3DC.%26aulast%3DAyscue%26aufirst%3DR.%26aulast%3DKlug-McLeod%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DWest%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DEkins%26aufirst%3DS.%26atitle%3DIntegrated%2520in%2520silico-in%2520vitro%2520strategy%2520for%2520addressing%2520cytochrome%2520P450%25203A4%2520time-dependent%2520inhibitionChem%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2010%26volume%3D23%26spage%3D664%26epage%3D676%26doi%3D10.1021%2Ftx900417f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span><span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0ljJku67sRTqPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0ljJku67sRTqPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, L.</span><span> </span><span class="NLM_article-title">PLS-regression: a basic tool of chemometrics</span> <span class="citation_source-journal">Chemom. Intell. Lab. Syst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1016/S0169-7439(01)00155-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2FS0169-7439%2801%2900155-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2001&pages=109-130&author=S.+Woldauthor=M.+Sj%C3%B6str%C3%B6mauthor=L.+Eriksson&title=PLS-regression%3A+a+basic+tool+of+chemometrics&doi=10.1016%2FS0169-7439%2801%2900155-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">PLS-regression: a basic tool of chemometrics</span></div><div class="casAuthors">Wold, Svante; Sjostrom, Michael; Eriksson, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Chemometrics and Intelligent Laboratory Systems</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-130</span>CODEN:
                <span class="NLM_cas:coden">CILSEN</span>;
        ISSN:<span class="NLM_cas:issn">0169-7439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review on PLS-regression (PLSR) as a std. tool in chemometrics and used in chem. and engineering.  The underlying model and its assumption and commonly used diagnostics are discussed, together with the interpretation of resulting parameters.  Two examples are used as illustrations: first, a Quant. Structure-Activity Relationship (QSAR)/Quant. Structure Property Relationship (QSPR) data set of peptides is used to outline the development, interpretation, and refinement of a PLSR model.  Second, a data set from the manufg. of recycled paper is analyzed to illustrate time series modeling of process data by means of PLSR and time-lagged X-variables.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIKGNtaZZXqbVg90H21EOLACvtfcHk0ljJku67sRTqPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotF2mtLw%253D&md5=2d7fd1e946600e138ac92699ebcc7e29</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0169-7439%2801%2900155-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-7439%252801%252900155-1%26sid%3Dliteratum%253Aachs%26aulast%3DWold%26aufirst%3DS.%26aulast%3DSj%25C3%25B6str%25C3%25B6m%26aufirst%3DM.%26aulast%3DEriksson%26aufirst%3DL.%26atitle%3DPLS-regression%253A%2520a%2520basic%2520tool%2520of%2520chemometrics%26jtitle%3DChemom.%2520Intell.%2520Lab.%2520Syst.%26date%3D2001%26volume%3D58%26spage%3D109%26epage%3D130%26doi%3D10.1016%2FS0169-7439%2801%2900155-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Abad-Zapatero, C.</span><span> </span><span class="NLM_article-title">Ligand efficiency indices for effective drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1517/17460441.2.4.469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1517%2F17460441.2.4.469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=23484756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=469-488&author=C.+Abad-Zapatero&title=Ligand+efficiency+indices+for+effective+drug+discovery&doi=10.1517%2F17460441.2.4.469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices for effective drug discovery</span></div><div class="casAuthors">Abad-Zapatero, Cele</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-488</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Successful drug discovery requires the optimization of a large no. of variables ranging from strictly physicochem. parameters such as mol. wt. to more complex parameters related to toxicity and bioavailability.  Presently, structure-based methodologies influence many aspects of the drug discovery process from lead discovery to the final preclin. characterization.  However, crit. biol. issues along the path to the market have diminished the impact and power of this methodol.  The physicochem. properties of the novel chem. entities designed and guided by structural methods have become the subject of intense scrutiny from lead discovery to drug candidate.  The idea of ligand efficiency (binding energy/non-hydrogen atoms) has recently emerged as a useful guide to optimize fragment and lead selection in the discovery process.  More generalized concepts of ligand efficiency, related to efficiency per dalton and per unit of polar surface area, have also been introduced and will be discussed in the broader context.  Preliminary results and trends obtained using ligand efficiencies as guides are reviewed and their future application to guide drug discovery will be discussed, as well as their integration into the structure-based drug design methods to make them more effective and numerically robust.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmKduo41JcS7Vg90H21EOLACvtfcHk0lgkisQxUH20dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVCqsL4%253D&md5=a1682fbc4545d8eab3a44417c0e88869</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.4.469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.4.469%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26atitle%3DLigand%2520efficiency%2520indices%2520for%2520effective%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D469%26epage%3D488%26doi%3D10.1517%2F17460441.2.4.469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Tanaka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiyo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tominaga, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusunose, N.</span><span> </span><span class="NLM_article-title">A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">851</span><span class="NLM_x">–</span> <span class="NLM_lpage">857</span><span class="refDoi"> DOI: 10.1021/jm101273e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101273e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=851-857&author=D.+Tanakaauthor=Y.+Tsudaauthor=R.+Shiyamaauthor=T.+Nishimuraauthor=N.+Chiyoauthor=Y.+Tominagaauthor=N.+Sawadaauthor=T.+Mimotoauthor=N.+Kusunose&title=A+practical+use+of+ligand+efficiency+indices+out+of+the+fragment-based+approach%3A+ligand+efficiency-guided+lead+identification+of+soluble+epoxide+hydrolase+inhibitors&doi=10.1021%2Fjm101273e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm101273e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101273e%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DD.%26aulast%3DTsuda%26aufirst%3DY.%26aulast%3DShiyama%26aufirst%3DR.%26aulast%3DNishimura%26aufirst%3DT.%26aulast%3DChiyo%26aufirst%3DN.%26aulast%3DTominaga%26aufirst%3DY.%26aulast%3DSawada%26aufirst%3DN.%26aulast%3DMimoto%26aufirst%3DT.%26aulast%3DKusunose%26aufirst%3DN.%26atitle%3DA%2520practical%2520use%2520of%2520ligand%2520efficiency%2520indices%2520out%2520of%2520the%2520fragment-based%2520approach%253A%2520ligand%2520efficiency-guided%2520lead%2520identification%2520of%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D851%26epage%3D857%26doi%3D10.1021%2Fjm101273e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, K.</span><span> </span><span class="NLM_article-title">Ruthenium(II)-Catalyzed Selective Intramolecular [2 + 2 + 2] Alkyne Cyclotrimerizations</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">12143</span><span class="NLM_x">–</span> <span class="NLM_lpage">12160</span><span class="refDoi"> DOI: 10.1021/ja0358697</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0358697" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1KlsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=12143-12160&author=Y.+Yamamotoauthor=T.+Arakawaauthor=R.+Ogawaauthor=K.+Itoh&title=Ruthenium%28II%29-Catalyzed+Selective+Intramolecular+%5B2+%2B+2+%2B+2%5D+Alkyne+Cyclotrimerizations&doi=10.1021%2Fja0358697"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ruthenium(II)-Catalyzed Selective Intramolecular [2 + 2 + 2] Alkyne Cyclotrimerizations</span></div><div class="casAuthors">Yamamoto, Yoshihiko; Arakawa, Takayasu; Ogawa, Ryuji; Itoh, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">12143-12160</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the presence of a catalytic amt. of Cp*RuCl(cod), 1,6-diynes chemoselectively reacted with monoalkynes at ambient temp. to afford the desired bicyclic benzene derivs. in good yields.  A wide variety of diynes and monoynes contg. functional groups such as ester, ketone, nitrile, amine, alc., sulfide, etc. can be used for the present ruthenium catalysis.  The most significant advantage of this protocol is that the cycloaddn. of unsym. 1,6-diynes with one internal alkyne moiety regioselectively gave rise to meta-substituted products with excellent regioselectivity.  Completely intramol. alkyne cyclotrimerization was also accomplished using triyne substrates to obtain tricyclic arom. compds. fused with 5-7-membered rings.  A ruthenabicycle complex relevant to these cyclotrimerizations was synthesized from Cp*RuCl(cod) and O(CH2C≡CPh)2, and its structure was unambiguously detd. by X-ray anal.  The intermediacy of such a ruthenacycle was further confirmed by its reaction with acetylene, giving rise to the expected cycloadduct.  The d. functional study on the cyclotrimerization mechanism elucidated that the cyclotrimerization proceeds via oxidative cyclization, producing a ruthenacycle intermediate and subsequent alkyne insertion initiated by the formal [2 + 2] cycloaddn. of the resultant ruthenacycle with an alkyne.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLZ9c8K_KBi7Vg90H21EOLACvtfcHk0lgkisQxUH20dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1KlsLk%253D&md5=7048fb116105ae68e359b6d1e6218562</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja0358697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0358697%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DArakawa%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DR.%26aulast%3DItoh%26aufirst%3DK.%26atitle%3DRuthenium%2528II%2529-Catalyzed%2520Selective%2520Intramolecular%2520%255B2%2520%252B%25202%2520%252B%25202%255D%2520Alkyne%2520Cyclotrimerizations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D12143%26epage%3D12160%26doi%3D10.1021%2Fja0358697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Trost, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomerantz, A. E.</span><span> </span><span class="NLM_article-title">Regioselectivity control in a ruthenium-catalyzed cycloisomerization of diyne-ols</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4235</span><span class="NLM_x">–</span> <span class="NLM_lpage">4238</span><span class="refDoi"> DOI: 10.1021/ol048351w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol048351w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4235-4238&author=B.+Trostauthor=M.+T.+Ruddauthor=M.+G.+Costaauthor=P.+I.+Leeauthor=A.+E.+Pomerantz&title=Regioselectivity+control+in+a+ruthenium-catalyzed+cycloisomerization+of+diyne-ols&doi=10.1021%2Fol048351w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fol048351w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol048351w%26sid%3Dliteratum%253Aachs%26aulast%3DTrost%26aufirst%3DB.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DCosta%26aufirst%3DM.%2BG.%26aulast%3DLee%26aufirst%3DP.%2BI.%26aulast%3DPomerantz%26aufirst%3DA.%2BE.%26atitle%3DRegioselectivity%2520control%2520in%2520a%2520ruthenium-catalyzed%2520cycloisomerization%2520of%2520diyne-ols%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4235%26epage%3D4238%26doi%3D10.1021%2Fol048351w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Tame, C.</span> Ph.D. thesis.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tame%2C+C.+Ph.D.+thesis."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTame%26aufirst%3DC." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Erdik, E.</span><span> </span><span class="NLM_article-title">Use of activation methods for organozinc reagents</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2212</span><span class="refDoi"> DOI: 10.1016/S0040-4020(01)86803-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2FS0040-4020%2801%2986803-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADyaL2sXkslKquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=2203-2212&author=E.+Erdik&title=Use+of+activation+methods+for+organozinc+reagents&doi=10.1016%2FS0040-4020%2801%2986803-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Use of activation methods for organozinc reagents</span></div><div class="casAuthors">Erdik, Ender</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2203-12</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">A review with 56 refs. on the activation of organozinc reagents by chem. or ultrasonic methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJy7oAxVwo5LVg90H21EOLACvtfcHk0ljJaS7F7AVe_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXkslKquro%253D&md5=3e0483a714e838d0178075c6f4eadfdb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2986803-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252986803-4%26sid%3Dliteratum%253Aachs%26aulast%3DErdik%26aufirst%3DE.%26atitle%3DUse%2520of%2520activation%2520methods%2520for%2520organozinc%2520reagents%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D2203%26epage%3D2212%26doi%3D10.1016%2FS0040-4020%2801%2986803-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Deng, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paone, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginnetti, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurihara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreher, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgey, C. S.</span><span> </span><span class="NLM_article-title">Copper-facilitated Suzuki reactions: application to 2-heterocyclic boronate</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span><span class="refDoi"> DOI: 10.1021/ol802556f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol802556f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=345-347&author=J.+Z.+Dengauthor=D.+V.+Paoneauthor=A.+T.+Ginnettiauthor=H.+Kuriharaauthor=S.+D.+Dreherauthor=S.+A.+Weissmanauthor=S.+R.+Staufferauthor=C.+S.+Burgey&title=Copper-facilitated+Suzuki+reactions%3A+application+to+2-heterocyclic+boronate&doi=10.1021%2Fol802556f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fol802556f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol802556f%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DJ.%2BZ.%26aulast%3DPaone%26aufirst%3DD.%2BV.%26aulast%3DGinnetti%26aufirst%3DA.%2BT.%26aulast%3DKurihara%26aufirst%3DH.%26aulast%3DDreher%26aufirst%3DS.%2BD.%26aulast%3DWeissman%26aufirst%3DS.%2BA.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26atitle%3DCopper-facilitated%2520Suzuki%2520reactions%253A%2520application%2520to%25202-heterocyclic%2520boronate%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D345%26epage%3D347%26doi%3D10.1021%2Fol802556f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">All animal studies were ethically reviewed and carried out in accordance with Animals (Scientific Procedures) Act 1986 and the GSK Policy on the Care, Welfare and Treatment of Animals.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">Compound <b>3</b>: pIC<sub>50</sub> < 5.0 against a panel of kinases comprised of ASK1, Aurora A, Aurora B, BTK, CHKB, Choline Kinase α, DAG Kinase, DAG Kinase Zeta, EGFR (HER1), FRAP1, GSK3B, IKK1, IKK2, ITK, JAK2, JAK3, LCK, LRRK2, PI4K2A, PIK3C2B, PIK4A, PIL4B, PIP4K2A, ROCK1, SPHK1, SPHK2, and SYK; also pIC<sub>50</sub> < 5.0 against p38a and PDE4B. DNA-PK apparent pIC<sub>50</sub> = 5.6, and equivocal data were reported in assays related to VPS34 inhibition.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Valko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunhuck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, D. P.</span><span> </span><span class="NLM_article-title">Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">2236</span><span class="NLM_x">–</span> <span class="NLM_lpage">2248</span><span class="refDoi"> DOI: 10.1002/jps.10494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1002%2Fjps.10494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=14603509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFCrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=2236-2248&author=K.+Valkoauthor=S.+Nunhuckauthor=C.+Bevanauthor=M.+H.+Abrahamauthor=D.+P.+Reynolds&title=Fast+gradient+HPLC+method+to+determine+compounds+binding+to+human+serum+albumin.+Relationships+with+octanol%2Fwater+and+immobilized+artificial+membrane+lipophilicity&doi=10.1002%2Fjps.10494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity</span></div><div class="casAuthors">Valko, Klara; Nunhuck, Shenaz; Bevan, Chris; Abraham, Michael H.; Reynolds, Derek P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2236-2248</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A fast gradient HPLC method (cycle time 15 min) has been developed to det. Human Serum Albumin (HSA) binding of discovery compds. using chem. bonded protein stationary phases.  The HSA binding values were derived from the gradient retention times that were converted to the logarithm of the equil. consts. (logK HSA) using data from a calibration set of mols.  The method has been validated using literature plasma protein binding data of 68 known drug mols.  The method is fully automated, and has been used for lead optimization in more than 20 company projects.  The HSA binding data obtained for more than 4000 compds. were suitable to set up global and project specific quant. structure binding relationships that helped compd. design in early drug discovery.  The obtained HSA binding of known drug mols. were compared to the Immobilizd Artificial Membrane binding data (CHI IAM) obtained by our previously described HPLC-based method.  The solvation equation approach has been used to characterize the normal binding ability of HSA, and this relationship shows that compd. lipophilicity is a significant factor.  It was found that the selectivity of the "baseline" lipophilicity governing HSA binding, membrane interaction, and octanol/water partition are very similar.  However, the effect of the presence of pos. or neg. charges have very different effects.  It was found that neg. charged compds. bind more strongly to HSA than it would be expected from the lipophilicity of the ionized species at pH 7.4.  Several compds. showed stronger HSA binding than can be expected from their lipophilicity alone, and comparison between predicted and exptl. binding affinity allows the identification of compds. that have good complementarities with any of the known binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr1LUBLdv-t7Vg90H21EOLACvtfcHk0ljJaS7F7AVe_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFCrs7Y%253D&md5=14eb1e0f0ad616846a2b5d1428133fa9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fjps.10494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10494%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DNunhuck%26aufirst%3DS.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DReynolds%26aufirst%3DD.%2BP.%26atitle%3DFast%2520gradient%2520HPLC%2520method%2520to%2520determine%2520compounds%2520binding%2520to%2520human%2520serum%2520albumin.%2520Relationships%2520with%2520octanol%252Fwater%2520and%2520immobilized%2520artificial%2520membrane%2520lipophilicity%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D2236%26epage%3D2248%26doi%3D10.1002%2Fjps.10494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Bhattachar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seadeek, C.</span><span> </span><span class="NLM_article-title">Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discovery</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span><span class="refDoi"> DOI: 10.1016/j.jpba.2005.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=10.1016%2Fj.jpba.2005.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=16364585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1ent7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=152-157&author=S.+N.+Bhattacharauthor=J.+A.+Wesleyauthor=C.+Seadeek&title=Evaluation+of+the+chemiluminescent+nitrogen+detector+for+solubility+determinations+to+support+drug+discovery&doi=10.1016%2Fj.jpba.2005.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discovery</span></div><div class="casAuthors">Bhattachar, Shobha N.; Wesley, James A.; Seadeek, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">152-157</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Soly. measurements using chemiluminescent nitrogen detection (CLND) has advantages of reduced compd. requirement and increased throughput compared to UV-spectrophotometric and HPLC-based measurements.  CLND with direct flow injection was evaluated for the measurement of thermodn. soly. to support drug discovery.  The limit of quantitation (LOQ), accuracy, and day-to-day reproducibility of the detector were measured.  Measurements made on CLND were compared to those obtained from UV spectrophotometry and HPLC.  Based on the results obtained, it was concluded that the CLND performs satisfactorily for discovery stage thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI5WHL9BI2NLVg90H21EOLACvtfcHk0ljJaS7F7AVe_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1ent7s%253D&md5=c11f76d20d59b740e9d2b1d7942f2f24</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2005.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2005.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DWesley%26aufirst%3DJ.%2BA.%26aulast%3DSeadeek%26aufirst%3DC.%26atitle%3DEvaluation%2520of%2520the%2520chemiluminescent%2520nitrogen%2520detector%2520for%2520solubility%2520determinations%2520to%2520support%2520drug%2520discovery%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2006%26volume%3D41%26spage%3D152%26epage%3D157%26doi%3D10.1016%2Fj.jpba.2005.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L72" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L72','PDB','5L72'); return false;">PDB: 5L72</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d42e2299-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i37"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00799">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_11823"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00799">10.1021/acs.jmedchem.6b00799</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00799/suppl_file/jm6b00799_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00799/suppl_file/jm6b00799_si_001.csv">jm6b00799_si_001.csv (1.28 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Compound <b>3</b> PDB accssion code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L72">5L72</a>. The authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00799&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00799%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-15%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00799" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ab90a6fcbd1bf","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
